| Product# | Name | Target | Pathway | Phenotype | Therapeutic Area |
| 1 | 4-1BB | Protein | Others | T Cell Activation | Immuno-Oncology |
| 2 | ADAM10 | Protein | Amyloid Processing | AD Pathology | CNS |
| 3 | Alpha-synuclein | Protein | Others | PD Pathology | CNS |
| 4 | Amyloid Precursor Protein | Protein | Others | AD Pathology | CNS |
| 5 | Amyloid-Beta 1-40 | Protein | Others | AD Pathology | CNS |
| 6 | Amyloid-Beta 1-42 | Protein | Others | AD Pathology | CNS |
| 7 | ApoA-I | Protein | Others | PD Pathology | CNS |
| 8 | APOE | Protein | Biosynthesis and Anabolic Pathways | AD Pathology | CNS |
| 9 | ARG1 | Protein | Biosynthesis and Anabolic Pathways | Immune Suppression | CNS |
| 10 | ARG1 | Protein | Biosynthesis and Anabolic Pathways | Immune Suppression | Immuno-Oncology |
| 11 | ATG12 | Protein | Autophagy | Others | Cardiovascular |
| 12 | ATG5 | Protein | Autophagy | Others | Cardiovascular |
| 13 | B7-H3 | Protein | Others | Immune Checkpoint | Immuno-Oncology |
| 14 | BACE1 | Protein | Amyloid Processing | AD Pathology | CNS |
| 15 | BAD | Protein | Apoptosis | Cellular Growth Factor | Oncology |
| 16 | BAG3 | Protein | Autophagy | Others | Cardiovascular |
| 17 | Bcl-2 | Protein | Apoptosis | Pan-Tumor | Oncology |
| 18 | BCL6 | Protein | Apoptosis | Others | Oncology |
| 19 | BCLXL | Protein | Apoptosis | Others | Oncology |
| 20 | Beta-2-microglobulin | Protein | Others | Antigen Presentation | Immuno-Oncology |
| 21 | BIM | Protein | Apoptosis | Others | Oncology |
| 22 | BRAF | Protein | FGFR Signaling | Immunity and Inflammation | Cardiovascular |
| 23 | BRAF | Protein | FGFR Signaling | Immunity and Inflammation | Inflammation |
| 24 | C4B | Protein | Others | Astrocyte | CNS |
| 25 | Calbindin | Protein | Others | PD Pathology | CNS |
| 26 | Caspase-3 cleaved | Protein | Others | Others | Others |
| 27 | CCR6 | Protein | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 28 | CD10 | Protein | Others | Others | Others |
| 29 | CD106 | Protein | Others | Others | Others |
| 30 | CD11b | Protein | Others | Microglia | CNS |
| 31 | CD11c | Protein | Others | Glial Cell Subtyping | CNS |
| 32 | CD127 | Protein | Others | Immune Activation Status | Immuno-Oncology |
| 33 | CD138 | Protein | Others | Others | Others |
| 34 | CD14 | Protein | Apoptosis | Antigen Presentation | Immuno-Oncology |
| 35 | CD14 | Protein | Apoptosis | Antigen Presentation | Oncology |
| 36 | CD16 | Protein | Others | Others | Others |
| 37 | CD163 | Protein | EMT | Immune Cell Typing | Immuno-Oncology |
| 38 | CD163 | Protein | EMT | Immune Cell Typing | Oncology |
| 39 | CD20 | Protein | Others | B Cell Function | Immuno-Oncology |
| 40 | CD204 | Protein | Others | Others | Others |
| 41 | CD21 | Protein | Others | Others | Others |
| 42 | CD24 | Protein | Cell Proliferation | Adhesion and Migration | CNS |
| 43 | CD25 | Protein | Others | Immune Activation Status | Immuno-Oncology |
| 44 | CD27 | Protein | Costimulatory Signaling | B Cell Exhaustion | Immuno-Oncology |
| 45 | CD3 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 46 | CD31 | Protein | Others | Neural Cell Typing | CNS |
| 47 | CD34 | Protein | Cell Proliferation | Adhesion and Migration | CNS |
| 48 | CD38 | Protein | Others | B Cell Function | Immuno-Oncology |
| 49 | CD39 | Protein | Others | Inflammation | Inflammation |
| 50 | CD4 | Protein | Costimulatory Signaling | Antigen Presentation | Immuno-Oncology |
| 51 | CD40 | Protein | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 52 | CD44 | Protein | Angiogenesis | Adhesion and Migration | CNS |
| 53 | CD44 | Protein | Angiogenesis | Adhesion and Migration | Cardiovascular |
| 54 | CD45 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 55 | CD45RB | Protein | TCR Signaling | Others | Immuno-Oncology |
| 56 | CD45RO | Protein | Others | Immune Activation Status | Immuno-Oncology |
| 57 | CD56 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 58 | CD66b | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 59 | CD68 | Protein | DNA Damage Repair | Immune Cell Typing | Epigenic and Nuclear Signaling |
| 60 | CD68 | Protein | DNA Damage Repair | Immune Cell Typing | Immuno-Oncology |
| 61 | CD8 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 62 | CD80 | Protein | Costimulatory Signaling | B Cell Function | Immuno-Oncology |
| 63 | CD9 | Protein | Myelination | Glial Cell Subtyping | CNS |
| 64 | CD95/Fas | Protein | Apoptosis | Others | Oncology |
| 65 | CLEC7A | Protein | Others | Glial Cell Subtyping | CNS |
| 66 | Collagen Type I | Protein | Others | Others | Others |
| 67 | CSF1R | Protein | Cytokine and Chemokine Signaling | Glial Cell Subtyping | Immuno-Oncology |
| 68 | CSF1R | Protein | Cytokine and Chemokine Signaling | Glial Cell Subtyping | CNS |
| 69 | CTLA4 | Protein | Costimulatory Signaling | B Cell Function | Immuno-Oncology |
| 70 | CTSD | Protein | Nutrient Capture and Catabolic Pathways | Glial Cell Subtyping | Metabolic Diseases |
| 71 | CTSD | Protein | Nutrient Capture and Catabolic Pathways | Glial Cell Subtyping | CNS |
| 72 | CXCR3 | Protein | Angiogenesis | B Cell Exhaustion | Cardiovascular |
| 73 | EMP1 | Protein | Others | Astrocyte | CNS |
| 74 | CXCR3 | Protein | Angiogenesis | B Cell Exhaustion | Immuno-Oncology |
| 75 | EpCAM | Protein | Cell Proliferation | Pan-Tumor | CNS |
| 76 | EpCAM | Protein | Cell Proliferation | Pan-Tumor | Oncology |
| 77 | ER-alpha | Protein | ER Signaling | Pan-Tumor | Oncology |
| 78 | Fibronectin | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 79 | Flt3 ligand | Protein | Others | Others | Others |
| 80 | Flt3/Flk-2/CD135 | Protein | Others | Others | Others |
| 81 | FOXP3 | Protein | Epigenic and Transcriptional Regulation | Cytokines | Epigenic and Nuclear Signaling |
| 82 | FOXP3 | Protein | Epigenic and Transcriptional Regulation | Cytokines | Immuno-Oncology |
| 83 | FUS | Protein | Others | Axon and Dendrite Structure | CNS |
| 84 | GAPDH | Protein | Biosynthesis and Anabolic Pathways | Immune Cell Typing | CNS |
| 85 | GAPDH | Protein | Biosynthesis and Anabolic Pathways | Immune Cell Typing | Immuno-Oncology |
| 86 | GATA3 | Protein | DNA Damage Repair | Immune Activation Status | Epigenic and Nuclear Signaling |
| 87 | GATA3 | Protein | DNA Damage Repair | Immune Activation Status | Immuno-Oncology |
| 88 | GBA | Protein | Autophagy | Immunity and Inflammation | Cardiovascular |
| 89 | GBA | Protein | Autophagy | Immunity and Inflammation | Inflammation |
| 90 | GFAP | Protein | Others | Astrocyte | CNS |
| 91 | GITR | Protein | Others | T Cell Activation | Immuno-Oncology |
| 92 | GPNMB | Protein | Others | Glial Cell Subtyping | CNS |
| 93 | GzB | Protein | Others | Others | Others |
| 94 | GZMA | Protein | Apoptosis | Immune Activation Status | Oncology |
| 95 | GZMA | Protein | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 96 | GZMB | Protein | Apoptosis | Immune Activation Status | Oncology |
| 97 | GZMB | Protein | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 98 | HER2 | Protein | Others | Pan-Tumor | Oncology |
| 99 | Histone H3 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 100 | HLA-DR | Protein | Others | Antigen Presentation | Immuno-Oncology |
| 101 | HSC70 | Protein | Autophagy | Others | Cardiovascular |
| 102 | IBA1 | Protein | Others | Microglia | CNS |
| 103 | ICOS | Protein | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 104 | IDE | Protein | Amyloid Processing | AD Pathology | CNS |
| 105 | IDO1 | Protein | Biosynthesis and Anabolic Pathways | Cytokines | CNS |
| 106 | IDO1 | Protein | Biosynthesis and Anabolic Pathways | Cytokines | Immuno-Oncology |
| 107 | IgD | Protein | Others | Others | Others |
| 108 | INPP4B | Protein | PI3K-AKT | Others | Oncology |
| 109 | Ki-67 | Protein | Proliferation | Immune Cell Typing | Immuno-Oncology |
| 110 | Ki-67 | Protein | Proliferation | Immune Cell Typing | Oncology |
| 111 | LAG3 | Protein | Costimulatory Signaling | Immune Cell Typing | Immuno-Oncology |
| 112 | LAMP2A | Protein | Autophagy | Others | Cardiovascular |
| 113 | LC3B | Protein | Autophagy | Others | Cardiovascular |
| 114 | LRRK2 | Protein | Epigenic and Transcriptional Regulation | Axon and Dendrite Structure | CNS |
| 115 | LRRK2 | Protein | Epigenic and Transcriptional Regulation | Axon and Dendrite Structure | Epigenic and Nuclear Signaling |
| 116 | MAP2 | Protein | Others | Axon and Dendrite Structure | CNS |
| 117 | MART1 | Protein | Others | Pan-Tumor | Oncology |
| 118 | MERTK | Protein | Others | Glial Cell Subtyping | CNS |
| 119 | MET | Protein | Cell Proliferation | Cellular Growth Factor | CNS |
| 120 | MET | Protein | Cell Proliferation | Cellular Growth Factor | Oncology |
| 121 | MPO | Protein | Cell Stress | Others | CNS |
| 122 | Ms IgG1 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 123 | Ms IgG2a | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 124 | Myelin basic protein | Protein | Others | Neural Cell Typing | CNS |
| 125 | Neprilysin | Protein | Amyloid Processing | AD Pathology | CNS |
| 126 | NeuN | Protein | Others | Neural Cell Typing | CNS |
| 127 | Neurofilament light | Protein | Others | Neural Cell Typing | CNS |
| 128 | NF1 | Protein | Apoptosis | Axon and Dendrite Structure | Oncology |
| 129 | NF1 | Protein | Apoptosis | Axon and Dendrite Structure | CNS |
| 130 | NRGN | Protein | Others | AD Pathology | CNS |
| 131 | NY-ESO-1 | Protein | Others | Pan-Tumor | Oncology |
| 132 | Olig2 | Protein | Myelination | Neural Cell Typing | CNS |
| 133 | OX40L | Protein | Others | Myeloid Compartment | CNS |
| 134 | P2RX7 | Protein | Others | Immunity and Inflammation | Inflammation |
| 135 | P2ry12 | Protein | Others | Immunity and Inflammation | Inflammation |
| 136 | P62 | Protein | Autophagy | Others | Cardiovascular |
| 137 | Pan-AKT | Protein | PI3K-AKT | Others | Oncology |
| 138 | PanCk | Protein | EMT | Immune Cell Typing | Oncology |
| 139 | PanCk | Protein | EMT | Immune Cell Typing | Immuno-Oncology |
| 140 | Pan-Keratin | Protein | Others | Others | Others |
| 141 | pan-RAS | Protein | MAPK | Others | Cardiovascular |
| 142 | Park5 | Protein | Others | PD Pathology | CNS |
| 143 | Park7 | Protein | Oxydative Stress | Axon and Dendrite Structure | Inflammation |
| 144 | Park7 | Protein | Oxydative Stress | Axon and Dendrite Structure | CNS |
| 145 | PARP | Protein | Apoptosis | Others | Oncology |
| 146 | PD-1 | Protein | Others | Immune Activation Status | Immuno-Oncology |
| 147 | PD-L1 | Protein | Others | Immune Activation Status | Immuno-Oncology |
| 148 | PD-L2 | Protein | Others | Immune Activation Status | Immuno-Oncology |
| 149 | Phospho-Alpha-synuclein (S129) | Protein | Others | PD Pathology | CNS |
| 150 | Phospho-GSK3B (S9) | Protein | PI3K-AKT | Others | Oncology |
| 151 | Phospho-JNK (T183/Y185) | Protein | MAPK | Others | Cardiovascular |
| 152 | Phospho-MEK1 (S217/S221) | Protein | MAPK | Others | Cardiovascular |
| 153 | Phospho-p44/42 MAPK ERK1/2 (T202/Y204) | Protein | MAPK | Others | Cardiovascular |
| 154 | Phospho-p90 RSK (T359/S363) | Protein | MAPK | Others | Cardiovascular |
| 155 | Phospho-Tau (S199) | Protein | Others | Cytoskeleton | CNS |
| 156 | Phospho-Tau (S214) | Protein | Others | Cytoskeleton | CNS |
| 157 | Phospho-Tau (S396) | Protein | Others | Cytoskeleton | CNS |
| 158 | Phospho-Tau (S404) | Protein | Others | Cytoskeleton | CNS |
| 159 | Phospho-Tau (T231) | Protein | Others | Cytoskeleton | CNS |
| 160 | Phospho-Tdp-43 (S409/S410) | Protein | Others | Others | Others |
| 161 | Phospho-Tuberin (T1462) | Protein | PI3K-AKT | Others | Oncology |
| 162 | PINK1 | Protein | Oxydative Stress | Axon and Dendrite Structure | Inflammation |
| 163 | PINK1 | Protein | Oxydative Stress | Axon and Dendrite Structure | CNS |
| 164 | PLCG1 | Protein | PI3K-AKT | Cellular Growth Factor | Oncology |
| 165 | PNAd | Protein | Others | Others | Others |
| 166 | podoplanin | Protein | Others | Others | Others |
| 167 | PR | Protein | ER Signaling | Pan-Tumor | Oncology |
| 168 | PSEN1 | Protein | Amyloid Processing | Axon and Dendrite Structure | CNS |
| 169 | Rb IgG | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 170 | S100B | Protein | Others | Astrocyte | CNS |
| 171 | S6 | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 172 | SMA | Protein | Others | Immune Cell Typing | Immuno-Oncology |
| 173 | STAT 3 | Protein | Others | Others | Others |
| 174 | STIM1 | Protein | Others | Immune Activation Status | Immuno-Oncology |
| 175 | STING | Protein | Interferon Signaling | Others | Immuno-Oncology |
| 176 | Synaptophysin | Protein | Others | Neural Cell Typing | CNS |
| 177 | Tau | Protein | Others | Cytoskeleton | CNS |
| 178 | Tbet | Protein | Others | Others | Others |
| 179 | Tdp-43 | Protein | Others | Others | Others |
| 180 | TFEB | Protein | Autophagy | Others | Cardiovascular |
| 181 | TIM3 | Protein | Others | Others | Others |
| 182 | Tim-3 | Protein | Others | Immune Checkpoint | Immuno-Oncology |
| 183 | TMEM119 | Protein | Others | Immunity and Inflammation | Inflammation |
| 184 | TSLP | Protein | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 185 | Tyrosine Hydroxylase | Protein | Others | PD Pathology | CNS |
| 186 | Ubiquitin | Protein | Others | Others | Others |
| 187 | Vimentin | Protein | Others | Astrocyte | CNS |
| 188 | VISTA | Protein | Others | Immune Checkpoint | Immuno-Oncology |
| 189 | VPS35 | Protein | Autophagy | Others | Cardiovascular |
| 190 | A2M | RNA | Matrix Remodeling and Metastases | Chemokines | CNS |
| 191 | A2M | RNA | Matrix Remodeling and Metastases | Chemokines | Immuno-Oncology |
| 192 | AADAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 193 | AAMP | RNA | Angiogenesis | Others | Cardiovascular |
| 194 | AANAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 195 | ABAT | RNA | Transmitter Synthesis | Transmitter Release | CNS |
| 196 | ABCA1 | RNA | Others | Others | Others |
| 197 | ABCA8 | RNA | Others | Others | Others |
| 198 | ABCB1 | RNA | Others | Others | Others |
| 199 | ABCB11 | RNA | Others | Others | Others |
| 200 | ABCC1 | RNA | Others | Others | Others |
| 201 | ABCC3 | RNA | Others | Immunity and Inflammation | Inflammation |
| 202 | ABCC4 | RNA | Androgen Signaling | Others | Oncology |
| 203 | ABCC8 | RNA | Others | Immunity and Inflammation | Inflammation |
| 204 | ABCF1 | RNA | Others | Others | Others |
| 205 | ABCG2 | RNA | Others | Others | Others |
| 206 | ABI3BP | RNA | Others | Others | Others |
| 207 | ABL1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 208 | ACAA1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 209 | ACAA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 210 | ACACA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 211 | ACACB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 212 | ACAD10 | RNA | Others | Others | Others |
| 213 | ACAD9 | RNA | Others | Others | Others |
| 214 | ACADL | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 215 | ACADVL | RNA | Others | Others | Others |
| 216 | ACAP2 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 217 | ACAT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 218 | ACAT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 219 | ACE | RNA | Others | Others | Others |
| 220 | ACHE | RNA | Cell Proliferation | Neural Connectivity | CNS |
| 221 | ACIN1 | RNA | Others | Others | Others |
| 222 | ACKR2 | RNA | Others | Others | Others |
| 223 | ACKR3 | RNA | Others | Others | Others |
| 224 | ACKR4 | RNA | Others | Others | Others |
| 225 | ACMSD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 226 | ACOT1/2 | RNA | Others | Others | Others |
| 227 | ACOT12 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 228 | ACOT2 | RNA | Others | Others | Others |
| 229 | ACOX1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 230 | ACOX2 | RNA | Others | Others | Others |
| 231 | ACP5 | RNA | Others | Others | Others |
| 232 | ACSF2 | RNA | Others | Others | Others |
| 233 | ACSF3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 234 | ACSL1 | RNA | Others | Others | Others |
| 235 | ACSL3 | RNA | Androgen Signaling | Others | Oncology |
| 236 | ACSL4 | RNA | Others | Others | Others |
| 237 | ACSL5 | RNA | Others | Others | Others |
| 238 | ACSL6 | RNA | Others | Others | Others |
| 239 | ACSM3 | RNA | Others | Others | Others |
| 240 | ACTA2 | RNA | Others | Others | Others |
| 241 | ACTB | RNA | Others | Others | Others |
| 242 | ACTG2 | RNA | Others | Others | Others |
| 243 | ACTN1 | RNA | Others | Neuronal Cytoskeleton | CNS |
| 244 | ACTR1A | RNA | Others | Others | Others |
| 245 | ACTR1B | RNA | Others | Others | Others |
| 246 | ACTR3B | RNA | Others | Others | Others |
| 247 | ACVR1 | RNA | Cellular Differentiation | Cellular Growth Factor | Oncology |
| 248 | ACVR1B | RNA | TGF Beta Signaling | Others | Oncology |
| 249 | ACVR1C | RNA | Proliferation | Cellular Growth Factor | Oncology |
| 250 | ACVR2A | RNA | Others | Others | Others |
| 251 | ACVRL1 | RNA | Angiogenesis | Axon and Dendrite Structure | Cardiovascular |
| 252 | ACVRL1 | RNA | Angiogenesis | Axon and Dendrite Structure | CNS |
| 253 | ACY1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 254 | ADA | RNA | Biosynthesis and Anabolic Pathways | B Cell Function | CNS |
| 255 | ADA | RNA | Biosynthesis and Anabolic Pathways | B Cell Function | Immuno-Oncology |
| 256 | ADA2 | RNA | Others | Others | Others |
| 257 | ADAL | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 258 | ADAM10 | RNA | Amyloid Processing | Neural Connectivity | CNS |
| 259 | ADAM12 | RNA | Others | Others | Others |
| 260 | ADAM15 | RNA | Angiogenesis | Others | Cardiovascular |
| 261 | ADAM17 | RNA | Cell Proliferation | Cellular Growth Factor | Oncology |
| 262 | ADAM17 | RNA | Cell Proliferation | Cellular Growth Factor | CNS |
| 263 | ADAM28 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 264 | ADAM8 | RNA | Angiogenesis | Others | Cardiovascular |
| 265 | ADAM9 | RNA | Matrix Remodeling and Metastases | Cellular Growth Factor | CNS |
| 266 | ADAM9 | RNA | Matrix Remodeling and Metastases | Cellular Growth Factor | Oncology |
| 267 | ADAMTS1 | RNA | Cell Proliferation | Others | CNS |
| 268 | ADAMTS12 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 269 | ADAMTS16 | RNA | Others | Immunity and Inflammation | Inflammation |
| 270 | ADAMTS8 | RNA | Cell Proliferation | Others | CNS |
| 271 | ADAP1 | RNA | Others | Others | Others |
| 272 | ADAR | RNA | Others | Others | Others |
| 273 | ADCY5 | RNA | Others | Transmitter Release | CNS |
| 274 | ADCY7 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 275 | ADCY8 | RNA | Others | Transmitter Release | CNS |
| 276 | ADCY9 | RNA | ER Signaling | Axon and Dendrite Structure | Oncology |
| 277 | ADCY9 | RNA | ER Signaling | Axon and Dendrite Structure | CNS |
| 278 | ADCYAP1 | RNA | Transmitter Synthesis | Axon and Dendrite Structure | CNS |
| 279 | ADD1 | RNA | Cellular Differentiation | Others | Oncology |
| 280 | ADGRE1 | RNA | Others | Others | Others |
| 281 | ADGRE5 | RNA | Others | Others | Others |
| 282 | ADGRG3 | RNA | Others | Others | Others |
| 283 | ADH1A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 284 | ADH1A/B/C | RNA | Others | Others | Others |
| 285 | ADH1B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 286 | ADH1C | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 287 | ADH4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 288 | ADH6 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 289 | ADH7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 290 | ADIPOQ | RNA | Others | Others | Others |
| 291 | ADIPOR1 | RNA | Others | Others | Others |
| 292 | ADK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 293 | ADM | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 294 | ADM2 | RNA | Angiogenesis | Others | Cardiovascular |
| 295 | ADORA1 | RNA | Others | Axon and Dendrite Structure | CNS |
| 296 | ADORA2A | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
| 297 | ADORA2B | RNA | Others | Immune Suppression | Immuno-Oncology |
| 298 | ADPGK | RNA | Others | Others | Others |
| 299 | ADRA2A | RNA | Others | Immunity and Inflammation | Inflammation |
| 300 | ADRA2B | RNA | Angiogenesis | Cellular Growth Factor | Cardiovascular |
| 301 | ADRA2B | RNA | Angiogenesis | Cellular Growth Factor | Oncology |
| 302 | ADRB2 | RNA | Others | Axon and Dendrite Structure | CNS |
| 303 | AEBP1 | RNA | Cellular Differentiation | Others | Oncology |
| 304 | AFDN | RNA | Others | Others | Others |
| 305 | AFMID | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 306 | AGER | RNA | Oxydative Stress | Axon and Dendrite Structure | Inflammation |
| 307 | AGER | RNA | Oxydative Stress | Axon and Dendrite Structure | CNS |
| 308 | AGGF1 | RNA | Angiogenesis | Others | Cardiovascular |
| 309 | AGK | RNA | Others | Others | Others |
| 310 | AGO2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 311 | AGO4 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Epigenic and Nuclear Signaling |
| 312 | AGO4 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Inflammation |
| 313 | AGR2 | RNA | EMT | Others | Oncology |
| 314 | AGRN | RNA | Others | Others | Others |
| 315 | AGT | RNA | Proliferation | Cellular Growth Factor | Oncology |
| 316 | AGTR1 | RNA | Others | Others | Others |
| 317 | AGXT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 318 | AGXT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 319 | AHNAK | RNA | Others | Others | Others |
| 320 | AHR | RNA | Others | Immune Suppression | Immuno-Oncology |
| 321 | AICDA | RNA | Others | Others | Others |
| 322 | AIF1 | RNA | Oxydative Stress | Others | Inflammation |
| 323 | AIFM1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 324 | AIM2 | RNA | Others | Others | Others |
| 325 | AIMP2 | RNA | Myc | Others | Oncology |
| 326 | AIRE | RNA | Others | Others | Others |
| 327 | AK1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 328 | AK3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 329 | AK4 | RNA | Others | Others | Others |
| 330 | AKAP1 | RNA | Others | Others | Others |
| 331 | AKAP12 | RNA | Others | Others | Others |
| 332 | AKAP2 | RNA | Others | Others | Others |
| 333 | AKR1B10 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 334 | AKR1C4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 335 | AKT1 | RNA | Apoptosis | Immune Activation Status | Oncology |
| 336 | AKT1 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 337 | AKT1S1 | RNA | Carbohydrate Metabolism | Others | CNS |
| 338 | AKT2 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
| 339 | AKT2 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
| 340 | AKT3 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
| 341 | AKT3 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
| 342 | ALAD | RNA | Others | Others | Others |
| 343 | ALAS1 | RNA | Others | Others | Others |
| 344 | ALAS2 | RNA | Others | Others | Others |
| 345 | ALB | RNA | Others | Others | Others |
| 346 | ALCAM | RNA | Others | Others | Others |
| 347 | ALDH1A1 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 348 | ALDH1A3 | RNA | Androgen Signaling | Immune Suppression | Oncology |
| 349 | ALDH1A3 | RNA | Androgen Signaling | Immune Suppression | Immuno-Oncology |
| 350 | ALDH1B1 | RNA | Others | Others | Others |
| 351 | ALDH1L1 | RNA | Others | Others | Others |
| 352 | ALDH1L2 | RNA | Others | Others | Others |
| 353 | ALDH2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 354 | ALDH3A1 | RNA | Others | Others | Others |
| 355 | ALDH3A2 | RNA | Others | Others | Others |
| 356 | ALDH3B2 | RNA | Others | Others | Others |
| 357 | ALDH7A1 | RNA | Others | Others | Others |
| 358 | ALDH8A1 | RNA | Others | Others | Others |
| 359 | ALDH9A1 | RNA | Others | Others | Others |
| 360 | ALDOA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 361 | ALDOB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 362 | ALDOC | RNA | Others | Others | Others |
| 363 | ALK | RNA | Others | Others | Others |
| 364 | ALKBH2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 365 | ALKBH3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 366 | ALOX12 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 367 | ALOX15 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 368 | ALOX5 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
| 369 | ALOX5 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
| 370 | ALOX5AP | RNA | Others | Others | Others |
| 371 | ALPK1 | RNA | Others | Others | Others |
| 372 | ALPL | RNA | Others | Others | Others |
| 373 | AMBP | RNA | Others | Others | Others |
| 374 | AMBRA1 | RNA | Others | Others | Others |
| 375 | AMDHD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 376 | AMER1 | RNA | Others | Others | Others |
| 377 | AMH | RNA | Others | Cellular Growth Factor | Oncology |
| 378 | AMICA1 | RNA | Others | Others | Others |
| 379 | AMIGO1 | RNA | Myelination | Axon and Dendrite Structure | CNS |
| 380 | AMIGO2 | RNA | Others | Others | Others |
| 381 | AMMECR1L | RNA | Others | Others | Others |
| 382 | AMOTL1 | RNA | Others | Others | Others |
| 383 | AMOTL2 | RNA | Hippo Signaling | Others | CNS |
| 384 | AMPD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 385 | AMPD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 386 | AMPD3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 387 | AMPH | RNA | Others | Neural Connectivity | CNS |
| 388 | ANAPC1 | RNA | Others | Others | Others |
| 389 | ANAPC10 | RNA | Others | Others | Others |
| 390 | ANAPC15 | RNA | Others | Others | Others |
| 391 | ANAPC4 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 392 | ANAPC7 | RNA | Others | Others | Others |
| 393 | ANG | RNA | Angiogenesis | Others | Cardiovascular |
| 394 | ANGPT1 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular |
| 395 | ANGPT1 | RNA | Angiogenesis | Immune Activation Status | Immuno-Oncology |
| 396 | ANGPT2 | RNA | Angiogenesis | Others | Cardiovascular |
| 397 | ANGPTL2 | RNA | Others | Others | Others |
| 398 | ANGPTL4 | RNA | Angiogenesis | Others | Cardiovascular |
| 399 | ANKRD28 | RNA | Others | Others | Others |
| 400 | ANLN | RNA | Apoptosis | Others | Oncology |
| 401 | ANP32B | RNA | Others | Others | Others |
| 402 | ANPEP | RNA | Angiogenesis | Others | Cardiovascular |
| 403 | ANXA1 | RNA | Others | Others | Others |
| 404 | ANXA2P2 | RNA | Angiogenesis | Others | Cardiovascular |
| 405 | ANXA9 | RNA | ER Signaling | Others | Oncology |
| 406 | AOC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 407 | AOC3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 408 | AOX1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 409 | AP1B1 | RNA | Others | Others | Others |
| 410 | AP1G1 | RNA | Others | Others | Others |
| 411 | AP1M1 | RNA | Others | Others | Others |
| 412 | AP1M2 | RNA | Others | Others | Others |
| 413 | AP1S1 | RNA | Others | Neural Connectivity | CNS |
| 414 | AP1S2 | RNA | Others | Others | Others |
| 415 | AP2A1 | RNA | Others | Others | Others |
| 416 | AP2A2 | RNA | Transmitter Synthesis | Others | CNS |
| 417 | AP2B1 | RNA | Transmitter Synthesis | Others | CNS |
| 418 | AP2M1 | RNA | Others | Others | Others |
| 419 | AP2S1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 420 | AP3M2 | RNA | Others | Others | Others |
| 421 | AP3S1 | RNA | Others | Others | Others |
| 422 | AP4S1 | RNA | Others | Others | Others |
| 423 | APAF1 | RNA | Others | Others | Others |
| 424 | APBB1IP | RNA | Others | Others | Others |
| 425 | APC | RNA | Apoptosis | Neural Connectivity | Oncology |
| 426 | APC | RNA | Apoptosis | Neural Connectivity | CNS |
| 427 | APCS | RNA | Others | Others | Others |
| 428 | APEX1 | RNA | Others | Others | Others |
| 429 | APH1A | RNA | Others | Immune Suppression | Immuno-Oncology |
| 430 | APH1B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 431 | API5 | RNA | Others | Others | Others |
| 432 | APLNR | RNA | Others | Others | Others |
| 433 | APLP2 | RNA | Others | Others | Others |
| 434 | APOA1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 435 | APOA2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 436 | APOA4 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 437 | APOB | RNA | Adenosine Pathway | Immune Activation Status | Immuno-Oncology |
| 438 | APOBEC3G | RNA | Others | Others | Others |
| 439 | APOC2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 440 | APOC3 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 441 | APOD | RNA | Angiogenesis | Cellular Growth Factor | Oncology |
| 442 | APOD | RNA | Angiogenesis | Cellular Growth Factor | Cardiovascular |
| 443 | APOE | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS |
| 444 | APOE | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | Inflammation |
| 445 | APOH | RNA | Cell Proliferation | Others | CNS |
| 446 | APOL6 | RNA | Others | Others | Others |
| 447 | APOM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 448 | APP | RNA | Adenosine Pathway | Neural Connectivity | Immuno-Oncology |
| 449 | APP | RNA | Adenosine Pathway | Neural Connectivity | CNS |
| 450 | APRT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 451 | AQP1 | RNA | Others | Others | Others |
| 452 | AQP4 | RNA | Others | Others | Others |
| 453 | AQP7 | RNA | Others | Others | Others |
| 454 | AQP8 | RNA | Others | Others | Others |
| 455 | AQP9 | RNA | Metabolism Stress | Others | Metabolic Diseases |
| 456 | AR | RNA | Androgen Signaling | Others | Oncology |
| 457 | ARAF | RNA | Others | Others | Others |
| 458 | ARAP2 | RNA | Others | Others | Others |
| 459 | ARC | RNA | Others | Neural Connectivity | CNS |
| 460 | AREG | RNA | Cell Proliferation | Cellular Growth Factor | CNS |
| 461 | AREG | RNA | Cell Proliferation | Cellular Growth Factor | Oncology |
| 462 | ARF1 | RNA | Others | Others | Others |
| 463 | ARF5 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 464 | ARG1 | RNA | Biosynthesis and Anabolic Pathways | Immune Suppression | CNS |
| 465 | ARG1 | RNA | Biosynthesis and Anabolic Pathways | Immune Suppression | Immuno-Oncology |
| 466 | ARG2 | RNA | Others | Others | Others |
| 467 | ARHGAP24 | RNA | Others | Immunity and Inflammation | Inflammation |
| 468 | ARHGAP32 | RNA | Others | Others | Others |
| 469 | ARHGAP35 | RNA | Others | Others | Others |
| 470 | ARHGAP44 | RNA | Others | Neural Connectivity | CNS |
| 471 | ARHGDIB | RNA | Others | Others | Others |
| 472 | ARHGEF1 | RNA | Others | Others | Others |
| 473 | ARHGEF10 | RNA | Myelination | Others | CNS |
| 474 | ARHGEF2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 475 | ARHGEF6 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 476 | ARID1A | RNA | Androgen Signaling | Others | Oncology |
| 477 | ARID1B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 478 | ARID2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 479 | ARID4A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 480 | ARID4B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 481 | ARNT | RNA | Others | Others | Others |
| 482 | ARNT2 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 483 | ARPC4 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 484 | ARRB1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 485 | ARRB2 | RNA | Others | Neural Connectivity | CNS |
| 486 | ARSA | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 487 | ASB2 | RNA | Others | Immunity and Inflammation | Inflammation |
| 488 | ASB4 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 489 | ASCL1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 490 | ASH1L | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 491 | ASH2L | RNA | Others | Others | Others |
| 492 | ASL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 493 | ASMT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 494 | ASNS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 495 | ASPA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 496 | ASPG | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 497 | ASPH | RNA | Others | Immunity and Inflammation | Inflammation |
| 498 | ASPM | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 499 | ASPN | RNA | EMT | Cellular Growth Factor | Oncology |
| 500 | ASS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 501 | ASXL1 | RNA | Others | Others | Others |
| 502 | ASXL2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 503 | ATAD2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 504 | ATCAY | RNA | Others | Neural Connectivity | CNS |
| 505 | ATF1 | RNA | Others | Others | Others |
| 506 | ATF2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 507 | ATF3 | RNA | Others | Immunity and Inflammation | Inflammation |
| 508 | ATF4 | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular |
| 509 | ATF4 | RNA | AP1 Signaling | Immune Activation Status | Immuno-Oncology |
| 510 | ATF6 | RNA | Others | Others | Others |
| 511 | ATF7 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 512 | ATF7IP | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 513 | ATG10 | RNA | Others | Others | Others |
| 514 | ATG101 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 515 | ATG12 | RNA | Autophagy | Others | Cardiovascular |
| 516 | ATG13 | RNA | Others | Others | Others |
| 517 | ATG14 | RNA | Others | Others | Others |
| 518 | ATG16L1 | RNA | Others | Others | Others |
| 519 | ATG2B | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 520 | ATG3 | RNA | Others | Others | Others |
| 521 | ATG4A | RNA | Others | Others | Others |
| 522 | ATG4B | RNA | Others | Others | Others |
| 523 | ATG5 | RNA | Others | Immunity and Inflammation | Inflammation |
| 524 | ATG7 | RNA | Others | Immunity and Inflammation | Inflammation |
| 525 | ATG9A | RNA | Others | Others | Others |
| 526 | ATM | RNA | DNA Damage Repair | Immune Activation Status | Epigenic and Nuclear Signaling |
| 527 | ATM | RNA | DNA Damage Repair | Immune Activation Status | Immuno-Oncology |
| 528 | ATOX1 | RNA | Cell Stress | Others | CNS |
| 529 | ATP10B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 530 | ATP11C | RNA | Others | Others | Others |
| 531 | ATP13A2 | RNA | Oxydative Stress | Others | Inflammation |
| 532 | ATP2A2 | RNA | Others | Others | Others |
| 533 | ATP2B3 | RNA | Others | Transmitter Release | CNS |
| 534 | ATP5F1D | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 535 | ATP5ME | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 536 | ATP5MF | RNA | Others | Others | Others |
| 537 | ATP5MG | RNA | Others | Others | Others |
| 538 | ATP5PD | RNA | Others | Others | Others |
| 539 | ATP6AP2 | RNA | Others | Others | Others |
| 540 | ATP6V0A1 | RNA | Others | Others | Others |
| 541 | ATP6V0C | RNA | Transmitter Synthesis | Others | CNS |
| 542 | ATP6V0D1 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 543 | ATP6V0E1 | RNA | Transmitter Synthesis | Immunity and Inflammation | CNS |
| 544 | ATP6V0E1 | RNA | Transmitter Synthesis | Immunity and Inflammation | Inflammation |
| 545 | ATP6V0E2 | RNA | Transmitter Synthesis | Others | CNS |
| 546 | ATP6V1A | RNA | Transmitter Synthesis | Immunity and Inflammation | CNS |
| 547 | ATP6V1A | RNA | Transmitter Synthesis | Immunity and Inflammation | Inflammation |
| 548 | ATP6V1B2 | RNA | Others | Others | Others |
| 549 | ATP6V1C2 | RNA | Others | Others | Others |
| 550 | ATP6V1D | RNA | Transmitter Synthesis | Others | CNS |
| 551 | ATP6V1E1 | RNA | Transmitter Synthesis | Others | CNS |
| 552 | ATP6V1F | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 553 | ATP6V1G2 | RNA | Transmitter Synthesis | Others | CNS |
| 554 | ATP6V1G3 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 555 | ATP6V1H | RNA | Transmitter Synthesis | Others | CNS |
| 556 | ATP7A | RNA | Oxydative Stress | Others | Inflammation |
| 557 | ATP8A2 | RNA | Others | Others | Others |
| 558 | ATPIF1 | RNA | Angiogenesis | Others | Cardiovascular |
| 559 | ATR | RNA | p53 Signaling | Immune Activation Status | Oncology |
| 560 | ATR | RNA | p53 Signaling | Immune Activation Status | Immuno-Oncology |
| 561 | ATRN | RNA | Myelination | Others | CNS |
| 562 | ATRX | RNA | Others | Others | Others |
| 563 | ATXN2 | RNA | Others | Others | Others |
| 564 | ATXN3 | RNA | Others | Vesicle Trafficking | CNS |
| 565 | ATXN7 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 566 | AURKA | RNA | Cell Cycle | Others | Oncology |
| 567 | AURKB | RNA | Cell Cycle | Others | Oncology |
| 568 | AVP | RNA | Others | Others | Others |
| 569 | AXIN1 | RNA | Wnt Signaling | Others | CNS |
| 570 | AXIN2 | RNA | Wnt Signaling | Others | CNS |
| 571 | AXL | RNA | Hippo Signaling | Immunity and Inflammation | CNS |
| 572 | AXL | RNA | Hippo Signaling | Immunity and Inflammation | Inflammation |
| 573 | B2M | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 574 | B3GAT1 | RNA | Others | Others | Others |
| 575 | B3GNT3 | RNA | EMT | Others | Oncology |
| 576 | B3GNT5 | RNA | Others | Others | Others |
| 577 | B4GALNT1 | RNA | Others | Others | Others |
| 578 | B4GALT1 | RNA | Androgen Signaling | Immune Suppression | Oncology |
| 579 | B4GALT1 | RNA | Androgen Signaling | Immune Suppression | Immuno-Oncology |
| 580 | B4GALT6 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 581 | BABAM1 | RNA | Others | Others | Others |
| 582 | BACE1 | RNA | Amyloid Processing | Others | CNS |
| 583 | BAD | RNA | Apoptosis | Cellular Growth Factor | Oncology |
| 584 | BAG1 | RNA | Others | Others | Others |
| 585 | BAG2 | RNA | Others | Others | Others |
| 586 | BAG3 | RNA | Autophagy | Others | Cardiovascular |
| 587 | BAG4 | RNA | Others | Immunity and Inflammation | Inflammation |
| 588 | BAGE | RNA | Others | Others | Others |
| 589 | BAI1 | RNA | Cell Proliferation | Others | CNS |
| 590 | BAI3 | RNA | Others | Others | Others |
| 591 | BAIAP2L1 | RNA | Others | Others | Others |
| 592 | BAIAP3 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 593 | BAK1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 594 | BAMBI | RNA | TGF Beta Signaling | Others | Oncology |
| 595 | BANF1 | RNA | Others | Others | Others |
| 596 | BAP1 | RNA | Others | Others | Others |
| 597 | BARD1 | RNA | Others | Others | Others |
| 598 | BATF | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular |
| 599 | BATF | RNA | AP1 Signaling | Immune Activation Status | Immuno-Oncology |
| 600 | BATF3 | RNA | Others | Others | Others |
| 601 | BAX | RNA | Apoptosis | Immune Activation Status | Oncology |
| 602 | BAX | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 603 | BBC3 | RNA | Apoptosis | Others | Oncology |
| 604 | BBOX1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 605 | BBS1 | RNA | Others | Others | Others |
| 606 | BCAP31 | RNA | Others | Others | Others |
| 607 | BCAS1 | RNA | EMT | Neural Connectivity | Oncology |
| 608 | BCAS1 | RNA | EMT | Neural Connectivity | CNS |
| 609 | BCAS2 | RNA | Others | Others | Others |
| 610 | BCAT1 | RNA | Others | Others | Others |
| 611 | BCHE | RNA | Carbohydrate Metabolism | Vesicle Trafficking | CNS |
| 612 | BCL10 | RNA | TCR Signaling | Immunity and Inflammation | Immuno-Oncology |
| 613 | BCL10 | RNA | TCR Signaling | Immunity and Inflammation | Inflammation |
| 614 | BCL11A | RNA | Others | Others | Others |
| 615 | BCL2 | RNA | Apoptosis | Immune Activation Status | Oncology |
| 616 | BCL2 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 617 | BCL2A1 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Epigenic and Nuclear Signaling |
| 618 | BCL2A1 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Inflammation |
| 619 | BCL2L1 | RNA | Apoptosis | Immune Activation Status | Oncology |
| 620 | BCL2L1 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 621 | BCL2L11 | RNA | Others | Others | Others |
| 622 | BCL2L2 | RNA | Others | Others | Others |
| 623 | BCL3 | RNA | Others | Others | Others |
| 624 | BCL6 | RNA | Apoptosis | Others | Oncology |
| 625 | BCL6B | RNA | Angiogenesis | Others | Cardiovascular |
| 626 | BCLAF1 | RNA | Others | Others | Others |
| 627 | BCOR | RNA | Others | Others | Others |
| 628 | BCR | RNA | Others | Others | Others |
| 629 | BDKRB1 | RNA | Others | Others | Others |
| 630 | BDKRB2 | RNA | Others | Others | Others |
| 631 | BDNF | RNA | MAPK | Transmitter Response and Reuptake | Cardiovascular |
| 632 | BDNF | RNA | MAPK | Transmitter Response and Reuptake | CNS |
| 633 | BECN1 | RNA | Others | Others | Others |
| 634 | BGN | RNA | Others | Others | Others |
| 635 | BHLHE40 | RNA | mTOR Signaling | Others | Oncology |
| 636 | BHMT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 637 | BHMT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 638 | BICC1 | RNA | Others | Others | Others |
| 639 | BID | RNA | Apoptosis | Immune Activation Status | Oncology |
| 640 | BID | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 641 | BIK | RNA | Others | Others | Others |
| 642 | BIN1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 643 | BIRC2 | RNA | Others | Immunity and Inflammation | Inflammation |
| 644 | BIRC3 | RNA | Apoptosis | Immunity and Inflammation | Oncology |
| 645 | BIRC3 | RNA | Apoptosis | Immunity and Inflammation | Inflammation |
| 646 | BIRC5 | RNA | Apoptosis | Others | Oncology |
| 647 | BIRC7 | RNA | Others | Others | Others |
| 648 | BLK | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 649 | BLM | RNA | Apoptosis | Others | Oncology |
| 650 | BLNK | RNA | Others | Immunity and Inflammation | Inflammation |
| 651 | BLVRA | RNA | Others | Others | Others |
| 652 | BMI1 | RNA | Others | Others | Others |
| 653 | BMP10 | RNA | Others | Others | Others |
| 654 | BMP2 | RNA | Hedgehog | Immune Suppression | CNS |
| 655 | BMP2 | RNA | Hedgehog | Immune Suppression | Immuno-Oncology |
| 656 | BMP4 | RNA | Cell Proliferation | Others | CNS |
| 657 | BMP5 | RNA | Proliferation | Others | Oncology |
| 658 | BMP6 | RNA | TGF Beta Signaling | Others | Oncology |
| 659 | BMP7 | RNA | Cell Proliferation | Others | CNS |
| 660 | BMP8A | RNA | TGF Beta Signaling | Others | Oncology |
| 661 | BMP8A/B | RNA | Others | Immune Suppression | Immuno-Oncology |
| 662 | BMPER | RNA | Cell Proliferation | Others | CNS |
| 663 | BMPR1A | RNA | Cell Proliferation | Others | CNS |
| 664 | BMPR1B | RNA | Proliferation | Others | Oncology |
| 665 | BMPR2 | RNA | Cell Proliferation | Others | CNS |
| 666 | BNC2 | RNA | EMT | Others | Oncology |
| 667 | BNIP3 | RNA | Autophagy | Immunity and Inflammation | Cardiovascular |
| 668 | BNIP3 | RNA | Autophagy | Immunity and Inflammation | Inflammation |
| 669 | BNIP3L | RNA | Others | Others | Others |
| 670 | BOK | RNA | Others | Others | Others |
| 671 | BOLA2 | RNA | Others | Immunity and Inflammation | Inflammation |
| 672 | BORCS7 | RNA | ER Signaling | Others | Oncology |
| 673 | BPI | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 674 | BRAF | RNA | FGFR Signaling | Immunity and Inflammation | Cardiovascular |
| 675 | BRAF | RNA | FGFR Signaling | Immunity and Inflammation | Inflammation |
| 676 | BRCA1 | RNA | Androgen Signaling | Others | Oncology |
| 677 | BRCA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 678 | BRCC3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 679 | BRD2 | RNA | Others | Others | Others |
| 680 | BRD3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 681 | BRD4 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 682 | BRD7 | RNA | Others | Others | Others |
| 683 | BRIP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 684 | BRMS1 | RNA | Cell Proliferation | Others | CNS |
| 685 | BRMS1L | RNA | Others | Others | Others |
| 686 | BRPF3 | RNA | Others | Others | Others |
| 687 | BRWD1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 688 | BST1 | RNA | Others | Others | Others |
| 689 | BST2 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 690 | BTBD6 | RNA | Others | Others | Others |
| 691 | BTG1 | RNA | Cell Proliferation | Others | CNS |
| 692 | BTG2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 693 | BTK | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
| 694 | BTK | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
| 695 | BTLA | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
| 696 | BTRC | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 697 | BUB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 698 | BUB1B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 699 | BYSL | RNA | Myc | Others | Oncology |
| 700 | C10orf76 | RNA | Others | Others | Others |
| 701 | C14orf166 | RNA | Others | Others | Others |
| 702 | C19orf40 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 703 | C1QA | RNA | Others | Immunity and Inflammation | Inflammation |
| 704 | C1QB | RNA | Others | Immunity and Inflammation | Inflammation |
| 705 | C1QBP | RNA | Others | Chemokines | Immuno-Oncology |
| 706 | C1QC | RNA | Others | Immunity and Inflammation | Inflammation |
| 707 | C1R | RNA | Others | Others | Others |
| 708 | C1S | RNA | Others | Others | Others |
| 709 | C2 | RNA | Others | Others | Others |
| 710 | C3 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
| 711 | C3 | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
| 712 | C3AR1 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
| 713 | C3AR1 | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
| 714 | C4A | RNA | Others | Others | Others |
| 715 | C4A/B | RNA | Others | Others | Others |
| 716 | C4B | RNA | Others | Glial Cell Subtyping | CNS |
| 717 | C4BPA | RNA | Others | Others | Others |
| 718 | C5 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 719 | C5AR1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 720 | C5orf38 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 721 | C6 | RNA | Others | Immunity and Inflammation | Inflammation |
| 722 | C7 | RNA | Others | Others | Others |
| 723 | C8A | RNA | Others | Others | Others |
| 724 | C8B | RNA | Others | Others | Others |
| 725 | C8G | RNA | Others | Others | Others |
| 726 | C9 | RNA | Others | Others | Others |
| 727 | C9orf72 | RNA | Others | Others | Others |
| 728 | CA12 | RNA | Cell Stress | Others | CNS |
| 729 | CA2 | RNA | Others | Vesicle Trafficking | CNS |
| 730 | CA9 | RNA | Cell Stress | Others | CNS |
| 731 | CAB39 | RNA | Carbohydrate Metabolism | Others | CNS |
| 732 | CABLES1 | RNA | Others | Others | Others |
| 733 | CACNA1A | RNA | Signaling Affecting Cellular Metabolism | Neural Connectivity | Metabolic Diseases |
| 734 | CACNA1A | RNA | Signaling Affecting Cellular Metabolism | Neural Connectivity | CNS |
| 735 | CACNA1B | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 736 | CACNA1C | RNA | Others | Neural Connectivity | CNS |
| 737 | CACNA1D | RNA | MAPK | Transmitter Release | Cardiovascular |
| 738 | CACNA1D | RNA | MAPK | Transmitter Release | CNS |
| 739 | CACNA1E | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 740 | CACNA1F | RNA | Others | Transmitter Release | CNS |
| 741 | CACNA1G | RNA | Others | Others | Others |
| 742 | CACNA1H | RNA | MAPK | Others | Cardiovascular |
| 743 | CACNA1S | RNA | Others | Transmitter Release | CNS |
| 744 | CACNA2D1 | RNA | MAPK | Others | Cardiovascular |
| 745 | CACNA2D2 | RNA | Others | Others | Others |
| 746 | CACNA2D3 | RNA | MAPK | Others | Cardiovascular |
| 747 | CACNA2D4 | RNA | Others | Others | Others |
| 748 | CACNB2 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 749 | CACNB3 | RNA | Others | Others | Others |
| 750 | CACNB4 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
| 751 | CACNB4 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
| 752 | CACNG1 | RNA | MAPK | Others | Cardiovascular |
| 753 | CACNG2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 754 | CACNG3 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 755 | CACNG4 | RNA | MAPK | Others | Cardiovascular |
| 756 | CACNG6 | RNA | MAPK | Others | Cardiovascular |
| 757 | CACNG7 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 758 | CACYBP | RNA | mTOR Signaling | Others | Oncology |
| 759 | CAD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 760 | CADM1 | RNA | Others | Others | Others |
| 761 | CADM3 | RNA | Others | Others | Others |
| 762 | CADPS | RNA | Others | Neural Connectivity | CNS |
| 763 | CALB1 | RNA | Others | Neural Connectivity | CNS |
| 764 | CALB2 | RNA | Others | Neural Connectivity | CNS |
| 765 | CALCOCO2 | RNA | Others | Others | Others |
| 766 | CALCRL | RNA | Angiogenesis | Others | Cardiovascular |
| 767 | CALD1 | RNA | Others | Others | Others |
| 768 | CALM1 | RNA | Adenosine Pathway | Immune Activation Status | Immuno-Oncology |
| 769 | CALML3 | RNA | RAS | Others | Oncology |
| 770 | CALML5 | RNA | MAPK | Transmitter Release | Cardiovascular |
| 771 | CALML5 | RNA | MAPK | Transmitter Release | CNS |
| 772 | CALML6 | RNA | RAS | Others | Oncology |
| 773 | CALR | RNA | Others | Immunity and Inflammation | Inflammation |
| 774 | CAMK2A | RNA | Others | Others | Others |
| 775 | CAMK2B | RNA | Wnt Signaling | Neural Connectivity | CNS |
| 776 | CAMK2D | RNA | Cellular Differentiation | Immune Activation Status | Oncology |
| 777 | CAMK2D | RNA | Cellular Differentiation | Immune Activation Status | Immuno-Oncology |
| 778 | CAMK2G | RNA | Others | Transmitter Release | CNS |
| 779 | CAMK4 | RNA | Others | Transmitter Release | CNS |
| 780 | CAMP | RNA | Others | Others | Others |
| 781 | CAP1 | RNA | Others | Others | Others |
| 782 | CAPN1 | RNA | Others | Others | Others |
| 783 | CAPN2 | RNA | Others | Others | Others |
| 784 | CAPN5 | RNA | Others | Others | Others |
| 785 | CARD10 | RNA | Others | Others | Others |
| 786 | CARD11 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
| 787 | CARD11 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
| 788 | CARD16 | RNA | Others | Others | Others |
| 789 | CARD17 | RNA | Others | Others | Others |
| 790 | CARD8 | RNA | Others | Others | Others |
| 791 | CARD9 | RNA | Others | Others | Others |
| 792 | CASP1 | RNA | Apoptosis | Immunity and Inflammation | Oncology |
| 793 | CASP1 | RNA | Apoptosis | Immunity and Inflammation | Inflammation |
| 794 | CASP10 | RNA | Others | Others | Others |
| 795 | CASP12 | RNA | Others | Others | Others |
| 796 | CASP2 | RNA | Others | Immunity and Inflammation | Inflammation |
| 797 | CASP3 | RNA | Apoptosis | Immune Activation Status | Oncology |
| 798 | CASP3 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 799 | CASP4 | RNA | Others | Immunity and Inflammation | Inflammation |
| 800 | CASP5 | RNA | Others | Others | Others |
| 801 | CASP6 | RNA | Others | Others | Others |
| 802 | CASP7 | RNA | Others | Immunity and Inflammation | Inflammation |
| 803 | CASP8 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular |
| 804 | CASP8 | RNA | Angiogenesis | Immune Activation Status | Immuno-Oncology |
| 805 | CASP9 | RNA | Apoptosis | Immune Activation Status | Oncology |
| 806 | CASP9 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 807 | CASS4 | RNA | Others | Immunity and Inflammation | Inflammation |
| 808 | CAST | RNA | Others | Others | Others |
| 809 | CAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 810 | CAV1 | RNA | Angiogenesis | Others | Cardiovascular |
| 811 | CBFB | RNA | Others | Others | Others |
| 812 | CBL | RNA | Nutrient Capture and Catabolic Pathways | Immune Activation Status | Metabolic Diseases |
| 813 | CBL | RNA | Nutrient Capture and Catabolic Pathways | Immune Activation Status | Immuno-Oncology |
| 814 | CBLB | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 815 | CBLC | RNA | Cytotoxicity | Others | Oncology |
| 816 | CBR4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 817 | CBX2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 818 | CC2D1B | RNA | Others | Others | Others |
| 819 | CCBE1 | RNA | Others | Others | Others |
| 820 | CCBP2 | RNA | Others | Others | Others |
| 821 | CCDC80 | RNA | Others | Others | Others |
| 822 | CCK | RNA | Others | Neural Connectivity | CNS |
| 823 | CCL1 | RNA | Others | Others | Others |
| 824 | CCL11 | RNA | Cell Proliferation | Others | CNS |
| 825 | CCL13 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
| 826 | CCL14 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 827 | CCL15 | RNA | Others | Others | Others |
| 828 | CCL16 | RNA | Others | Others | Others |
| 829 | CCL17 | RNA | Others | Others | Others |
| 830 | CCL18 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 831 | CCL19 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 832 | CCL2 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
| 833 | CCL20 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
| 834 | CCL21 | RNA | Cellular Differentiation | Immune Activation Status | Oncology |
| 835 | CCL21 | RNA | Cellular Differentiation | Immune Activation Status | Immuno-Oncology |
| 836 | CCL22 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
| 837 | CCL23 | RNA | Others | Others | Others |
| 838 | CCL24 | RNA | Others | Others | Others |
| 839 | CCL25 | RNA | Others | Others | Others |
| 840 | CCL26 | RNA | Others | Others | Others |
| 841 | CCL27 | RNA | Others | Others | Others |
| 842 | CCL28 | RNA | Others | Others | Others |
| 843 | CCL3 | RNA | Others | Immunity and Inflammation | Inflammation |
| 844 | CCL3/L1 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
| 845 | CCL3/L1/L3 | RNA | Others | Others | Others |
| 846 | CCL3L1 | RNA | Others | Cytokines | Immuno-Oncology |
| 847 | CCL4 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
| 848 | CCL4 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
| 849 | CCL4/L1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 850 | CCL4/L1/L2 | RNA | Others | Others | Others |
| 851 | CCL5 | RNA | Cytokine and Chemokine Signaling | Cytokines | Immuno-Oncology |
| 852 | CCL7 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
| 853 | CCL7 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
| 854 | CCL8 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
| 855 | CCL8 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
| 856 | CCN2 | RNA | Others | Others | Others |
| 857 | CCNA1 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
| 858 | CCNA1 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
| 859 | CCNA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 860 | CCNB1 | RNA | Cell Cycle | Immune Activation Status | Oncology |
| 861 | CCNB1 | RNA | Cell Cycle | Immune Activation Status | Immuno-Oncology |
| 862 | CCNB2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 863 | CCNB3 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 864 | CCNC | RNA | Others | Immune Suppression | Immuno-Oncology |
| 865 | CCND1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 866 | CCND2 | RNA | Angiogenesis | Others | Cardiovascular |
| 867 | CCND3 | RNA | JAK-STAT | Others | CNS |
| 868 | CCNE1 | RNA | Androgen Signaling | Others | Oncology |
| 869 | CCNE2 | RNA | Cell Cycle | Others | Oncology |
| 870 | CCNF | RNA | Cell Cycle | Others | Oncology |
| 871 | CCNG2 | RNA | Others | Others | Others |
| 872 | CCNH | RNA | Others | Others | Others |
| 873 | CCNI | RNA | Others | Others | Others |
| 874 | CCNK | RNA | Cell Cycle | Others | Oncology |
| 875 | CCNO | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 876 | CCNT1 | RNA | Cell Cycle | Immune Suppression | Oncology |
| 877 | CCNT1 | RNA | Cell Cycle | Immune Suppression | Immuno-Oncology |
| 878 | CCNT2 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 879 | CCR1 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 880 | CCR10 | RNA | Others | Others | Others |
| 881 | CCR2 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
| 882 | CCR3 | RNA | Cell Proliferation | Others | CNS |
| 883 | CCR4 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
| 884 | CCR5 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status | Immuno-Oncology |
| 885 | CCR6 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 886 | CCR7 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 887 | CCR8 | RNA | Others | Others | Others |
| 888 | CCR9 | RNA | Others | Others | Others |
| 889 | CCRL1 | RNA | Others | Others | Others |
| 890 | CCRL2 | RNA | Others | Others | Others |
| 891 | CCS | RNA | Oxydative Stress | Others | Inflammation |
| 892 | CD101 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 893 | CD109 | RNA | Others | Others | Others |
| 894 | CD14 | RNA | Apoptosis | Immune Activation Status | Oncology |
| 895 | CD14 | RNA | Apoptosis | Immune Activation Status | Immuno-Oncology |
| 896 | CD160 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 897 | CD163 | RNA | EMT | Immune Cell Typing | Oncology |
| 898 | CD163 | RNA | EMT | Immune Cell Typing | Immuno-Oncology |
| 899 | CD164 | RNA | Others | Others | Others |
| 900 | CD177 | RNA | Others | Others | Others |
| 901 | CD180 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
| 902 | CD180 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
| 903 | CD19 | RNA | PI3K-AKT | Immune Activation Status | Oncology |
| 904 | CD19 | RNA | PI3K-AKT | Immune Activation Status | Immuno-Oncology |
| 905 | CD1A | RNA | Others | Others | Others |
| 906 | CD1B | RNA | Others | Others | Others |
| 907 | CD1C | RNA | Others | Lymphoid Compartment | Immuno-Oncology |
| 908 | CD1D | RNA | Others | Others | Others |
| 909 | CD1E | RNA | Antigen Processing | Others | Immuno-Oncology |
| 910 | CD2 | RNA | Costimulatory Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 911 | CD200 | RNA | Others | Others | Others |
| 912 | CD200R1 | RNA | Others | Immune Checkpoint | Immuno-Oncology |
| 913 | CD207 | RNA | Others | Others | Others |
| 914 | CD209 | RNA | Others | Immune Cell Typing | Immuno-Oncology |
| 915 | CD22 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 916 | CD226 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 917 | CD24 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
| 918 | CD24 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
| 919 | CD244 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 920 | CD247 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 921 | CD27 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 922 | CD274 | RNA | Costimulatory Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 923 | CD276 | RNA | Signaling Affecting Cellular Metabolism | Immune Cell Adhesion and Migration | Metabolic Diseases |
| 924 | CD276 | RNA | Signaling Affecting Cellular Metabolism | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 925 | CD28 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 926 | CD2AP | RNA | Others | Others | Others |
| 927 | CD300A | RNA | Metabolism Stress | Inflammation | Metabolic Diseases |
| 928 | CD300A | RNA | Metabolism Stress | Inflammation | Inflammation |
| 929 | CD300C | RNA | Others | Others | Others |
| 930 | CD300E | RNA | Others | Others | Others |
| 931 | CD300LF | RNA | Others | Immunity and Inflammation | Inflammation |
| 932 | CD33 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 933 | CD34 | RNA | Cell Proliferation | Immune Cell Typing | CNS |
| 934 | CD34 | RNA | Cell Proliferation | Immune Cell Typing | Immuno-Oncology |
| 935 | CD36 | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | CNS |
| 936 | CD36 | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | Inflammation |
| 937 | CD37 | RNA | Others | Others | Others |
| 938 | CD38 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 939 | CD3D | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 940 | CD3E | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 941 | CD3EAP | RNA | Others | Others | Others |
| 942 | CD3G | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 943 | CD4 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 944 | CD40 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 945 | CD40LG | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 946 | CD44 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular |
| 947 | CD44 | RNA | Angiogenesis | Immune Activation Status | Immuno-Oncology |
| 948 | CD45R0 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| 949 | CD45RA | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| 950 | CD45RB | RNA | TCR Signaling | Others | Immuno-Oncology |
| 951 | CD45RO | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 952 | CD46 | RNA | Others | Others | Others |
| 953 | CD47 | RNA | Cytotoxicity | Inflammation | Oncology |
| 954 | CD47 | RNA | Cytotoxicity | Inflammation | Inflammation |
| 955 | CD48 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 956 | CD5 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 957 | CD52 | RNA | Others | Others | Others |
| 958 | CD53 | RNA | Others | Inflammation | Inflammation |
| 959 | CD55 | RNA | Others | Others | Others |
| 960 | CD58 | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 961 | CD59 | RNA | Others | Others | Others |
| 962 | CD6 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| 963 | CD63 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 964 | CD68 | RNA | DNA Damage Repair | Immune Cell Typing | Epigenic and Nuclear Signaling |
| 965 | CD68 | RNA | DNA Damage Repair | Immune Cell Typing | Immuno-Oncology |
| 966 | CD69 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 967 | CD7 | RNA | Others | Lymphoid Compartment | Immuno-Oncology |
| 968 | CD70 | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
| 969 | CD72 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 970 | CD74 | RNA | Others | Immunity and Inflammation | Inflammation |
| 971 | CD79A | RNA | Others | Lymphoid Compartment | Immuno-Oncology |
| 972 | CD79B | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 973 | CD80 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 974 | CD81 | RNA | Others | Others | Others |
| 975 | CD82 | RNA | Others | Others | Others |
| 976 | CD83 | RNA | Others | Immunity and Inflammation | Inflammation |
| 977 | CD84 | RNA | Others | Immune Cell Typing | Immuno-Oncology |
| 978 | CD86 | RNA | Costimulatory Signaling | Immune Activation Status | Immuno-Oncology |
| 979 | CD8A | RNA | Antigen Processing | Immune Activation Status | Immuno-Oncology |
| 980 | CD8B | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases |
| 981 | CD8B | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Immuno-Oncology |
| 982 | CD9 | RNA | Myelination | Others | CNS |
| 983 | CD96 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 984 | CD97 | RNA | Others | Others | Others |
| 985 | CD99 | RNA | Others | Others | Others |
| 986 | CDA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 987 | CDC14A | RNA | Proliferation | Others | Oncology |
| 988 | CDC14B | RNA | Proliferation | Immune Activation Status | Oncology |
| 989 | CDC14B | RNA | Proliferation | Immune Activation Status | Immuno-Oncology |
| 990 | CDC16 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 991 | CDC20 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | CNS |
| 992 | CDC20 | RNA | Biosynthesis and Anabolic Pathways | Immune Activation Status | Immuno-Oncology |
| 993 | CDC25A | RNA | Cell Cycle | Immune Activation Status | Oncology |
| 994 | CDC25A | RNA | Cell Cycle | Immune Activation Status | Immuno-Oncology |
| 995 | CDC25B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 996 | CDC25C | RNA | Cell Cycle | Others | Oncology |
| 997 | CDC26 | RNA | Others | Others | Others |
| 998 | CDC27 | RNA | Others | Others | Others |
| 999 | CDC40 | RNA | Others | Others | Others |
| 1000 | CDC42 | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 1001 | CDC6 | RNA | Proliferation | Others | Oncology |
| 1002 | CDC7 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1003 | CDCA5 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1004 | CDCA7L | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1005 | CDCA8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1006 | CDCP1 | RNA | Others | Others | Others |
| 1007 | CDH1 | RNA | Apoptosis | Immune Cell Adhesion and Migration | Oncology |
| 1008 | CDH1 | RNA | Apoptosis | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1009 | CDH11 | RNA | Others | Others | Others |
| 1010 | CDH13 | RNA | Cell Proliferation | Others | CNS |
| 1011 | CDH2 | RNA | EMT | Immune Cell Adhesion and Migration | Oncology |
| 1012 | CDH2 | RNA | EMT | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1013 | CDH3 | RNA | Others | Others | Others |
| 1014 | CDH5 | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Cardiovascular |
| 1015 | CDH5 | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1016 | CDK1 | RNA | Cell Cycle | Others | Oncology |
| 1017 | CDK12 | RNA | p53 Signaling | Others | Oncology |
| 1018 | CDK14 | RNA | Others | Others | Others |
| 1019 | CDK2 | RNA | Cell Cycle | Others | Oncology |
| 1020 | CDK20 | RNA | Others | Others | Others |
| 1021 | CDK4 | RNA | Cell Cycle | Others | Oncology |
| 1022 | CDK5 | RNA | Others | Neural Connectivity | CNS |
| 1023 | CDK5R1 | RNA | Others | Neural Connectivity | CNS |
| 1024 | CDK5RAP3 | RNA | Others | Others | Others |
| 1025 | CDK6 | RNA | Cell Cycle | Others | Oncology |
| 1026 | CDK7 | RNA | Others | Others | Others |
| 1027 | CDK8 | RNA | Others | Others | Others |
| 1028 | CDK9 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1029 | CDKN1A | RNA | Cell Cycle | Immunity and Inflammation | Oncology |
| 1030 | CDKN1A | RNA | Cell Cycle | Immunity and Inflammation | Inflammation |
| 1031 | CDKN1B | RNA | PI3K-AKT | Others | Oncology |
| 1032 | CDKN1C | RNA | DNA Damage Repair | Immune Activation Status | Epigenic and Nuclear Signaling |
| 1033 | CDKN1C | RNA | DNA Damage Repair | Immune Activation Status | Immuno-Oncology |
| 1034 | CDKN2A | RNA | Cell Cycle | Others | Oncology |
| 1035 | CDKN2B | RNA | Metabolism Stress | Others | Metabolic Diseases |
| 1036 | CDKN2C | RNA | Proliferation | Immune Activation Status | Oncology |
| 1037 | CDKN2C | RNA | Proliferation | Immune Activation Status | Immuno-Oncology |
| 1038 | CDKN2D | RNA | Proliferation | Others | Oncology |
| 1039 | CDKN3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1040 | CDON | RNA | Others | Others | Others |
| 1041 | CDS1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1042 | CDY2A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1043 | CEACAM1 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular |
| 1044 | CEACAM1 | RNA | Angiogenesis | Immune Activation Status | Immuno-Oncology |
| 1045 | CEACAM3 | RNA | Others | Immune Cell Typing | Immuno-Oncology |
| 1046 | CEACAM5 | RNA | EMT | Others | Oncology |
| 1047 | CEACAM6 | RNA | EMT | Others | Oncology |
| 1048 | CEACAM8 | RNA | Others | Others | Others |
| 1049 | CEBPA | RNA | Others | Others | Others |
| 1050 | CEBPB | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular |
| 1051 | CEBPB | RNA | AP1 Signaling | Immune Activation Status | Immuno-Oncology |
| 1052 | CEBPD | RNA | Others | Immune Activation Status | Immuno-Oncology |
| 1053 | CEBPE | RNA | Others | Others | Others |
| 1054 | CENPA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1055 | CENPF | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1056 | CEP170 | RNA | Others | Others | Others |
| 1057 | CEP295 | RNA | Others | Others | Others |
| 1058 | CEP55 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1059 | CER1 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1060 | CERS1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1061 | CERS2 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1062 | CERS4 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1063 | CERS6 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1064 | CES3 | RNA | Angiogenesis | Others | Cardiovascular |
| 1065 | CETN2 | RNA | Proliferation | Others | Oncology |
| 1066 | CETP | RNA | Others | Others | Others |
| 1067 | CFB | RNA | Others | Others | Others |
| 1068 | CFD | RNA | Others | Others | Others |
| 1069 | CFH | RNA | Others | Others | Others |
| 1070 | CFHR1 | RNA | Others | Others | Others |
| 1071 | CFHR4 | RNA | Others | Others | Others |
| 1072 | CFHR5 | RNA | Others | Others | Others |
| 1073 | CFI | RNA | Others | Others | Others |
| 1074 | CFL1 | RNA | Others | Others | Others |
| 1075 | CFLAR | RNA | Others | Immunity and Inflammation | Inflammation |
| 1076 | CFP | RNA | Others | Others | Others |
| 1077 | CFTR | RNA | Others | Others | Others |
| 1078 | CGAS | RNA | Others | Others | Others |
| 1079 | CGN | RNA | Others | Others | Others |
| 1080 | CH25H | RNA | Others | Immunity and Inflammation | Inflammation |
| 1081 | CHAD | RNA | PI3K-AKT | Others | Oncology |
| 1082 | CHAT | RNA | Lipid Metabolism | Neural Connectivity | Metabolic Diseases |
| 1083 | CHAT | RNA | Lipid Metabolism | Neural Connectivity | CNS |
| 1084 | CHD4 | RNA | Others | Others | Others |
| 1085 | CHD8 | RNA | Others | Others | Others |
| 1086 | CHEK1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1087 | CHEK2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1088 | CHI3L1 | RNA | Others | Others | Others |
| 1089 | CHIT1 | RNA | Others | Others | Others |
| 1090 | CHL1 | RNA | Others | Others | Others |
| 1091 | CHMP2A | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1092 | CHMP2B | RNA | Others | Others | Others |
| 1093 | CHMP3 | RNA | Others | Others | Others |
| 1094 | CHMP4A | RNA | Others | Others | Others |
| 1095 | CHMP4B | RNA | Others | Others | Others |
| 1096 | CHMP6 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1097 | CHN2 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1098 | CHP1 | RNA | Others | Others | Others |
| 1099 | CHP2 | RNA | Others | Others | Others |
| 1100 | CHRD | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1101 | CHRDL1 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1102 | CHRM5 | RNA | Others | Neural Connectivity | CNS |
| 1103 | CHRNA5 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1104 | CHRNA7 | RNA | Cell Proliferation | Neural Connectivity | CNS |
| 1105 | CHRNB2 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 1106 | CHST8 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1107 | CHUK | RNA | Costimulatory Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1108 | CHUK | RNA | Costimulatory Signaling | Immunity and Inflammation | Inflammation |
| 1109 | CIB1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1110 | CIC | RNA | Others | Others | Others |
| 1111 | CIDEA | RNA | Others | Others | Others |
| 1112 | CIDEB | RNA | Others | Others | Others |
| 1113 | CIITA | RNA | Others | Others | Others |
| 1114 | CISH | RNA | Others | Others | Others |
| 1115 | CKAP4 | RNA | Others | Others | Others |
| 1116 | CKAP5 | RNA | Others | Others | Others |
| 1117 | CKB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1118 | CKLF | RNA | Others | Others | Others |
| 1119 | CKMT1A | RNA | EMT | Others | Oncology |
| 1120 | CKS1B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1121 | CLCA1 | RNA | Others | Others | Others |
| 1122 | CLCF1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1123 | CLDN1 | RNA | Others | Others | Others |
| 1124 | CLDN15 | RNA | Others | Others | Others |
| 1125 | CLDN23 | RNA | Others | Others | Others |
| 1126 | CLDN3 | RNA | EMT | Others | Oncology |
| 1127 | CLDN4 | RNA | EMT | Others | Oncology |
| 1128 | CLDN5 | RNA | Myelination | Others | CNS |
| 1129 | CLDN7 | RNA | EMT | Others | Oncology |
| 1130 | CLEC14A | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Cardiovascular |
| 1131 | CLEC14A | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1132 | CLEC2B | RNA | Others | Others | Others |
| 1133 | CLEC3B | RNA | Others | Others | Others |
| 1134 | CLEC4A | RNA | Others | Others | Others |
| 1135 | CLEC4C | RNA | Others | Others | Others |
| 1136 | CLEC4E | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1137 | CLEC5A | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1138 | CLEC6A | RNA | Others | Others | Others |
| 1139 | CLEC7A | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1140 | CLECL1 | RNA | Others | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1141 | CLIC4 | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular |
| 1142 | CLIC4 | RNA | Angiogenesis | Immunity and Inflammation | Inflammation |
| 1143 | CLN3 | RNA | Others | Neural Connectivity | CNS |
| 1144 | CLN8 | RNA | Oxydative Stress | Neural Connectivity | Inflammation |
| 1145 | CLN8 | RNA | Oxydative Stress | Neural Connectivity | CNS |
| 1146 | CLOCK | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1147 | CLSPN | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1148 | CLSTN1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1149 | CLU | RNA | Cell Proliferation | Others | CNS |
| 1150 | CMA1 | RNA | Cellular Differentiation | Others | Oncology |
| 1151 | CMIP | RNA | Others | Others | Others |
| 1152 | CMKLR1 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 1153 | CMTM4 | RNA | Others | Others | Others |
| 1154 | CMTM6 | RNA | Others | Others | Others |
| 1155 | CMV UL83 | RNA | Others | Others | Others |
| 1156 | CNKSR2 | RNA | Others | Neural Connectivity | CNS |
| 1157 | CNN1 | RNA | Others | Others | Others |
| 1158 | CNN2 | RNA | Others | Others | Others |
| 1159 | CNOT10 | RNA | Others | Others | Others |
| 1160 | CNOT2 | RNA | Others | Others | Others |
| 1161 | CNOT4 | RNA | Others | Others | Others |
| 1162 | CNP | RNA | Others | Others | Others |
| 1163 | CNR1 | RNA | Others | Transmitter Response and Reuptake | CNS |
| 1164 | CNTF | RNA | Others | Others | Others |
| 1165 | CNTFR | RNA | Cytotoxicity | Others | Oncology |
| 1166 | CNTN1 | RNA | Others | Others | Others |
| 1167 | CNTN4 | RNA | Others | Vesicle Trafficking | CNS |
| 1168 | CNTNAP1 | RNA | Myelination | Others | CNS |
| 1169 | CNTNAP2 | RNA | Others | Others | Others |
| 1170 | COA5 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1171 | COG7 | RNA | Others | Others | Others |
| 1172 | COL10A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1173 | COL11A1 | RNA | Matrix Remodeling and Metastases | Myeloid Compartment | CNS |
| 1174 | COL11A2 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 1175 | COL14A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1176 | COL16A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1177 | COL17A1 | RNA | Matrix Remodeling and Metastases | Myeloid Compartment | CNS |
| 1178 | COL18A1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1179 | COL1A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1180 | COL1A2 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1181 | COL24A1 | RNA | Others | Others | Others |
| 1182 | COL27A1 | RNA | PI3K-AKT | Others | Oncology |
| 1183 | COL2A1 | RNA | PI3K-AKT | Others | Oncology |
| 1184 | COL3A1 | RNA | Cellular Differentiation | Others | Oncology |
| 1185 | COL4A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1186 | COL4A2 | RNA | Angiogenesis | Others | Cardiovascular |
| 1187 | COL4A3 | RNA | Others | Others | Others |
| 1188 | COL4A4 | RNA | Others | Others | Others |
| 1189 | COL4A5 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 1190 | COL4A6 | RNA | PI3K-AKT | Others | Oncology |
| 1191 | COL5A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1192 | COL5A2 | RNA | Cellular Differentiation | Others | Oncology |
| 1193 | COL5A3 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1194 | COL6A1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 1195 | COL6A2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 1196 | COL6A3 | RNA | Collagen Biosynthesis & Modification | Immunity and Inflammation | CNS |
| 1197 | COL6A3 | RNA | Collagen Biosynthesis & Modification | Immunity and Inflammation | Inflammation |
| 1198 | COL6A5 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1199 | COL6A6 | RNA | Others | Others | Others |
| 1200 | COL7A1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1201 | COL9A3 | RNA | Others | Others | Others |
| 1202 | COLEC12 | RNA | Others | Others | Others |
| 1203 | COMP | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 1204 | COMT | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 1205 | COP1 | RNA | Cell Cycle | Others | Oncology |
| 1206 | COPS6 | RNA | Cell Stress | Others | CNS |
| 1207 | COTL1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1208 | COX14 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1209 | COX16 | RNA | Others | Others | Others |
| 1210 | COX19 | RNA | Others | Others | Others |
| 1211 | COX4I1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1212 | COX4I2 | RNA | Others | Others | Others |
| 1213 | COX5A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1214 | COX5B | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS |
| 1215 | COX5B | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | Inflammation |
| 1216 | COX6A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1217 | COX6B1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1218 | COX6C | RNA | Others | Others | Others |
| 1219 | COX7A2 | RNA | Others | Others | Others |
| 1220 | COX7B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1221 | COX7C | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1222 | COX8A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1223 | CP | RNA | Others | Others | Others |
| 1224 | CPA3 | RNA | Others | Immune Cell Typing | Immuno-Oncology |
| 1225 | CPA4 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1226 | CPB2 | RNA | Others | Others | Others |
| 1227 | CPLX1 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 1228 | CPN1 | RNA | Others | Others | Others |
| 1229 | CPS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1230 | CPSF7 | RNA | Others | Others | Others |
| 1231 | CPT1A | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1232 | CPT1B | RNA | Carbohydrate Metabolism | Others | CNS |
| 1233 | CPT1C | RNA | Others | Others | Others |
| 1234 | CPT2 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1235 | CR1 | RNA | Others | Others | Others |
| 1236 | CR2 | RNA | Others | Others | Others |
| 1237 | CRABP2 | RNA | Others | Myeloid Compartment | CNS |
| 1238 | CRADD | RNA | Others | Others | Others |
| 1239 | CRCP | RNA | Others | Others | Others |
| 1240 | CREB1 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
| 1241 | CREB1 | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
| 1242 | CREB3 | RNA | Others | Others | Others |
| 1243 | CREB3L1 | RNA | Others | Others | Others |
| 1244 | CREB3L2 | RNA | Others | Others | Others |
| 1245 | CREB3L3 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 1246 | CREB3L4 | RNA | Others | Others | Others |
| 1247 | CREB5 | RNA | Others | Others | Others |
| 1248 | CREBBP | RNA | Chromatin Modification | Immune Suppression | Epigenic and Nuclear Signaling |
| 1249 | CREBBP | RNA | Chromatin Modification | Immune Suppression | Immuno-Oncology |
| 1250 | CREM | RNA | Others | Others | Others |
| 1251 | CRH | RNA | Others | Transmitter Release | CNS |
| 1252 | CRIP1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1253 | CRIP2 | RNA | Cell Proliferation | Others | CNS |
| 1254 | CRISPLD2 | RNA | Others | Others | Others |
| 1255 | CRK | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 1256 | CRKL | RNA | Others | Others | Others |
| 1257 | CRLF1 | RNA | Others | Others | Others |
| 1258 | CRLF2 | RNA | Others | Others | Others |
| 1259 | CRP | RNA | Others | Others | Others |
| 1260 | CRTAM | RNA | Others | Others | Others |
| 1261 | CRTC2 | RNA | Carbohydrate Metabolism | Others | CNS |
| 1262 | CRYAB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1263 | CRYBA4 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1264 | CS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1265 | CSF1 | RNA | Cytokine and Chemokine Signaling | Immune Suppression | Immuno-Oncology |
| 1266 | CSF1R | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1267 | CSF1R | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
| 1268 | CSF2 | RNA | Cytokine and Chemokine Signaling | Immune Suppression | Immuno-Oncology |
| 1269 | CSF2RA | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 1270 | CSF2RB | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1271 | CSF2RB | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1272 | CSF2RB | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
| 1273 | CSF3 | RNA | Cytokine and Chemokine Signaling | Immune Suppression | Immuno-Oncology |
| 1274 | CSF3R | RNA | Cytokine and Chemokine Signaling | Immune Cell Typing | Immuno-Oncology |
| 1275 | CSH2/GH2 | RNA | Others | Others | Others |
| 1276 | CSK | RNA | Others | Immunity and Inflammation | Inflammation |
| 1277 | CSNK1A1 | RNA | Others | Others | Others |
| 1278 | CSNK1D | RNA | Others | Others | Others |
| 1279 | CSNK1E | RNA | Others | Others | Others |
| 1280 | CSNK1G3 | RNA | Others | Others | Others |
| 1281 | CSNK2A1 | RNA | Others | Others | Others |
| 1282 | CSNK2B | RNA | Others | Others | Others |
| 1283 | CSPG4 | RNA | Angiogenesis | Others | Cardiovascular |
| 1284 | CST2 | RNA | Others | Others | Others |
| 1285 | CST7 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1286 | CT45A1 | RNA | Others | Others | Others |
| 1287 | CTAG1A/B | RNA | Others | Others | Others |
| 1288 | CTAG1B | RNA | Others | Others | Others |
| 1289 | CTAGE1 | RNA | Others | Others | Others |
| 1290 | CTBP2 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1291 | CTCF | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1292 | CTCFL | RNA | Others | Others | Others |
| 1293 | CTF1 | RNA | Others | Others | Others |
| 1294 | CTLA4 | RNA | Costimulatory Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1295 | CTLA4_all (common probe) | RNA | TCR Signaling | Others | Immuno-Oncology |
| 1296 | CTLA4-TM (membrane-bound form) | RNA | TCR Signaling | Others | Immuno-Oncology |
| 1297 | CTNNA1 | RNA | Hippo Signaling | Others | CNS |
| 1298 | CTNNB1 | RNA | Androgen Signaling | Immune Cell Adhesion and Migration | Oncology |
| 1299 | CTNNB1 | RNA | Androgen Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1300 | CTNND1 | RNA | Others | Others | Others |
| 1301 | CTNS | RNA | Others | Others | Others |
| 1302 | CTPS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1303 | CTSA | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1304 | CTSB | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1305 | CTSC | RNA | Others | Others | Others |
| 1306 | CTSD | RNA | Nutrient Capture and Catabolic Pathways | Microglia | Metabolic Diseases |
| 1307 | CTSD | RNA | Nutrient Capture and Catabolic Pathways | Microglia | CNS |
| 1308 | CTSE | RNA | Others | Immunity and Inflammation | Inflammation |
| 1309 | CTSF | RNA | Others | Immunity and Inflammation | Inflammation |
| 1310 | CTSG | RNA | Cellular Differentiation | Others | Oncology |
| 1311 | CTSH | RNA | Cell Proliferation | Others | CNS |
| 1312 | CTSK | RNA | Others | Others | Others |
| 1313 | CTSL | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 1314 | CTSO | RNA | Others | Others | Others |
| 1315 | CTSS | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | CNS |
| 1316 | CTSS | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | Inflammation |
| 1317 | CTSW | RNA | Nutrient Capture and Catabolic Pathways | Immune Cell Typing | Metabolic Diseases |
| 1318 | CTSW | RNA | Nutrient Capture and Catabolic Pathways | Immune Cell Typing | Immuno-Oncology |
| 1319 | CTSZ | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1320 | CUL1 | RNA | Cell Proliferation | Immune Suppression | CNS |
| 1321 | CUL1 | RNA | Cell Proliferation | Immune Suppression | Immuno-Oncology |
| 1322 | CUL2 | RNA | Others | Others | Others |
| 1323 | CUL3 | RNA | Others | Others | Others |
| 1324 | CUL9 | RNA | Others | Others | Others |
| 1325 | CX3CL1 | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular |
| 1326 | CX3CL1 | RNA | Angiogenesis | Immunity and Inflammation | Inflammation |
| 1327 | CX3CR1 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1328 | CX3CR1 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
| 1329 | CXADR | RNA | EMT | Others | Oncology |
| 1330 | CXCL1 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
| 1331 | CXCL1 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
| 1332 | CXCL1/2/3 | RNA | Others | Others | Others |
| 1333 | CXCL10 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
| 1334 | CXCL10 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
| 1335 | CXCL11 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
| 1336 | CXCL12 | RNA | Cell Proliferation | Immune Cell Adhesion and Migration | CNS |
| 1337 | CXCL12 | RNA | Cell Proliferation | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1338 | CXCL13 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
| 1339 | CXCL14 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 1340 | CXCL16 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
| 1341 | CXCL17 | RNA | Angiogenesis | Others | Cardiovascular |
| 1342 | CXCL2 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
| 1343 | CXCL2 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
| 1344 | CXCL3 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
| 1345 | CXCL3 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
| 1346 | CXCL5 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
| 1347 | CXCL5 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
| 1348 | CXCL6 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | Immuno-Oncology |
| 1349 | CXCL6 | RNA | Cytokine and Chemokine Signaling | Myeloid Compartment | CNS |
| 1350 | CXCL8 | RNA | Angiogenesis | Immune Suppression | Cardiovascular |
| 1351 | CXCL8 | RNA | Angiogenesis | Immune Suppression | Immuno-Oncology |
| 1352 | CXCL9 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1353 | CXCL9 | RNA | Cytokine and Chemokine Signaling | Immunity and Inflammation | Inflammation |
| 1354 | CXCR1 | RNA | Others | Others | Others |
| 1355 | CXCR2 | RNA | Cell Proliferation | Others | CNS |
| 1356 | CXCR3 | RNA | Angiogenesis | Lymphoid Compartment | Cardiovascular |
| 1357 | CXCR3 | RNA | Angiogenesis | Lymphoid Compartment | Immuno-Oncology |
| 1358 | CXCR4 | RNA | Cytokine and Chemokine Signaling | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1359 | CXCR5 | RNA | Others | Others | Others |
| 1360 | CXCR6 | RNA | Cytokine and Chemokine Signaling | M1 Activation | Immuno-Oncology |
| 1361 | CXCR6 | RNA | Cytokine and Chemokine Signaling | M1 Activation | CNS |
| 1362 | CXorf36 | RNA | Angiogenesis | Others | Cardiovascular |
| 1363 | CXXC1 | RNA | Others | Others | Others |
| 1364 | CXXC4 | RNA | Others | Others | Others |
| 1365 | CXXC5 | RNA | Others | Others | Others |
| 1366 | CYB561 | RNA | Others | Others | Others |
| 1367 | CYBA | RNA | Others | Others | Others |
| 1368 | CYBB | RNA | Cell Stress | Immune Cell Adhesion and Migration | CNS |
| 1369 | CYBB | RNA | Cell Stress | Immune Cell Adhesion and Migration | Immuno-Oncology |
| 1370 | CYC1 | RNA | Others | Others | Others |
| 1371 | CYCS | RNA | Oxydative Stress | Others | Inflammation |
| 1372 | CYFIP1 | RNA | Others | Inflammation | Inflammation |
| 1373 | CYFIP2 | RNA | Others | Others | Others |
| 1374 | CYLD | RNA | Others | Others | Others |
| 1375 | CYP19A1 | RNA | Others | Others | Others |
| 1376 | CYP1A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1377 | CYP1A2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1378 | CYP1B1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1379 | CYP26A1 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1380 | CYP26C1 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1381 | CYP27A1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1382 | CYP2C19 | RNA | Others | Others | Others |
| 1383 | CYP2C8 | RNA | Others | Others | Others |
| 1384 | CYP2C9 | RNA | Others | Others | Others |
| 1385 | CYP2E1 | RNA | Others | Others | Others |
| 1386 | CYP2J2 | RNA | Others | Others | Others |
| 1387 | CYP4A11 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1388 | CYP4A11/22 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1389 | CYP4A22 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1390 | CYP4F3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1391 | CYP4X1 | RNA | Others | Transmitter Release | CNS |
| 1392 | CYP7A1 | RNA | Others | Others | Others |
| 1393 | CYP7B1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1394 | CYP8B1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1395 | CYSLTR1 | RNA | Others | Others | Others |
| 1396 | CYSLTR2 | RNA | Others | Others | Others |
| 1397 | CYSTM1 | RNA | Others | Others | Others |
| 1398 | CYTIP | RNA | Others | Immunity and Inflammation | Inflammation |
| 1399 | D2HGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1400 | DAB2 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1401 | DAB2IP | RNA | Others | Others | Others |
| 1402 | DACH2 | RNA | Others | Others | Others |
| 1403 | DAG1 | RNA | Others | Others | Others |
| 1404 | DAGLA | RNA | Transmitter Synthesis | Transmitter Response and Reuptake | CNS |
| 1405 | DAO | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1406 | DAP3 | RNA | Others | Others | Others |
| 1407 | DAPK1 | RNA | Others | Others | Others |
| 1408 | DAPP1 | RNA | Others | Others | Others |
| 1409 | DAXX | RNA | Others | Others | Others |
| 1410 | DBH | RNA | Transmitter Synthesis | Vesicle Trafficking | CNS |
| 1411 | DCC | RNA | Others | Others | Others |
| 1412 | DCK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1413 | DCN | RNA | DNA Damage Repair | Immune Suppression | Epigenic and Nuclear Signaling |
| 1414 | DCN | RNA | DNA Damage Repair | Immune Suppression | Immuno-Oncology |
| 1415 | DCTN6 | RNA | Others | Others | Others |
| 1416 | DCX | RNA | Others | Others | Others |
| 1417 | DDAH2 | RNA | Others | Others | Others |
| 1418 | DDB2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1419 | DDC | RNA | Biosynthesis and Anabolic Pathways | Neural Connectivity | CNS |
| 1420 | DDIT3 | RNA | Oxydative Stress | Others | Inflammation |
| 1421 | DDIT4 | RNA | Others | Others | Others |
| 1422 | DDOST | RNA | Others | Others | Others |
| 1423 | DDR2 | RNA | EMT | Others | Oncology |
| 1424 | DDX23 | RNA | Others | Others | Others |
| 1425 | DDX24 | RNA | Others | Others | Others |
| 1426 | DDX39A | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1427 | DDX43 | RNA | Others | Others | Others |
| 1428 | DDX5 | RNA | Others | Others | Others |
| 1429 | DDX50 | RNA | Others | Others | Others |
| 1430 | DDX58 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1431 | DECR1 | RNA | Others | Others | Others |
| 1432 | DEFA1 | RNA | Others | Others | Others |
| 1433 | DEFA4 | RNA | Others | Others | Others |
| 1434 | DEFB1 | RNA | Others | Others | Others |
| 1435 | DEFB103A | RNA | Others | Others | Others |
| 1436 | DEFB103A/B | RNA | Others | Others | Others |
| 1437 | DEFB103B | RNA | Others | Others | Others |
| 1438 | DEFB134 | RNA | Others | Others | Others |
| 1439 | DEFB4A | RNA | Others | Others | Others |
| 1440 | DENND5A | RNA | Others | Others | Others |
| 1441 | DENR | RNA | Cell Proliferation | Others | CNS |
| 1442 | DEPDC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1443 | DEPDC5 | RNA | Others | Others | Others |
| 1444 | DEPTOR | RNA | Autophagy | Others | Cardiovascular |
| 1445 | DERA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1446 | DERL1 | RNA | Others | Others | Others |
| 1447 | DERL2 | RNA | Others | Others | Others |
| 1448 | DES | RNA | Others | Neural Connectivity | CNS |
| 1449 | DESI1 | RNA | Others | Others | Others |
| 1450 | DGKA | RNA | Others | Others | Others |
| 1451 | DGKB | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1452 | DGKE | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1453 | DGKZ | RNA | Others | Others | Others |
| 1454 | DGLUCY | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1455 | DGUOK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1456 | DHFR2 | RNA | Others | Others | Others |
| 1457 | DHRS2 | RNA | Others | Others | Others |
| 1458 | DHRS3 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1459 | DHRS4 | RNA | Others | Others | Others |
| 1460 | DHX16 | RNA | Others | Others | Others |
| 1461 | DHX58 | RNA | Others | Others | Others |
| 1462 | DIABLO | RNA | Others | Others | Others |
| 1463 | DIAPH1 | RNA | Others | Others | Others |
| 1464 | DICER1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1465 | DIPK2B | RNA | Others | Others | Others |
| 1466 | DKC1 | RNA | Cell Cycle | Others | Oncology |
| 1467 | DKK1 | RNA | Wnt Signaling | Others | CNS |
| 1468 | DKK2 | RNA | Wnt Signaling | Others | CNS |
| 1469 | DKK4 | RNA | Others | Others | Others |
| 1470 | DLAT | RNA | Carbohydrate Metabolism | Others | CNS |
| 1471 | DLC1 | RNA | Cellular Differentiation | Others | Oncology |
| 1472 | DLD | RNA | Carbohydrate Metabolism | Immune Suppression | CNS |
| 1473 | DLD | RNA | Carbohydrate Metabolism | Immune Suppression | Immuno-Oncology |
| 1474 | DLG1 | RNA | Cell Proliferation | Others | CNS |
| 1475 | DLG3 | RNA | Others | Neural Connectivity | CNS |
| 1476 | DLG4 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1477 | DLGAP1 | RNA | Others | Neural Connectivity | CNS |
| 1478 | DLGAP5 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1479 | DLL1 | RNA | Notch | Others | Immuno-Oncology |
| 1480 | DLL3 | RNA | Notch | Immune Suppression | Immuno-Oncology |
| 1481 | DLL4 | RNA | Angiogenesis | Immune Suppression | Cardiovascular |
| 1482 | DLL4 | RNA | Angiogenesis | Immune Suppression | Immuno-Oncology |
| 1483 | DLX1 | RNA | Others | Others | Others |
| 1484 | DLX2 | RNA | Others | Others | Others |
| 1485 | DMBT1 | RNA | Others | Others | Others |
| 1486 | DMGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1487 | DNA2 | RNA | Cell Cycle | Others | Oncology |
| 1488 | DNAH1 | RNA | Others | Neuronal Cytoskeleton | CNS |
| 1489 | DNAJA2 | RNA | Others | Others | Others |
| 1490 | DNAJC10 | RNA | Others | Others | Others |
| 1491 | DNAJC12 | RNA | ER Signaling | Others | Oncology |
| 1492 | DNAJC14 | RNA | Others | Others | Others |
| 1493 | DNM1L | RNA | Others | Neural Connectivity | CNS |
| 1494 | DNM2 | RNA | Oxydative Stress | Neural Connectivity | Inflammation |
| 1495 | DNM2 | RNA | Oxydative Stress | Neural Connectivity | CNS |
| 1496 | DNMT1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1497 | DNMT3A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1498 | DNMT3B | RNA | Others | Others | Others |
| 1499 | DNMT3L | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1500 | DOCK1 | RNA | Others | Others | Others |
| 1501 | DOCK2 | RNA | Others | Inflammation | Inflammation |
| 1502 | DOCK9 | RNA | Others | Others | Others |
| 1503 | DOT1L | RNA | Others | Others | Others |
| 1504 | DPP4 | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
| 1505 | DPT | RNA | Cell Proliferation | Others | CNS |
| 1506 | DPYSL3 | RNA | Others | Others | Others |
| 1507 | DRAP1 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1508 | DRD1 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 1509 | DRD2 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 1510 | DRD4 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 1511 | DSC2 | RNA | EMT | Others | Oncology |
| 1512 | DSC3 | RNA | Others | Others | Others |
| 1513 | DSP | RNA | Others | Others | Others |
| 1514 | DST | RNA | Others | Immunity and Inflammation | Inflammation |
| 1515 | DTL | RNA | Cell Stress | Others | CNS |
| 1516 | DTX1 | RNA | Notch | Others | Immuno-Oncology |
| 1517 | DTX3 | RNA | Notch | Others | Immuno-Oncology |
| 1518 | DTX3L | RNA | Notch | Others | Immuno-Oncology |
| 1519 | DTX4 | RNA | Notch | Immune Suppression | Immuno-Oncology |
| 1520 | DUOX1 | RNA | Cell Stress | Others | CNS |
| 1521 | DUOX2 | RNA | Cell Stress | Others | CNS |
| 1522 | DUOXA1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1523 | DUSP1 | RNA | MAPK | Others | Cardiovascular |
| 1524 | DUSP10 | RNA | Others | Others | Others |
| 1525 | DUSP2 | RNA | MAPK | Others | Cardiovascular |
| 1526 | DUSP4 | RNA | MAPK | Others | Cardiovascular |
| 1527 | DUSP5 | RNA | MAPK | Others | Cardiovascular |
| 1528 | DUSP6 | RNA | MAPK | Others | Cardiovascular |
| 1529 | DUSP7 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1530 | DUSP8 | RNA | Others | Others | Others |
| 1531 | DUSP9 | RNA | Others | Others | Others |
| 1532 | DVL1 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1533 | DVL2 | RNA | Others | Others | Others |
| 1534 | DYDC1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1535 | DYNLL1 | RNA | Others | Others | Others |
| 1536 | DYNLL2 | RNA | Others | Others | Others |
| 1537 | DYSF | RNA | Others | Others | Others |
| 1538 | E2F1 | RNA | Cell Cycle | Immune Suppression | Oncology |
| 1539 | E2F1 | RNA | Cell Cycle | Immune Suppression | Immuno-Oncology |
| 1540 | E2F2 | RNA | Cell Cycle | Others | Oncology |
| 1541 | E2F3 | RNA | Angiogenesis | Others | Cardiovascular |
| 1542 | E2F4 | RNA | Others | Others | Others |
| 1543 | E2F5 | RNA | Proliferation | Immune Suppression | Oncology |
| 1544 | E2F5 | RNA | Proliferation | Immune Suppression | Immuno-Oncology |
| 1545 | EBI3 | RNA | Others | Others | Others |
| 1546 | EBV LMP2 | RNA | Others | Others | Others |
| 1547 | ECHS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1548 | ECM1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1549 | ECM2 | RNA | EMT | Others | Oncology |
| 1550 | ECSCR | RNA | Angiogenesis | Others | Cardiovascular |
| 1551 | ECSIT | RNA | Others | Others | Others |
| 1552 | EDC3 | RNA | Others | Others | Others |
| 1553 | EDN1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1554 | EDNRB | RNA | Others | Others | Others |
| 1555 | EEA1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1556 | EED | RNA | Others | Others | Others |
| 1557 | EEF2K | RNA | Others | Immunity and Inflammation | Inflammation |
| 1558 | EFNA1 | RNA | RAS | Others | Oncology |
| 1559 | EFNA2 | RNA | RAS | Others | Oncology |
| 1560 | EFNA3 | RNA | MAPK | Others | Cardiovascular |
| 1561 | EFNA4 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 1562 | EFNA5 | RNA | MAPK | Others | Cardiovascular |
| 1563 | EFNB3 | RNA | Others | Others | Others |
| 1564 | EFR3A | RNA | Others | Others | Others |
| 1565 | EGF | RNA | Angiogenesis | Others | Cardiovascular |
| 1566 | EGFL7 | RNA | Angiogenesis | Others | Cardiovascular |
| 1567 | EGFR | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
| 1568 | EGFR | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
| 1569 | EGLN1 | RNA | Others | Others | Others |
| 1570 | EGLN2 | RNA | Proliferation | Others | Oncology |
| 1571 | EGLN3 | RNA | Cell Proliferation | Others | CNS |
| 1572 | EGR1 | RNA | Costimulatory Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1573 | EGR1 | RNA | Costimulatory Signaling | Immunity and Inflammation | Inflammation |
| 1574 | EGR2 | RNA | Myelination | Vesicle Trafficking | CNS |
| 1575 | EHHADH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1576 | EHMT1 | RNA | Others | Others | Others |
| 1577 | EHMT2 | RNA | Others | Others | Others |
| 1578 | EIF1 | RNA | Others | Others | Others |
| 1579 | EIF2AK2 | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 1580 | EIF2AK3 | RNA | Angiogenesis | Others | Cardiovascular |
| 1581 | EIF2B4 | RNA | Others | Others | Others |
| 1582 | EIF2S1 | RNA | Others | Others | Others |
| 1583 | EIF3B | RNA | ER Signaling | Others | Oncology |
| 1584 | EIF3F | RNA | Others | Others | Others |
| 1585 | EIF4A2 | RNA | Others | Others | Others |
| 1586 | EIF4B | RNA | Others | Others | Others |
| 1587 | EIF4E2 | RNA | Cellular Differentiation | Others | Oncology |
| 1588 | EIF4EBP1 | RNA | Hypoxia | Others | Cardiovascular |
| 1589 | EIF4G1 | RNA | mTOR Signaling | Others | Oncology |
| 1590 | EIF5AL1 | RNA | Others | Others | Others |
| 1591 | ELANE | RNA | Others | Others | Others |
| 1592 | ELAVL1 | RNA | Others | Others | Others |
| 1593 | ELF3 | RNA | EMT | Others | Oncology |
| 1594 | ELK1 | RNA | Others | Others | Others |
| 1595 | ELK3 | RNA | Angiogenesis | Others | Cardiovascular |
| 1596 | ELMO1 | RNA | Others | Others | Others |
| 1597 | ELN | RNA | Others | Others | Others |
| 1598 | ELOB | RNA | Others | Others | Others |
| 1599 | ELOVL2 | RNA | ER Signaling | Others | Oncology |
| 1600 | ELOVL3 | RNA | Others | Others | Others |
| 1601 | ELOVL4 | RNA | Others | Others | Others |
| 1602 | ELOVL5 | RNA | Androgen Signaling | Others | Oncology |
| 1603 | ELOVL6 | RNA | Others | Others | Others |
| 1604 | ELOVL7 | RNA | Others | Others | Others |
| 1605 | EMCN | RNA | Angiogenesis | Others | Cardiovascular |
| 1606 | EME1 | RNA | Cell Stress | Others | CNS |
| 1607 | EMILIN1 | RNA | Cellular Differentiation | Others | Oncology |
| 1608 | EMILIN3 | RNA | Others | Others | Others |
| 1609 | EMP1 | RNA | Others | Others | Others |
| 1610 | EMP2 | RNA | Others | Others | Others |
| 1611 | EMP3 | RNA | Cell Proliferation | Others | CNS |
| 1612 | ENDOG | RNA | Others | Others | Others |
| 1613 | ENG | RNA | Others | Others | Others |
| 1614 | ENO1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1615 | ENO2 | RNA | Others | Others | Others |
| 1616 | ENO3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1617 | ENPEP | RNA | Angiogenesis | Others | Cardiovascular |
| 1618 | ENPP2 | RNA | EMT | Others | Oncology |
| 1619 | ENPP6 | RNA | Others | Others | Others |
| 1620 | ENTPD1 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1621 | ENTPD2 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1622 | ENTPD4 | RNA | Others | Others | Others |
| 1623 | EOMES | RNA | Transcriptional Regulation | Immune Cell Typing | Epigenic and Nuclear Signaling |
| 1624 | EOMES | RNA | Transcriptional Regulation | Immune Cell Typing | Immuno-Oncology |
| 1625 | EP300 | RNA | DNA Damage Repair | Immunity and Inflammation | Epigenic and Nuclear Signaling |
| 1626 | EP300 | RNA | DNA Damage Repair | Immunity and Inflammation | Inflammation |
| 1627 | EP400 | RNA | Others | Others | Others |
| 1628 | EPAS1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1629 | EPC1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1630 | EPCAM | RNA | Cell Proliferation | Pan-Tumor | CNS |
| 1631 | EPCAM | RNA | Cell Proliferation | Pan-Tumor | Oncology |
| 1632 | EPG5 | RNA | Others | Others | Others |
| 1633 | EPHA1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1634 | EPHA2 | RNA | Angiogenesis | Others | Cardiovascular |
| 1635 | EPHA3 | RNA | Others | Others | Others |
| 1636 | EPHA4 | RNA | Others | Neural Connectivity | CNS |
| 1637 | EPHA5 | RNA | Others | Others | Others |
| 1638 | EPHA6 | RNA | Others | Others | Others |
| 1639 | EPHA7 | RNA | Others | Neural Connectivity | CNS |
| 1640 | EPHB1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1641 | EPHB3 | RNA | Angiogenesis | Others | Cardiovascular |
| 1642 | EPHB4 | RNA | Angiogenesis | Others | Cardiovascular |
| 1643 | EPHX2 | RNA | Others | Others | Others |
| 1644 | EPM2AIP1 | RNA | Others | Others | Others |
| 1645 | EPN3 | RNA | Others | Others | Others |
| 1646 | EPO | RNA | Others | Others | Others |
| 1647 | EPOR | RNA | Others | Others | Others |
| 1648 | EPS8L1 | RNA | Others | Others | Others |
| 1649 | EPSTI1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1650 | ERAP2 | RNA | Others | Others | Others |
| 1651 | ERBB2 | RNA | EMT | Others | Oncology |
| 1652 | ERBB2IP | RNA | Others | Others | Others |
| 1653 | ERBB3 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
| 1654 | ERBB3 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
| 1655 | ERBB4 | RNA | Others | Others | Others |
| 1656 | ERC1 | RNA | Others | Others | Others |
| 1657 | ERCC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1658 | ERCC2 | RNA | DNA Damage Repair | Immunity and Inflammation | Epigenic and Nuclear Signaling |
| 1659 | ERCC2 | RNA | DNA Damage Repair | Immunity and Inflammation | Inflammation |
| 1660 | ERCC3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1661 | ERCC6 | RNA | Cell Stress | Others | CNS |
| 1662 | EREG | RNA | Angiogenesis | Others | Cardiovascular |
| 1663 | ERG | RNA | Others | Others | Others |
| 1664 | ERLEC1 | RNA | Others | Others | Others |
| 1665 | ERMP1 | RNA | Others | Others | Others |
| 1666 | ERN1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1667 | ERO1A | RNA | Metabolism Stress | Others | Metabolic Diseases |
| 1668 | ERP29 | RNA | Others | Others | Others |
| 1669 | ESAM | RNA | Others | Others | Others |
| 1670 | ESPL1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1671 | ESR1 | RNA | ER Signaling | Others | Oncology |
| 1672 | ESR2 | RNA | Others | Others | Others |
| 1673 | ESRP1 | RNA | FGFR Signaling | Others | Cardiovascular |
| 1674 | ESRP2 | RNA | FGFR Signaling | Others | Cardiovascular |
| 1675 | ETS1 | RNA | Others | Others | Others |
| 1676 | ETS2 | RNA | RAS | Immunity and Inflammation | Oncology |
| 1677 | ETS2 | RNA | RAS | Immunity and Inflammation | Inflammation |
| 1678 | ETV1 | RNA | Others | Others | Others |
| 1679 | ETV4 | RNA | Cell Proliferation | Others | CNS |
| 1680 | ETV7 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 1681 | EVI2A | RNA | Others | Others | Others |
| 1682 | EVL | RNA | Others | Others | Others |
| 1683 | EVPL | RNA | Others | Others | Others |
| 1684 | EWSR1 | RNA | Others | Others | Others |
| 1685 | EXO1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1686 | EYA1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1687 | EYA2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1688 | EYA4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1689 | EZH1 | RNA | Others | Others | Others |
| 1690 | EZH2 | RNA | Angiogenesis | Others | Cardiovascular |
| 1691 | F11R | RNA | Cellular Differentiation | Others | Oncology |
| 1692 | F12 | RNA | Others | Others | Others |
| 1693 | F13A1 | RNA | Others | Others | Others |
| 1694 | F2 | RNA | Others | Transmitter Response and Reuptake | CNS |
| 1695 | F2RL1 | RNA | Others | Lymphoid Compartment | Immuno-Oncology |
| 1696 | F3 | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
| 1697 | F3 | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
| 1698 | F5 | RNA | Others | Others | Others |
| 1699 | F8 | RNA | Others | Others | Others |
| 1700 | FA2H | RNA | Myelination | Others | CNS |
| 1701 | FAAP24 | RNA | Others | Others | Others |
| 1702 | FABP1 | RNA | Others | Others | Others |
| 1703 | FABP4 | RNA | Others | Others | Others |
| 1704 | FABP5 | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS |
| 1705 | FABP5 | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | Inflammation |
| 1706 | FADD | RNA | Apoptosis | Immunity and Inflammation | Oncology |
| 1707 | FADD | RNA | Apoptosis | Immunity and Inflammation | Inflammation |
| 1708 | FAH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1709 | FAHD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1710 | FAM124B | RNA | Angiogenesis | Others | Cardiovascular |
| 1711 | FAM126A | RNA | Myelination | Others | CNS |
| 1712 | FAM129C | RNA | Others | Others | Others |
| 1713 | FAM174B | RNA | Others | Others | Others |
| 1714 | FAM198B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1715 | FAM214A | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1716 | FAM30A | RNA | Others | Others | Others |
| 1717 | FAM83A | RNA | EGFR Signaling | Others | Oncology |
| 1718 | FAM83D | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1719 | FANCA | RNA | Cell Stress | Others | CNS |
| 1720 | FANCB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1721 | FANCC | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1722 | FANCD2 | RNA | Cell Stress | Others | CNS |
| 1723 | FANCE | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1724 | FANCF | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1725 | FANCG | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1726 | FANCI | RNA | Cell Stress | Others | CNS |
| 1727 | FANCL | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1728 | FAP | RNA | Angiogenesis | Others | Cardiovascular |
| 1729 | FAS | RNA | Apoptosis | Immunity and Inflammation | Oncology |
| 1730 | FAS | RNA | Apoptosis | Immunity and Inflammation | Inflammation |
| 1731 | FASLG | RNA | Cell Proliferation | Immunity and Inflammation | CNS |
| 1732 | FASLG | RNA | Cell Proliferation | Immunity and Inflammation | Inflammation |
| 1733 | FASN | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1734 | FBLIM1 | RNA | Others | Others | Others |
| 1735 | FBLL1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1736 | FBLN1 | RNA | Others | Others | Others |
| 1737 | FBLN2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 1738 | FBLN5 | RNA | Cellular Differentiation | Others | Oncology |
| 1739 | FBN1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 1740 | FBN2 | RNA | Others | Others | Others |
| 1741 | FBP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1742 | FBP2 | RNA | Others | Others | Others |
| 1743 | FBXO6 | RNA | Others | Others | Others |
| 1744 | FBXO7 | RNA | Others | Others | Others |
| 1745 | FBXW11 | RNA | Others | Others | Others |
| 1746 | FBXW4 | RNA | Others | Others | Others |
| 1747 | FBXW7 | RNA | Others | Others | Others |
| 1748 | FCAR | RNA | Others | Inflammation | Inflammation |
| 1749 | FCER1A | RNA | Others | Others | Others |
| 1750 | FCER1G | RNA | Others | Immunity and Inflammation | Inflammation |
| 1751 | FCER2 | RNA | Others | Immune Suppression | Immuno-Oncology |
| 1752 | FCF1 | RNA | Others | Others | Others |
| 1753 | FCGR1A | RNA | Interferon Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1754 | FCGR1A | RNA | Interferon Signaling | Immunity and Inflammation | Inflammation |
| 1755 | FCGR1A/B | RNA | Others | Others | Others |
| 1756 | FCGR2A | RNA | Others | Others | Others |
| 1757 | FCGR2A/C | RNA | Others | Others | Others |
| 1758 | FCGR2B | RNA | Others | Immunity and Inflammation | Inflammation |
| 1759 | FCGR3A | RNA | Others | Immunity and Inflammation | Inflammation |
| 1760 | FCGR3A/B | RNA | Others | Inflammation | Inflammation |
| 1761 | FCGRT | RNA | Others | Others | Others |
| 1762 | FCN1 | RNA | Others | Myeloid Compartment | CNS |
| 1763 | FCRL1 | RNA | Others | Others | Others |
| 1764 | FCRL2 | RNA | Others | Others | Others |
| 1765 | FCRL3 | RNA | Others | Others | Others |
| 1766 | FCRL4 | RNA | Others | Others | Others |
| 1767 | FCRL5 | RNA | Others | Others | Others |
| 1768 | FCRLA | RNA | Others | Immunity and Inflammation | Inflammation |
| 1769 | FCRLB | RNA | Others | Immunity and Inflammation | Inflammation |
| 1770 | FDX1 | RNA | Cell Stress | Others | CNS |
| 1771 | FDXR | RNA | Cell Stress | Others | CNS |
| 1772 | FEN1 | RNA | Cell Cycle | Others | Oncology |
| 1773 | FERMT2 | RNA | Others | Others | Others |
| 1774 | FES | RNA | Others | Others | Others |
| 1775 | FEZ1 | RNA | Others | Others | Others |
| 1776 | FGA | RNA | Others | Others | Others |
| 1777 | FGB | RNA | Others | Others | Others |
| 1778 | FGCR2A/B | RNA | Others | Others | Others |
| 1779 | FGD2 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology |
| 1780 | FGD2 | RNA | Adenosine Pathway | Immunity and Inflammation | Inflammation |
| 1781 | FGF1 | RNA | MAPK | Others | Cardiovascular |
| 1782 | FGF10 | RNA | MAPK | Others | Cardiovascular |
| 1783 | FGF11 | RNA | RAS | Others | Oncology |
| 1784 | FGF12 | RNA | MAPK | Vesicle Trafficking | Cardiovascular |
| 1785 | FGF12 | RNA | MAPK | Vesicle Trafficking | CNS |
| 1786 | FGF13 | RNA | MAPK | Immunity and Inflammation | Cardiovascular |
| 1787 | FGF13 | RNA | MAPK | Immunity and Inflammation | Inflammation |
| 1788 | FGF14 | RNA | RAS | Vesicle Trafficking | Oncology |
| 1789 | FGF14 | RNA | RAS | Vesicle Trafficking | CNS |
| 1790 | FGF16 | RNA | RAS | Others | Oncology |
| 1791 | FGF17 | RNA | RAS | Others | Oncology |
| 1792 | FGF18 | RNA | Angiogenesis | Others | Cardiovascular |
| 1793 | FGF19 | RNA | RAS | Others | Oncology |
| 1794 | FGF2 | RNA | Cell Proliferation | Others | CNS |
| 1795 | FGF20 | RNA | RAS | Others | Oncology |
| 1796 | FGF21 | RNA | RAS | Others | Oncology |
| 1797 | FGF22 | RNA | RAS | Others | Oncology |
| 1798 | FGF23 | RNA | RAS | Others | Oncology |
| 1799 | FGF3 | RNA | RAS | Others | Oncology |
| 1800 | FGF4 | RNA | RAS | Others | Oncology |
| 1801 | FGF5 | RNA | RAS | Others | Oncology |
| 1802 | FGF6 | RNA | RAS | Others | Oncology |
| 1803 | FGF7 | RNA | FGFR Signaling | Others | Cardiovascular |
| 1804 | FGF8 | RNA | RAS | Others | Oncology |
| 1805 | FGF9 | RNA | Angiogenesis | Others | Cardiovascular |
| 1806 | FGFBP1 | RNA | FGFR Signaling | Others | Cardiovascular |
| 1807 | FGFR1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1808 | FGFR2 | RNA | Angiogenesis | Others | Cardiovascular |
| 1809 | FGFR3 | RNA | Cell Proliferation | Others | CNS |
| 1810 | FGFR4 | RNA | Cell Proliferation | Others | CNS |
| 1811 | FGG | RNA | Others | Others | Others |
| 1812 | FGL2 | RNA | EMT | Immunity and Inflammation | Oncology |
| 1813 | FGL2 | RNA | EMT | Immunity and Inflammation | Inflammation |
| 1814 | FGR | RNA | Others | Others | Others |
| 1815 | FH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1816 | FHL1 | RNA | EMT | Others | Oncology |
| 1817 | FIGF | RNA | Angiogenesis | Others | Cardiovascular |
| 1818 | FKBP1A | RNA | Others | Others | Others |
| 1819 | FKBP5 | RNA | Others | Others | Others |
| 1820 | FLCN | RNA | Others | Others | Others |
| 1821 | FLG | RNA | Others | Others | Others |
| 1822 | FLI1 | RNA | EMT | Others | Oncology |
| 1823 | FLNA | RNA | Others | Others | Others |
| 1824 | FLNB | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 1825 | FLNC | RNA | MAPK | Others | Cardiovascular |
| 1826 | FLRT3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1827 | FLT1 | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular |
| 1828 | FLT1 | RNA | Angiogenesis | Immunity and Inflammation | Inflammation |
| 1829 | FLT3 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 1830 | FLT3LG | RNA | Others | Others | Others |
| 1831 | FLT4 | RNA | Cell Proliferation | Others | CNS |
| 1832 | FMOD | RNA | Cellular Differentiation | Others | Oncology |
| 1833 | FMR1 | RNA | Others | Neural Connectivity | CNS |
| 1834 | FN1 | RNA | Angiogenesis | Others | Cardiovascular |
| 1835 | FNBP1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1836 | FNIP1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 1837 | FNIP2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 1838 | FOLH1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1839 | FOLH1B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1840 | FOLR1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1841 | FOLR3 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1842 | FOS | RNA | AP1 Signaling | Immunity and Inflammation | Cardiovascular |
| 1843 | FOS | RNA | AP1 Signaling | Immunity and Inflammation | Inflammation |
| 1844 | FOSB | RNA | Others | Others | Others |
| 1845 | FOSL1 | RNA | Wnt Signaling | Myeloid Compartment | CNS |
| 1846 | FOXA1 | RNA | Others | Others | Others |
| 1847 | FOXA2 | RNA | Others | Others | Others |
| 1848 | FOXC1 | RNA | Others | Others | Others |
| 1849 | FOXC2 | RNA | Cell Proliferation | Others | CNS |
| 1850 | FOXJ1 | RNA | Others | Others | Others |
| 1851 | FOXL2 | RNA | Others | Others | Others |
| 1852 | FOXM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1853 | FOXO1 | RNA | Others | Others | Others |
| 1854 | FOXO3 | RNA | Others | Others | Others |
| 1855 | FOXO4 | RNA | Cell Proliferation | Others | CNS |
| 1856 | FOXP1 | RNA | Androgen Signaling | Others | Oncology |
| 1857 | FOXP3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 1858 | FPR1 | RNA | Adenosine Pathway | Inflammation | Immuno-Oncology |
| 1859 | FPR1 | RNA | Adenosine Pathway | Inflammation | Inflammation |
| 1860 | FPR2 | RNA | Others | Others | Others |
| 1861 | FPR3 | RNA | Others | Myeloid Compartment | CNS |
| 1862 | FRAS1 | RNA | Cellular Differentiation | Others | Oncology |
| 1863 | FREM1 | RNA | Others | Others | Others |
| 1864 | FREM2 | RNA | Others | Others | Others |
| 1865 | FRMD6 | RNA | Hippo Signaling | Others | CNS |
| 1866 | FRMPD4 | RNA | Others | Neural Connectivity | CNS |
| 1867 | FRS2 | RNA | Others | Others | Others |
| 1868 | FSCN1 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1869 | FST | RNA | TGF Beta Signaling | Others | Oncology |
| 1870 | FSTL1 | RNA | EMT | Others | Oncology |
| 1871 | FSTL3 | RNA | Angiogenesis | Others | Cardiovascular |
| 1872 | FTCD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1873 | FTSJ2 | RNA | Others | Others | Others |
| 1874 | FUBP1 | RNA | Others | Others | Others |
| 1875 | FURIN | RNA | Others | Others | Others |
| 1876 | FUS | RNA | Others | Neural Connectivity | CNS |
| 1877 | FUT3 | RNA | EMT | Others | Oncology |
| 1878 | FUT4 | RNA | Others | Others | Others |
| 1879 | FUT5 | RNA | Others | Others | Others |
| 1880 | FUT7 | RNA | Others | Leucocyte Function | Immuno-Oncology |
| 1881 | FUT8 | RNA | Others | Others | Others |
| 1882 | FXN | RNA | Oxydative Stress | Others | Inflammation |
| 1883 | FXYD2 | RNA | Others | Others | Others |
| 1884 | FXYD3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1885 | FXYD6 | RNA | Others | Others | Others |
| 1886 | FYN | RNA | Costimulatory Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1887 | FYN | RNA | Costimulatory Signaling | Immunity and Inflammation | Inflammation |
| 1888 | FZD1 | RNA | Others | Others | Others |
| 1889 | FZD10 | RNA | Wnt Signaling | Others | CNS |
| 1890 | FZD2 | RNA | Others | Others | Others |
| 1891 | FZD3 | RNA | Others | Others | Others |
| 1892 | FZD4 | RNA | Others | Others | Others |
| 1893 | FZD5 | RNA | Others | Others | Others |
| 1894 | FZD6 | RNA | Others | Others | Others |
| 1895 | FZD7 | RNA | Wnt Signaling | Others | CNS |
| 1896 | FZD8 | RNA | Wnt Signaling | Others | CNS |
| 1897 | FZD9 | RNA | Wnt Signaling | Others | CNS |
| 1898 | G6PC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1899 | G6PD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1900 | GAA | RNA | Others | Others | Others |
| 1901 | GAB1 | RNA | Others | Others | Others |
| 1902 | GAB2 | RNA | Others | Others | Others |
| 1903 | GABARAP | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1904 | GABPA | RNA | Others | Others | Others |
| 1905 | GABRA1 | RNA | Others | Neural Connectivity | CNS |
| 1906 | GABRA4 | RNA | Others | Neural Connectivity | CNS |
| 1907 | GABRB2 | RNA | Others | Neural Connectivity | CNS |
| 1908 | GABRB3 | RNA | Others | Neural Connectivity | CNS |
| 1909 | GABRG2 | RNA | Others | Neural Connectivity | CNS |
| 1910 | GABRP | RNA | Others | Neural Connectivity | CNS |
| 1911 | GABRR1 | RNA | Others | Neural Connectivity | CNS |
| 1912 | GABRR3 | RNA | Others | Neural Connectivity | CNS |
| 1913 | GAD1 | RNA | Biosynthesis and Anabolic Pathways | Neural Connectivity | CNS |
| 1914 | GAD2 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| 1915 | GADD45A | RNA | MAPK | Others | Cardiovascular |
| 1916 | GADD45B | RNA | MAPK | Others | Cardiovascular |
| 1917 | GADD45G | RNA | MAPK | Others | Cardiovascular |
| 1918 | GADL1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1919 | GAGE1 | RNA | Others | Others | Others |
| 1920 | GAL3ST1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1921 | GALC | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1922 | GALNT3 | RNA | FGFR Signaling | Others | Cardiovascular |
| 1923 | GALNT7 | RNA | Others | Others | Others |
| 1924 | GAPDH | RNA | Biosynthesis and Anabolic Pathways | Neural Cell Typing | CNS |
| 1925 | GAPDHS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1926 | GAPVD1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 1927 | GARS | RNA | Others | Others | Others |
| 1928 | GART | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1929 | GAS1 | RNA | Hedgehog | Others | CNS |
| 1930 | GATA1 | RNA | Others | Others | Others |
| 1931 | GATA2 | RNA | Others | Others | Others |
| 1932 | GATA3 | RNA | DNA Damage Repair | M2 Activation | Epigenic and Nuclear Signaling |
| 1933 | GATA3 | RNA | DNA Damage Repair | M2 Activation | CNS |
| 1934 | GATA4 | RNA | Proliferation | Others | Oncology |
| 1935 | GATA6 | RNA | Others | Others | Others |
| 1936 | GATM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1937 | GBA | RNA | Autophagy | Immunity and Inflammation | Cardiovascular |
| 1938 | GBA | RNA | Autophagy | Immunity and Inflammation | Inflammation |
| 1939 | GBP1 | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 1940 | GBP2 | RNA | Interferon Signaling | Immunity and Inflammation | Immuno-Oncology |
| 1941 | GBP2 | RNA | Interferon Signaling | Immunity and Inflammation | Inflammation |
| 1942 | GBP3 | RNA | Others | Others | Others |
| 1943 | GBP4 | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 1944 | GBP5 | RNA | Others | Others | Others |
| 1945 | GCA | RNA | Others | Others | Others |
| 1946 | GCDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1947 | GCK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1948 | GCKR | RNA | Others | Others | Others |
| 1949 | GCLC | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS |
| 1950 | GCLC | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | Inflammation |
| 1951 | GCNT1 | RNA | Others | Others | Others |
| 1952 | GDA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1953 | GDF15 | RNA | EMT | Others | Oncology |
| 1954 | GDF5 | RNA | Proliferation | Others | Oncology |
| 1955 | GDF6 | RNA | Others | Others | Others |
| 1956 | GDNF | RNA | Others | Transmitter Release | CNS |
| 1957 | GDPD2 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 1958 | GFAP | RNA | Others | Inflammation | Inflammation |
| 1959 | GFER | RNA | Others | Others | Others |
| 1960 | GFI1 | RNA | Others | Others | Others |
| 1961 | GFM1 | RNA | Others | Others | Others |
| 1962 | GFPT1 | RNA | Others | Others | Others |
| 1963 | GGA1 | RNA | Others | Others | Others |
| 1964 | GGH | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1965 | GGT1 | RNA | Carbohydrate Metabolism | Others | CNS |
| 1966 | GHDC | RNA | Others | Others | Others |
| 1967 | GHR | RNA | Cytotoxicity | Others | Oncology |
| 1968 | GIMAP4 | RNA | Others | Others | Others |
| 1969 | GIMAP6 | RNA | Others | Others | Others |
| 1970 | GJA1 | RNA | Others | Others | Others |
| 1971 | GJA5 | RNA | Angiogenesis | Others | Cardiovascular |
| 1972 | GJB1 | RNA | Myelination | Others | CNS |
| 1973 | GJB2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 1974 | GK | RNA | Others | Others | Others |
| 1975 | GLA | RNA | Others | Others | Others |
| 1976 | GLB1 | RNA | Others | Others | Others |
| 1977 | GLI1 | RNA | Hedgehog | Others | CNS |
| 1978 | GLI2 | RNA | Others | Others | Others |
| 1979 | GLI3 | RNA | Hedgehog | Others | CNS |
| 1980 | GLP1R | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 1981 | GLRB | RNA | Others | Neural Connectivity | CNS |
| 1982 | GLRX | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1983 | GLS | RNA | Biosynthesis and Anabolic Pathways | Transmitter Release | CNS |
| 1984 | GLS2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1985 | GLUD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1986 | GLUD1/2 | RNA | Others | Others | Others |
| 1987 | GLUD2 | RNA | Others | Others | Others |
| 1988 | GLUL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1989 | GLYAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1990 | GLYCTK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1991 | GLYR1 | RNA | Others | Others | Others |
| 1992 | GMIP | RNA | Others | Others | Others |
| 1993 | GMPR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1994 | GMPR2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1995 | GMPS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 1996 | GNA11 | RNA | Others | Others | Others |
| 1997 | GNA15 | RNA | Others | Immunity and Inflammation | Inflammation |
| 1998 | GNAI1 | RNA | Others | Transmitter Release | CNS |
| 1999 | GNAI2 | RNA | Others | Transmitter Release | CNS |
| 2000 | GNAI3 | RNA | Others | Inflammation | Inflammation |
| 2001 | GNAO1 | RNA | Oxydative Stress | Transmitter Release | Inflammation |
| 2002 | GNAO1 | RNA | Oxydative Stress | Transmitter Release | CNS |
| 2003 | GNAQ | RNA | Others | Transmitter Release | CNS |
| 2004 | GNAS | RNA | Others | Others | Others |
| 2005 | GNB1 | RNA | Others | Others | Others |
| 2006 | GNB4 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2007 | GNB5 | RNA | Others | Transmitter Release | CNS |
| 2008 | GNG10 | RNA | Others | Others | Others |
| 2009 | GNG12 | RNA | RAS | Others | Oncology |
| 2010 | GNG2 | RNA | Adenosine Pathway | Transmitter Release | Immuno-Oncology |
| 2011 | GNG2 | RNA | Adenosine Pathway | Transmitter Release | CNS |
| 2012 | GNG4 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2013 | GNG7 | RNA | RAS | Others | Oncology |
| 2014 | GNGT1 | RNA | RAS | Transmitter Release | Oncology |
| 2015 | GNGT1 | RNA | RAS | Transmitter Release | CNS |
| 2016 | GNLY | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2017 | GNLY | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2018 | GNPTAB | RNA | Others | Others | Others |
| 2019 | GNPTG | RNA | Others | Others | Others |
| 2020 | GNS | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 2021 | GOT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2022 | GOT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2023 | GP1BB | RNA | Others | Others | Others |
| 2024 | GPATCH3 | RNA | Others | Others | Others |
| 2025 | GPC4 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2026 | GPD1L | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 2027 | GPI | RNA | Angiogenesis | Others | Cardiovascular |
| 2028 | GPNMB | RNA | Others | Others | Others |
| 2029 | GPR124 | RNA | Others | Others | Others |
| 2030 | GPR160 | RNA | Others | Others | Others |
| 2031 | GPR183 | RNA | Others | Immunity and Inflammation | Inflammation |
| 2032 | GPR34 | RNA | Others | Immunity and Inflammation | Inflammation |
| 2033 | GPR37 | RNA | Oxydative Stress | Others | Inflammation |
| 2034 | GPR4 | RNA | Others | Others | Others |
| 2035 | GPR56 | RNA | Angiogenesis | Others | Cardiovascular |
| 2036 | GPR62 | RNA | Others | Others | Others |
| 2037 | GPR65 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2038 | GPR84 | RNA | Others | Immunity and Inflammation | Inflammation |
| 2039 | GPRASP1 | RNA | Others | Others | Others |
| 2040 | GPS1 | RNA | Cell Stress | Others | CNS |
| 2041 | GPSM3 | RNA | Others | Others | Others |
| 2042 | GPT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2043 | GPX1 | RNA | Angiogenesis | Others | Cardiovascular |
| 2044 | GPX2 | RNA | Others | Others | Others |
| 2045 | GPX3 | RNA | Others | Others | Others |
| 2046 | GPX4 | RNA | Cell Stress | Others | CNS |
| 2047 | GPX7 | RNA | Others | Others | Others |
| 2048 | GRAP | RNA | Others | Immunity and Inflammation | Inflammation |
| 2049 | GRAP2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2050 | GRB10 | RNA | Others | Others | Others |
| 2051 | GRB2 | RNA | JAK-STAT | Others | CNS |
| 2052 | GRB7 | RNA | ERBB2 Signaling | Others | Oncology |
| 2053 | GREM1 | RNA | EMT | Others | Oncology |
| 2054 | GREM2 | RNA | Others | Others | Others |
| 2055 | GRHL2 | RNA | Others | Others | Others |
| 2056 | GRIA1 | RNA | Others | Neural Connectivity | CNS |
| 2057 | GRIA2 | RNA | Others | Neural Connectivity | CNS |
| 2058 | GRIA3 | RNA | Transcriptional Misregulation | Neural Connectivity | Epigenic and Nuclear Signaling |
| 2059 | GRIA3 | RNA | Transcriptional Misregulation | Neural Connectivity | CNS |
| 2060 | GRIA4 | RNA | Others | Neural Connectivity | CNS |
| 2061 | GRIK2 | RNA | Others | Neural Connectivity | CNS |
| 2062 | GRIN1 | RNA | Biosynthesis and Anabolic Pathways | Neural Connectivity | CNS |
| 2063 | GRIN2A | RNA | MAPK | Immunity and Inflammation | Cardiovascular |
| 2064 | GRIN2A | RNA | MAPK | Immunity and Inflammation | Inflammation |
| 2065 | GRIN2B | RNA | RAS | Immunity and Inflammation | Oncology |
| 2066 | GRIN2B | RNA | RAS | Immunity and Inflammation | Inflammation |
| 2067 | GRIN2C | RNA | Others | Neural Connectivity | CNS |
| 2068 | GRIN2D | RNA | Others | Neural Connectivity | CNS |
| 2069 | GRIN3B | RNA | Others | Neural Connectivity | CNS |
| 2070 | GRK2 | RNA | Others | Others | Others |
| 2071 | GRK4 | RNA | Others | Others | Others |
| 2072 | GRK6 | RNA | Others | Others | Others |
| 2073 | GRM1 | RNA | Others | Neural Connectivity | CNS |
| 2074 | GRM2 | RNA | Others | Neural Connectivity | CNS |
| 2075 | GRM3 | RNA | Others | Others | Others |
| 2076 | GRM5 | RNA | Others | Neural Connectivity | CNS |
| 2077 | GRM8 | RNA | Others | Neural Connectivity | CNS |
| 2078 | GRN | RNA | Others | Immunity and Inflammation | Inflammation |
| 2079 | GRPEL1 | RNA | Others | Others | Others |
| 2080 | GSDMD | RNA | Others | Others | Others |
| 2081 | GSK3B | RNA | Biosynthesis and Anabolic Pathways | Neural Connectivity | CNS |
| 2082 | GSN | RNA | Others | Neuronal Cytoskeleton | CNS |
| 2083 | GSR | RNA | Androgen Signaling | Others | Oncology |
| 2084 | GSS | RNA | Carbohydrate Metabolism | Others | CNS |
| 2085 | GSTM1 | RNA | Others | Others | Others |
| 2086 | GSTM4 | RNA | Others | Inflammation | Inflammation |
| 2087 | GSTP1 | RNA | Oxydative Stress | Others | Inflammation |
| 2088 | GTF2A1 | RNA | Others | Others | Others |
| 2089 | GTF2B | RNA | Others | Others | Others |
| 2090 | GTF2H1 | RNA | Others | Others | Others |
| 2091 | GTF2H2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2092 | GTF2H3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2093 | GTF2I | RNA | Others | Others | Others |
| 2094 | GTF2IRD1 | RNA | Others | Transmitter Response and Reuptake | CNS |
| 2095 | GTF3C1 | RNA | Others | Others | Others |
| 2096 | GTSE1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2097 | GUCY1A1 | RNA | Others | Others | Others |
| 2098 | GUCY1B1 | RNA | Others | Others | Others |
| 2099 | GUCY1B3 | RNA | Oxydative Stress | Transmitter Response and Reuptake | Inflammation |
| 2100 | GUCY1B3 | RNA | Oxydative Stress | Transmitter Response and Reuptake | CNS |
| 2101 | GUSB | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 2102 | GYS2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2103 | GZMA | RNA | Apoptosis | Lymphoid Compartment | Oncology |
| 2104 | GZMA | RNA | Apoptosis | Lymphoid Compartment | Immuno-Oncology |
| 2105 | GZMB | RNA | Apoptosis | Lymphoid Compartment | Oncology |
| 2106 | GZMB | RNA | Apoptosis | Lymphoid Compartment | Immuno-Oncology |
| 2107 | GZMH | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2108 | GZMH | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2109 | GZMK | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2110 | GZMK | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2111 | GZMM | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2112 | GZMM | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2113 | H2AFX | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2114 | H2AFY2 | RNA | Others | Others | Others |
| 2115 | H2AX | RNA | Others | Others | Others |
| 2116 | H3-3A | RNA | Others | Others | Others |
| 2117 | H3-5 | RNA | Others | Others | Others |
| 2118 | H3C10 | RNA | Others | Others | Others |
| 2119 | H3C2 | RNA | Others | Others | Others |
| 2120 | H3C8 | RNA | Others | Others | Others |
| 2121 | H3F3A | RNA | Others | Others | Others |
| 2122 | H3F3C | RNA | Others | Others | Others |
| 2123 | H6PD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2124 | HAAO | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2125 | HACD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2126 | HACD4 | RNA | Others | Others | Others |
| 2127 | HADH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2128 | HADHA | RNA | Others | Others | Others |
| 2129 | HADHB | RNA | Others | Others | Others |
| 2130 | HAMP | RNA | Others | Others | Others |
| 2131 | HAP1 | RNA | Others | Neural Connectivity | CNS |
| 2132 | HAPLN1 | RNA | Others | Others | Others |
| 2133 | HAS1 | RNA | Others | Others | Others |
| 2134 | HAT1 | RNA | Others | Others | Others |
| 2135 | HAVCR1 | RNA | Others | Others | Others |
| 2136 | HAVCR2 | RNA | Costimulatory Signaling | Inflammation | Immuno-Oncology |
| 2137 | HAVCR2 | RNA | Costimulatory Signaling | Inflammation | Inflammation |
| 2138 | HBB | RNA | Others | Others | Others |
| 2139 | HCAR2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2140 | HCFC1 | RNA | Others | Others | Others |
| 2141 | HCK | RNA | Cytokine and Chemokine Signaling | Inflammation | Immuno-Oncology |
| 2142 | HCK | RNA | Cytokine and Chemokine Signaling | Inflammation | Inflammation |
| 2143 | HCN1 | RNA | Others | Transmitter Release | CNS |
| 2144 | HCST | RNA | Others | Others | Others |
| 2145 | HDAC1 | RNA | Androgen Signaling | Others | Oncology |
| 2146 | HDAC10 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2147 | HDAC11 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2148 | HDAC2 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2149 | HDAC3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2150 | HDAC4 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2151 | HDAC5 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2152 | HDAC6 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2153 | HDAC7 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2154 | HDAC8 | RNA | Others | Others | Others |
| 2155 | HDAC9 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2156 | HDC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2157 | HDHD3 | RNA | Others | Others | Others |
| 2158 | HEG1 | RNA | Cellular Differentiation | Others | Oncology |
| 2159 | HELLS | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2160 | HEMK1 | RNA | ER Signaling | Others | Oncology |
| 2161 | HERC1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2162 | HERC5 | RNA | Others | Others | Others |
| 2163 | HERC6 | RNA | Others | Others | Others |
| 2164 | HES1 | RNA | Notch | Others | Immuno-Oncology |
| 2165 | HES5 | RNA | Others | Others | Others |
| 2166 | HEXA | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 2167 | HEXB | RNA | Myelination | Others | CNS |
| 2168 | HEY1 | RNA | Angiogenesis | Others | Cardiovascular |
| 2169 | HEY2 | RNA | Others | Others | Others |
| 2170 | HFE | RNA | Others | Others | Others |
| 2171 | HGF | RNA | Cell Proliferation | Others | CNS |
| 2172 | HHEX | RNA | Others | Others | Others |
| 2173 | HHIP | RNA | Others | Others | Others |
| 2174 | HIF1A | RNA | Angiogenesis | T Cell Exhaustion | Cardiovascular |
| 2175 | HIF1A | RNA | Angiogenesis | T Cell Exhaustion | Immuno-Oncology |
| 2176 | HIF3A | RNA | Cell Stress | Others | CNS |
| 2177 | HIKESHI | RNA | Others | Others | Others |
| 2178 | HILPDA | RNA | Others | Others | Others |
| 2179 | HIPK1 | RNA | Cell Proliferation | Others | CNS |
| 2180 | HIPK2 | RNA | Cell Proliferation | Others | CNS |
| 2181 | HIRA | RNA | Others | Others | Others |
| 2182 | HIST1H1C | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2183 | HIST1H1D | RNA | Others | Others | Others |
| 2184 | HIST1H2AC | RNA | Others | Others | Others |
| 2185 | HIST1H2AE | RNA | Others | Others | Others |
| 2186 | HIST1H2BD | RNA | Others | Others | Others |
| 2187 | HIST1H2BF | RNA | Others | Others | Others |
| 2188 | HIST1H2BH | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2189 | HIST1H2BK | RNA | Others | Others | Others |
| 2190 | HIST1H3B | RNA | Others | Others | Others |
| 2191 | HIST1H3G | RNA | Others | Others | Others |
| 2192 | HIST1H3H | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 2193 | HIST1H4E | RNA | Others | Others | Others |
| 2194 | HIST1H4H | RNA | Others | Others | Others |
| 2195 | HIST3H2BB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2196 | HJURP | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2197 | HK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2198 | HK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2199 | HK3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2200 | HKDC1 | RNA | Others | Others | Others |
| 2201 | HLA-A | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2202 | HLA-B | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2203 | HLA-C | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2204 | HLA-DMA | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2205 | HLA-DMB | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2206 | HLA-DOA | RNA | Others | Others | Others |
| 2207 | HLA-DOB | RNA | Antigen Processing | Lymphoid Compartment | Immuno-Oncology |
| 2208 | HLA-DPA1 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2209 | HLA-DPB1 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2210 | HLA-DQA | RNA | Others | Others | Others |
| 2211 | HLA-DQA1 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2212 | HLA-DQA2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2213 | HLA-DQB1 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2214 | HLA-DQB2 | RNA | Others | Others | Others |
| 2215 | HLA-DRA | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2216 | HLA-DRB | RNA | Others | Others | Others |
| 2217 | HLA-DRB1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2218 | HLA-DRB1/3 | RNA | Others | Others | Others |
| 2219 | HLA-DRB3 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2220 | HLA-DRB3/4 | RNA | Others | Others | Others |
| 2221 | HLA-DRB4 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 2222 | HLA-DRB5 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2223 | HLA-E | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2224 | HLA-F | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 2225 | HLA-G | RNA | Others | Others | Others |
| 2226 | HLX | RNA | Others | Others | Others |
| 2227 | HMGA1 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2228 | HMGA2 | RNA | Others | Others | Others |
| 2229 | HMGB1 | RNA | Apoptosis | Others | Oncology |
| 2230 | HMGB2 | RNA | Others | Others | Others |
| 2231 | HMGCR | RNA | Others | Others | Others |
| 2232 | HMGCS2 | RNA | Others | Others | Others |
| 2233 | HMGN1 | RNA | Others | Others | Others |
| 2234 | HMGN5 | RNA | Others | Others | Others |
| 2235 | HMOX1 | RNA | Angiogenesis | Others | Cardiovascular |
| 2236 | HNF1A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2237 | HNF4A | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2238 | HNRNPM | RNA | Others | Others | Others |
| 2239 | HOMER1 | RNA | Others | Neural Connectivity | CNS |
| 2240 | HOXA10 | RNA | Others | Others | Others |
| 2241 | HOXA11 | RNA | Others | Others | Others |
| 2242 | HOXA5 | RNA | Cell Proliferation | Others | CNS |
| 2243 | HOXA7 | RNA | Angiogenesis | Others | Cardiovascular |
| 2244 | HOXA9 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 2245 | HOXB13 | RNA | Angiogenesis | Others | Cardiovascular |
| 2246 | HOXB3 | RNA | Angiogenesis | Others | Cardiovascular |
| 2247 | HPD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2248 | HPGD | RNA | Others | Others | Others |
| 2249 | HPGDS | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 2250 | HPRT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2251 | HPS4 | RNA | Others | Others | Others |
| 2252 | HPSE | RNA | Cellular Differentiation | Others | Oncology |
| 2253 | HRAS | RNA | Autophagy | Transmitter Release | Cardiovascular |
| 2254 | HRAS | RNA | Autophagy | Transmitter Release | CNS |
| 2255 | HRK | RNA | Others | Others | Others |
| 2256 | HSBP1 | RNA | Others | Others | Others |
| 2257 | HSD11B1 | RNA | Others | Others | Others |
| 2258 | HSD17B12 | RNA | Others | Others | Others |
| 2259 | HSD17B4 | RNA | Others | Others | Others |
| 2260 | HSD17B8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2261 | HSF1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2262 | HSF2 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2263 | HSH2D | RNA | Others | Others | Others |
| 2264 | HSP90AA1 | RNA | Others | Others | Others |
| 2265 | HSP90AB1 | RNA | Others | Others | Others |
| 2266 | HSP90B1 | RNA | Cellular Differentiation | Others | Oncology |
| 2267 | HSPA1A | RNA | Others | Others | Others |
| 2268 | HSPA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2269 | HSPA4 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2270 | HSPA6 | RNA | Others | Others | Others |
| 2271 | HSPA9 | RNA | Others | Others | Others |
| 2272 | HSPB1 | RNA | Cellular Differentiation | Others | Oncology |
| 2273 | HSPB2 | RNA | Others | Others | Others |
| 2274 | HSPE1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2275 | HSPG2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2276 | HTR1A | RNA | Transmitter Synthesis | Transmitter Release | CNS |
| 2277 | HTR5A | RNA | Others | Transmitter Release | CNS |
| 2278 | HTRA2 | RNA | Oxydative Stress | Others | Inflammation |
| 2279 | HTT | RNA | Others | Neural Connectivity | CNS |
| 2280 | HUNK | RNA | Cellular Differentiation | Others | Oncology |
| 2281 | HUS1 | RNA | Others | Others | Others |
| 2282 | HUWE1 | RNA | Others | Inflammation | Inflammation |
| 2283 | HVCN1 | RNA | Others | Others | Others |
| 2284 | IBSP | RNA | PI3K-AKT | Others | Oncology |
| 2285 | ICAM1 | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 2286 | ICAM2 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 2287 | ICAM3 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 2288 | ICAM4 | RNA | Others | Others | Others |
| 2289 | ICAM5 | RNA | Others | Others | Others |
| 2290 | ICOS | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
| 2291 | ICOSLG | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
| 2292 | ID1 | RNA | Angiogenesis | Others | Cardiovascular |
| 2293 | ID2 | RNA | Cell Proliferation | Others | CNS |
| 2294 | ID4 | RNA | Cell Proliferation | Others | CNS |
| 2295 | IDE | RNA | Amyloid Processing | Others | CNS |
| 2296 | IDH1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2297 | IDH2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2298 | IDH3A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2299 | IDH3B | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2300 | IDH3G | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2301 | IDNK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2302 | IDO1 | RNA | Biosynthesis and Anabolic Pathways | Lymphoid Compartment | CNS |
| 2303 | IDO1 | RNA | Biosynthesis and Anabolic Pathways | Lymphoid Compartment | Immuno-Oncology |
| 2304 | IDO2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2305 | IER3 | RNA | Others | Myeloid Compartment | CNS |
| 2306 | IFI16 | RNA | Cytotoxicity | Others | Oncology |
| 2307 | IFI27 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2308 | IFI27 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2309 | IFI30 | RNA | Others | Others | Others |
| 2310 | IFI35 | RNA | Cytotoxicity | Others | Oncology |
| 2311 | IFI44 | RNA | Others | Others | Others |
| 2312 | IFI44L | RNA | Others | Others | Others |
| 2313 | IFI6 | RNA | Cytotoxicity | Others | Oncology |
| 2314 | IFIH1 | RNA | Cytotoxicity | Others | Oncology |
| 2315 | IFIT1 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2316 | IFIT1 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2317 | IFIT2 | RNA | Cytotoxicity | Others | Oncology |
| 2318 | IFIT3 | RNA | Cytotoxicity | Others | Oncology |
| 2319 | IFITM1 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2320 | IFITM1 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2321 | IFITM2 | RNA | Cytotoxicity | Others | Oncology |
| 2322 | IFITM3 | RNA | Others | Others | Others |
| 2323 | IFNA1 | RNA | Interferon Signaling | Interleukins | Immuno-Oncology |
| 2324 | IFNA1 | RNA | Interferon Signaling | Interleukins | Inflammation |
| 2325 | IFNA1/13 | RNA | Others | Others | Others |
| 2326 | IFNA14/16 | RNA | Others | Others | Others |
| 2327 | IFNA17 | RNA | Others | Interleukins | Inflammation |
| 2328 | IFNA2 | RNA | Others | Interleukins | Inflammation |
| 2329 | IFNA4/7/10/17/21 | RNA | Others | Others | Others |
| 2330 | IFNA5 | RNA | Others | Others | Others |
| 2331 | IFNA6 | RNA | Others | Others | Others |
| 2332 | IFNA7 | RNA | Others | Interleukins | Inflammation |
| 2333 | IFNA7/17 | RNA | Others | Others | Others |
| 2334 | IFNA8 | RNA | Others | Interleukins | Inflammation |
| 2335 | IFNAR1 | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 2336 | IFNAR2 | RNA | Others | Others | Others |
| 2337 | IFNB1 | RNA | Others | Others | Others |
| 2338 | IFNG | RNA | Cell Proliferation | Interleukins | CNS |
| 2339 | IFNG | RNA | Cell Proliferation | Interleukins | Inflammation |
| 2340 | IFNGR1 | RNA | Hypoxia | M1 Activation | Cardiovascular |
| 2341 | IFNGR1 | RNA | Hypoxia | M1 Activation | CNS |
| 2342 | IFNGR2 | RNA | Hypoxia | Others | Cardiovascular |
| 2343 | IFNK | RNA | Others | Others | Others |
| 2344 | IFNL1 | RNA | Others | Interleukins | Inflammation |
| 2345 | IFNL2 | RNA | Others | Others | Others |
| 2346 | IFNL2/3 | RNA | Others | Others | Others |
| 2347 | IFNL4 | RNA | Others | Others | Others |
| 2348 | IFNLR1 | RNA | Others | Others | Others |
| 2349 | IFNW1 | RNA | Others | Others | Others |
| 2350 | IFT140 | RNA | ER Signaling | Others | Oncology |
| 2351 | IGF1 | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake | CNS |
| 2352 | IGF1R | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake | CNS |
| 2353 | IGF2R | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2354 | IGF2R | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2355 | IGFBP3 | RNA | HIF1 Signaling | Others | Inflammation |
| 2356 | IGFBP4 | RNA | Cell Proliferation | Others | CNS |
| 2357 | IGFBP7 | RNA | Cell Proliferation | Others | CNS |
| 2358 | IGHA1 | RNA | Others | Others | Others |
| 2359 | IGHD | RNA | Others | Others | Others |
| 2360 | IGHG1 | RNA | Others | Others | Others |
| 2361 | IGHG2 | RNA | Others | Others | Others |
| 2362 | IGHG3 | RNA | Others | Others | Others |
| 2363 | IGHG4 | RNA | Others | Others | Others |
| 2364 | IGHM | RNA | Others | Others | Others |
| 2365 | IGHV4-59 | RNA | Others | Others | Others |
| 2366 | IGKC | RNA | Others | Others | Others |
| 2367 | IGLC1 | RNA | Others | Others | Others |
| 2368 | IGLL1 | RNA | Others | Others | Others |
| 2369 | IGSF10 | RNA | Others | Others | Others |
| 2370 | IGSF6 | RNA | Others | Others | Others |
| 2371 | IHH | RNA | Hedgehog | Others | CNS |
| 2372 | IKBKAP | RNA | Others | Others | Others |
| 2373 | IKBKB | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2374 | IKBKE | RNA | Others | Others | Others |
| 2375 | IKBKG | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2376 | IKZF1 | RNA | Others | Others | Others |
| 2377 | IKZF2 | RNA | Others | Others | Others |
| 2378 | IKZF3 | RNA | Angiogenesis | Others | Cardiovascular |
| 2379 | IKZF4 | RNA | Others | Others | Others |
| 2380 | IL10 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
| 2381 | IL10 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
| 2382 | IL10RA | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2383 | IL10RB | RNA | Others | Others | Others |
| 2384 | IL11 | RNA | Cell Proliferation | Interleukins | CNS |
| 2385 | IL11 | RNA | Cell Proliferation | Interleukins | Inflammation |
| 2386 | IL11RA | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2387 | IL12A | RNA | Others | Interleukins | Inflammation |
| 2388 | IL12B | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
| 2389 | IL12B | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
| 2390 | IL12RB1 | RNA | Interleukin Signaling | NK Cell Function | Immuno-Oncology |
| 2391 | IL12RB2 | RNA | Cytokine and Chemokine Signaling | Lymphoid Compartment | Immuno-Oncology |
| 2392 | IL13 | RNA | Others | Interleukins | Inflammation |
| 2393 | IL13RA1 | RNA | Others | Others | Others |
| 2394 | IL13RA2 | RNA | Others | Others | Others |
| 2395 | IL15 | RNA | Cell Proliferation | Interleukins | CNS |
| 2396 | IL15 | RNA | Cell Proliferation | Interleukins | Inflammation |
| 2397 | IL15RA | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 2398 | IL16 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
| 2399 | IL16 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
| 2400 | IL17A | RNA | Costimulatory Signaling | Interleukins | Immuno-Oncology |
| 2401 | IL17A | RNA | Costimulatory Signaling | Interleukins | Inflammation |
| 2402 | IL17B | RNA | Others | Interleukins | Inflammation |
| 2403 | IL17C | RNA | Others | Others | Others |
| 2404 | IL17D | RNA | Others | Others | Others |
| 2405 | IL17F | RNA | Others | Interleukins | Inflammation |
| 2406 | IL17RA | RNA | Others | Others | Others |
| 2407 | IL17RB | RNA | Others | Others | Others |
| 2408 | IL17RC | RNA | Others | Others | Others |
| 2409 | IL17RD | RNA | Others | Others | Others |
| 2410 | IL17RE | RNA | Others | Others | Others |
| 2411 | IL18 | RNA | Angiogenesis | Interleukins | Cardiovascular |
| 2412 | IL18 | RNA | Angiogenesis | Interleukins | Inflammation |
| 2413 | IL18BP | RNA | Others | Others | Others |
| 2414 | IL18R1 | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
| 2415 | IL18RAP | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2416 | IL19 | RNA | Others | Interleukins | Inflammation |
| 2417 | IL1A | RNA | Cell Proliferation | Interleukins | CNS |
| 2418 | IL1A | RNA | Cell Proliferation | Interleukins | Inflammation |
| 2419 | IL1B | RNA | Cell Proliferation | Interleukins | CNS |
| 2420 | IL1B | RNA | Cell Proliferation | Interleukins | Inflammation |
| 2421 | IL1F10 | RNA | Others | Others | Others |
| 2422 | IL1R1 | RNA | Oxydative Stress | Neural Connectivity | Inflammation |
| 2423 | IL1R1 | RNA | Oxydative Stress | Neural Connectivity | CNS |
| 2424 | IL1R2 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2425 | IL1RAP | RNA | Others | Others | Others |
| 2426 | IL1RAPL1 | RNA | Others | Others | Others |
| 2427 | IL1RAPL2 | RNA | Others | Others | Others |
| 2428 | IL1RL1 | RNA | Others | Others | Others |
| 2429 | IL1RL2 | RNA | Others | Others | Others |
| 2430 | IL1RN | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
| 2431 | IL1RN | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
| 2432 | IL2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2433 | IL20 | RNA | Others | Others | Others |
| 2434 | IL20RA | RNA | JAK-STAT | Others | CNS |
| 2435 | IL20RB | RNA | JAK-STAT | Others | CNS |
| 2436 | IL21 | RNA | Others | Interleukins | Inflammation |
| 2437 | IL21R | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2438 | IL22 | RNA | Others | Others | Others |
| 2439 | IL22RA1 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2440 | IL22RA2 | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 2441 | IL23A | RNA | Others | Interleukins | Inflammation |
| 2442 | IL23R | RNA | Others | Others | Others |
| 2443 | IL24 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
| 2444 | IL24 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
| 2445 | IL25 | RNA | Others | Interleukins | Inflammation |
| 2446 | IL26 | RNA | Others | Interleukins | Inflammation |
| 2447 | IL27 | RNA | Others | Interleukins | Inflammation |
| 2448 | IL27RA | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 2449 | IL28A | RNA | Others | Others | Others |
| 2450 | IL28A/B | RNA | Others | Others | Others |
| 2451 | IL29 | RNA | Others | Others | Others |
| 2452 | IL2RA | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2453 | IL2RB | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2454 | IL2RG | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
| 2455 | IL3 | RNA | Others | Others | Others |
| 2456 | IL31 | RNA | Others | Others | Others |
| 2457 | IL31RA | RNA | Others | Others | Others |
| 2458 | IL32 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
| 2459 | IL32 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
| 2460 | IL33 | RNA | Cytokine and Chemokine Signaling | M2 Activation | Immuno-Oncology |
| 2461 | IL33 | RNA | Cytokine and Chemokine Signaling | M2 Activation | CNS |
| 2462 | IL34 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology |
| 2463 | IL34 | RNA | Cytokine and Chemokine Signaling | Interleukins | Inflammation |
| 2464 | IL36A | RNA | Others | Others | Others |
| 2465 | IL36B | RNA | Others | Others | Others |
| 2466 | IL36G | RNA | Others | Others | Others |
| 2467 | IL36RN | RNA | Others | Others | Others |
| 2468 | IL37 | RNA | Others | Others | Others |
| 2469 | IL3RA | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 2470 | IL4 | RNA | Costimulatory Signaling | M2 Activation | Immuno-Oncology |
| 2471 | IL4 | RNA | Costimulatory Signaling | M2 Activation | CNS |
| 2472 | IL4I1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2473 | IL4R | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 2474 | IL5 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 2475 | IL5RA | RNA | Others | Others | Others |
| 2476 | IL6 | RNA | Cell Proliferation | M2 Activation | CNS |
| 2477 | IL6R | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2478 | IL6ST | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 2479 | IL7 | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 2480 | IL7R | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2481 | IL8 | RNA | Others | Others | Others |
| 2482 | IL9 | RNA | Others | Others | Others |
| 2483 | IL9R | RNA | Interleukin Signaling | Others | Immuno-Oncology |
| 2484 | ILF3 | RNA | Others | Others | Others |
| 2485 | ILK | RNA | Cell Proliferation | Others | CNS |
| 2486 | IMPDH1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2487 | IMPDH2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2488 | INA | RNA | Others | Neuronal Cytoskeleton | CNS |
| 2489 | INHBA | RNA | Cell Proliferation | Others | CNS |
| 2490 | INHBB | RNA | TGF Beta Signaling | Others | Oncology |
| 2491 | INHBE | RNA | Others | Others | Others |
| 2492 | INMT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2493 | INPP4A | RNA | Others | Others | Others |
| 2494 | INPP5D | RNA | Others | Others | Others |
| 2495 | INPP5F | RNA | Others | Others | Others |
| 2496 | INPPL1 | RNA | Others | Others | Others |
| 2497 | INS | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake | CNS |
| 2498 | INSR | RNA | Carbohydrate Metabolism | Neural Connectivity | CNS |
| 2499 | IPCEF1 | RNA | Oxydative Stress | Others | Inflammation |
| 2500 | IQGAP1 | RNA | Others | Others | Others |
| 2501 | IQSEC1 | RNA | Others | Others | Others |
| 2502 | IRAK1 | RNA | Others | Others | Others |
| 2503 | IRAK2 | RNA | Others | Others | Others |
| 2504 | IRAK3 | RNA | Others | Others | Others |
| 2505 | IRAK4 | RNA | Others | Others | Others |
| 2506 | IRF1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
| 2507 | IRF1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
| 2508 | IRF2 | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 2509 | IRF3 | RNA | Interferon Signaling | Others | Immuno-Oncology |
| 2510 | IRF4 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2511 | IRF4 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2512 | IRF5 | RNA | Others | Others | Others |
| 2513 | IRF6 | RNA | Cell Proliferation | Others | CNS |
| 2514 | IRF7 | RNA | Others | Others | Others |
| 2515 | IRF8 | RNA | Others | Others | Others |
| 2516 | IRF9 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2517 | IRF9 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2518 | IRGM | RNA | Others | Others | Others |
| 2519 | IRS1 | RNA | Others | Others | Others |
| 2520 | IRX1 | RNA | Others | Others | Others |
| 2521 | ISG15 | RNA | Cytotoxicity | Lymphoid Compartment | Oncology |
| 2522 | ISG15 | RNA | Cytotoxicity | Lymphoid Compartment | Immuno-Oncology |
| 2523 | ISG20 | RNA | Others | Others | Others |
| 2524 | ISL1 | RNA | Cell Proliferation | Others | CNS |
| 2525 | ISLR | RNA | Others | Others | Others |
| 2526 | ISLR2 | RNA | Others | Others | Others |
| 2527 | ISM1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2528 | ITCH | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 2529 | ITGA1 | RNA | ECM Remodeling | Lymphoid Compartment | Metabolic Diseases |
| 2530 | ITGA1 | RNA | ECM Remodeling | Lymphoid Compartment | Immuno-Oncology |
| 2531 | ITGA10 | RNA | Others | Others | Others |
| 2532 | ITGA11 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2533 | ITGA2 | RNA | Cellular Differentiation | Others | Oncology |
| 2534 | ITGA2B | RNA | Others | Others | Others |
| 2535 | ITGA3 | RNA | Others | Others | Others |
| 2536 | ITGA4 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 2537 | ITGA5 | RNA | Angiogenesis | Neural Connectivity | Cardiovascular |
| 2538 | ITGA5 | RNA | Angiogenesis | Neural Connectivity | CNS |
| 2539 | ITGA6 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 2540 | ITGA7 | RNA | Others | Others | Others |
| 2541 | ITGA8 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2542 | ITGA9 | RNA | Others | Others | Others |
| 2543 | ITGAE | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 2544 | ITGAL | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 2545 | ITGAM | RNA | Matrix Remodeling and Metastases | Myeloid Compartment | CNS |
| 2546 | ITGAV | RNA | Androgen Signaling | Others | Oncology |
| 2547 | ITGAX | RNA | ECM Remodeling | Myeloid Compartment | Metabolic Diseases |
| 2548 | ITGAX | RNA | ECM Remodeling | Myeloid Compartment | CNS |
| 2549 | ITGB1 | RNA | Cell Proliferation | Others | CNS |
| 2550 | ITGB1BP1 | RNA | Others | Others | Others |
| 2551 | ITGB2 | RNA | Cellular Differentiation | Others | Oncology |
| 2552 | ITGB3 | RNA | Angiogenesis | Others | Cardiovascular |
| 2553 | ITGB4 | RNA | Others | Others | Others |
| 2554 | ITGB5 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2555 | ITGB6 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2556 | ITGB7 | RNA | Others | Others | Others |
| 2557 | ITGB8 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2558 | ITK | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2559 | ITLN1 | RNA | Others | Others | Others |
| 2560 | ITLN2 | RNA | Others | Others | Others |
| 2561 | ITM2A | RNA | Others | Others | Others |
| 2562 | ITPK1 | RNA | Angiogenesis | Others | Cardiovascular |
| 2563 | ITPR1 | RNA | ER Signaling | Neural Connectivity | Oncology |
| 2564 | ITPR1 | RNA | ER Signaling | Neural Connectivity | CNS |
| 2565 | ITPR2 | RNA | Adenosine Pathway | Transmitter Release | Immuno-Oncology |
| 2566 | ITPR2 | RNA | Adenosine Pathway | Transmitter Release | CNS |
| 2567 | ITPR3 | RNA | Others | Transmitter Release | CNS |
| 2568 | JADE1 | RNA | Others | Others | Others |
| 2569 | JAG1 | RNA | Angiogenesis | Others | Cardiovascular |
| 2570 | JAG2 | RNA | Notch | Others | Immuno-Oncology |
| 2571 | JAK1 | RNA | Cytotoxicity | Others | Oncology |
| 2572 | JAK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2573 | JAK3 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 2574 | JAM2 | RNA | EMT | Others | Oncology |
| 2575 | JAM3 | RNA | Angiogenesis | Others | Cardiovascular |
| 2576 | JAML | RNA | Others | Others | Others |
| 2577 | JARID2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2578 | JCAD | RNA | EMT | Others | Oncology |
| 2579 | JMJD1C | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2580 | JMJD4 | RNA | Others | Others | Others |
| 2581 | JUN | RNA | Angiogenesis | Transmitter Response and Reuptake | Cardiovascular |
| 2582 | JUN | RNA | Angiogenesis | Transmitter Response and Reuptake | CNS |
| 2583 | JUNB | RNA | AP1 Signaling | Others | Cardiovascular |
| 2584 | JUND | RNA | AP1 Signaling | Others | Cardiovascular |
| 2585 | JUP | RNA | Others | Others | Others |
| 2586 | KANSL1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2587 | KAT2A | RNA | Others | Others | Others |
| 2588 | KAT2B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2589 | KAT6A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2590 | KAT6B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2591 | KATNA1 | RNA | Others | Neuronal Cytoskeleton | CNS |
| 2592 | KBTBD8 | RNA | Others | Others | Others |
| 2593 | KCNA1 | RNA | Others | Neural Connectivity | CNS |
| 2594 | KCNB1 | RNA | DNA Damage Repair | Neural Connectivity | Epigenic and Nuclear Signaling |
| 2595 | KCNB1 | RNA | DNA Damage Repair | Neural Connectivity | CNS |
| 2596 | KCND1 | RNA | Others | Others | Others |
| 2597 | KCNJ10 | RNA | Myelination | Neural Connectivity | CNS |
| 2598 | KCNJ2 | RNA | Others | Others | Others |
| 2599 | KCNJ8 | RNA | Others | Others | Others |
| 2600 | KCNK13 | RNA | Others | Others | Others |
| 2601 | KCNK2 | RNA | Others | Others | Others |
| 2602 | KDM1A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2603 | KDM1B | RNA | Others | Others | Others |
| 2604 | KDM2A | RNA | Others | Others | Others |
| 2605 | KDM2B | RNA | Others | Others | Others |
| 2606 | KDM3A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2607 | KDM3B | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2608 | KDM4A | RNA | Others | Others | Others |
| 2609 | KDM4B | RNA | Others | Others | Others |
| 2610 | KDM4C | RNA | Others | Others | Others |
| 2611 | KDM4D | RNA | Others | Others | Others |
| 2612 | KDM5A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2613 | KDM5B | RNA | Others | Others | Others |
| 2614 | KDM5C | RNA | Others | Others | Others |
| 2615 | KDM5D | RNA | Others | Others | Others |
| 2616 | KDM6A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2617 | KDM6B | RNA | Others | Others | Others |
| 2618 | KDR | RNA | Angiogenesis | Others | Cardiovascular |
| 2619 | KEAP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2620 | KEL | RNA | Myelination | Others | CNS |
| 2621 | KIAA0040 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2622 | KIAA1161 | RNA | Others | Others | Others |
| 2623 | KIAA1462 | RNA | Others | Others | Others |
| 2624 | KIF11 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2625 | KIF14 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2626 | KIF20A | RNA | Cell Cycle | Others | Oncology |
| 2627 | KIF22 | RNA | Others | Others | Others |
| 2628 | KIF23 | RNA | Cell Cycle | Others | Oncology |
| 2629 | KIF2C | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2630 | KIF3A | RNA | Others | Neural Connectivity | CNS |
| 2631 | KIFC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2632 | KIR Family | RNA | Others | Others | Others |
| 2633 | KIR_Activating_Subgroup_1 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2634 | KIR_Activating_Subgroup_2 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2635 | KIR_Inhibiting_Subgroup_1 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2636 | KIR_Inhibiting_Subgroup_2 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2637 | KIR2DL1 | RNA | Others | Others | Others |
| 2638 | KIR2DL1/2 | RNA | Others | Others | Others |
| 2639 | KIR2DL3 | RNA | Cytotoxicity | Others | Oncology |
| 2640 | KIR2DL3/4 | RNA | Others | Others | Others |
| 2641 | KIR2DL4 | RNA | Others | Others | Others |
| 2642 | KIR2DL5A/B | RNA | Others | Others | Others |
| 2643 | KIR2DS1/4 | RNA | Others | Others | Others |
| 2644 | KIR2DS4 | RNA | Others | Others | Others |
| 2645 | KIR3DL1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
| 2646 | KIR3DL1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
| 2647 | KIR3DL1/2 | RNA | Others | Others | Others |
| 2648 | KIR3DL1/3 | RNA | Others | Others | Others |
| 2649 | KIR3DL2 | RNA | Cytotoxicity | NK Cell Function | Oncology |
| 2650 | KIR3DL2 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
| 2651 | KIR3DL3 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2652 | KISS1 | RNA | Cell Proliferation | Others | CNS |
| 2653 | KIT | RNA | MAPK | Others | Cardiovascular |
| 2654 | KITLG | RNA | RAS | Others | Oncology |
| 2655 | KLC1 | RNA | Others | Others | Others |
| 2656 | KLF2 | RNA | Others | Others | Others |
| 2657 | KLF4 | RNA | Others | Others | Others |
| 2658 | KLF5 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2659 | KLK2 | RNA | Androgen Signaling | Others | Oncology |
| 2660 | KLK3 | RNA | Androgen Signaling | Others | Oncology |
| 2661 | KLK4 | RNA | Androgen Signaling | Others | Oncology |
| 2662 | KLK6 | RNA | Myelination | Others | CNS |
| 2663 | KLKB1 | RNA | Others | Others | Others |
| 2664 | KLRAP1 | RNA | Others | Others | Others |
| 2665 | KLRB1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
| 2666 | KLRB1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
| 2667 | KLRC1 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2668 | KLRC1/2 | RNA | Others | Others | Others |
| 2669 | KLRC2 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2670 | KLRC2/3 | RNA | Others | Others | Others |
| 2671 | KLRC3 | RNA | Others | Others | Others |
| 2672 | KLRC4 | RNA | Others | Others | Others |
| 2673 | KLRD1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
| 2674 | KLRD1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
| 2675 | KLRF1 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2676 | KLRF2 | RNA | Others | Others | Others |
| 2677 | KLRG1 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2678 | KLRG2 | RNA | Others | Others | Others |
| 2679 | KLRK1 | RNA | Cytotoxicity | NK Cell Function | Oncology |
| 2680 | KLRK1 | RNA | Cytotoxicity | NK Cell Function | Immuno-Oncology |
| 2681 | KMO | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2682 | KMT2A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2683 | KMT2C | RNA | Others | Others | Others |
| 2684 | KMT2D | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2685 | KMT2E | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2686 | KNG1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2687 | KPNA2 | RNA | Cell Stress | Others | CNS |
| 2688 | KPNB1 | RNA | Others | Others | Others |
| 2689 | KRAS | RNA | Autophagy | Transmitter Release | Cardiovascular |
| 2690 | KRAS | RNA | Autophagy | Transmitter Release | CNS |
| 2691 | KRIT1 | RNA | Angiogenesis | Others | Cardiovascular |
| 2692 | KRT1 | RNA | Cell Stress | Others | CNS |
| 2693 | KRT10 | RNA | Others | Others | Others |
| 2694 | KRT14 | RNA | Cellular Differentiation | Others | Oncology |
| 2695 | KRT16 | RNA | Others | Others | Others |
| 2696 | KRT17 | RNA | Others | Others | Others |
| 2697 | KRT18 | RNA | Others | Others | Others |
| 2698 | KRT19 | RNA | Others | Others | Others |
| 2699 | KRT5 | RNA | Others | Others | Others |
| 2700 | KRT6A/B/C | RNA | Others | Others | Others |
| 2701 | KRT6B | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2702 | KRT7 | RNA | EMT | Others | Oncology |
| 2703 | KYAT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2704 | KYAT3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2705 | KYNU | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2706 | L1CAM | RNA | Others | Others | Others |
| 2707 | L2HGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2708 | LACC1 | RNA | Others | Others | Others |
| 2709 | LAD1 | RNA | EMT | Others | Oncology |
| 2710 | LAG3 | RNA | Costimulatory Signaling | T Cell Activation | Immuno-Oncology |
| 2711 | LAIR1 | RNA | Others | Others | Others |
| 2712 | LAIR2 | RNA | Others | Others | Others |
| 2713 | LAMA1 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 2714 | LAMA2 | RNA | ECM Remodeling | Neural Connectivity | Metabolic Diseases |
| 2715 | LAMA2 | RNA | ECM Remodeling | Neural Connectivity | CNS |
| 2716 | LAMA3 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 2717 | LAMA4 | RNA | Cellular Differentiation | Others | Oncology |
| 2718 | LAMA5 | RNA | Angiogenesis | Others | Cardiovascular |
| 2719 | LAMB1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2720 | LAMB2 | RNA | Others | Neural Connectivity | CNS |
| 2721 | LAMB3 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2722 | LAMB4 | RNA | Others | Others | Others |
| 2723 | LAMC1 | RNA | Cell Proliferation | Others | CNS |
| 2724 | LAMC2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2725 | LAMC3 | RNA | Others | Others | Others |
| 2726 | LAMP1 | RNA | Others | Neural Connectivity | CNS |
| 2727 | LAMP2 | RNA | Others | Others | Others |
| 2728 | LAMP3 | RNA | Others | Others | Others |
| 2729 | LAMTOR1 | RNA | mTOR Signaling | Others | Oncology |
| 2730 | LAMTOR2 | RNA | mTOR Signaling | Others | Oncology |
| 2731 | LAMTOR3 | RNA | Others | Others | Others |
| 2732 | LAMTOR4 | RNA | mTOR Signaling | Others | Oncology |
| 2733 | LAMTOR5 | RNA | mTOR Signaling | Others | Oncology |
| 2734 | LANCL1 | RNA | Others | Others | Others |
| 2735 | LAT | RNA | RAS | Others | Oncology |
| 2736 | LAT2 | RNA | Others | Others | Others |
| 2737 | LATS1 | RNA | Hippo Signaling | Others | CNS |
| 2738 | LATS2 | RNA | Others | Others | Others |
| 2739 | LBP | RNA | Others | Others | Others |
| 2740 | LCK | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2741 | LCLAT1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 2742 | LCN2 | RNA | Others | Others | Others |
| 2743 | LCOR | RNA | Others | Others | Others |
| 2744 | LCP1 | RNA | Others | Others | Others |
| 2745 | LCP2 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 2746 | LDHA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2747 | LDHAL6A | RNA | Others | Others | Others |
| 2748 | LDHB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2749 | LDHC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2750 | LDLRAD3 | RNA | Others | Others | Others |
| 2751 | LDLRAP1 | RNA | Others | Others | Others |
| 2752 | LEF1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2753 | LEFTY1 | RNA | Others | Others | Others |
| 2754 | LEFTY1/2 | RNA | Others | Others | Others |
| 2755 | LEFTY2 | RNA | TGF Beta Signaling | Others | Oncology |
| 2756 | LEMD1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2757 | LEP | RNA | JAK-STAT | Others | CNS |
| 2758 | LEPR | RNA | JAK-STAT | Others | CNS |
| 2759 | LFNG | RNA | Notch | Others | Immuno-Oncology |
| 2760 | LGALS1 | RNA | Others | Others | Others |
| 2761 | LGALS3 | RNA | Others | Others | Others |
| 2762 | LGALS9 | RNA | Others | Others | Others |
| 2763 | LGMN | RNA | Others | Others | Others |
| 2764 | LGR5 | RNA | Others | Others | Others |
| 2765 | LHFP | RNA | Others | Others | Others |
| 2766 | LIF | RNA | Cytotoxicity | Others | Oncology |
| 2767 | LIFR | RNA | Cell Proliferation | Others | CNS |
| 2768 | LIG1 | RNA | Cell Cycle | Others | Oncology |
| 2769 | LIG4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2770 | LILRA1 | RNA | Others | Others | Others |
| 2771 | LILRA2 | RNA | Others | Others | Others |
| 2772 | LILRA3 | RNA | Others | Others | Others |
| 2773 | LILRA4 | RNA | Others | Others | Others |
| 2774 | LILRA5 | RNA | Others | Others | Others |
| 2775 | LILRA6 | RNA | Others | Others | Others |
| 2776 | LILRB1 | RNA | Others | NK Cell Function | Immuno-Oncology |
| 2777 | LILRB2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2778 | LILRB3 | RNA | Others | Others | Others |
| 2779 | LILRB4 | RNA | Others | Others | Others |
| 2780 | LILRB5 | RNA | Others | Others | Others |
| 2781 | LIMK1 | RNA | Others | Others | Others |
| 2782 | LIMK2 | RNA | Others | Others | Others |
| 2783 | LIN9 | RNA | Cell Cycle | Others | Oncology |
| 2784 | LINC02381 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2785 | LINGO1 | RNA | Others | Others | Others |
| 2786 | LIPA | RNA | Others | Others | Others |
| 2787 | LIPC | RNA | Others | Others | Others |
| 2788 | LIPG | RNA | Others | Others | Others |
| 2789 | LITAF | RNA | Others | Others | Others |
| 2790 | LLGL2 | RNA | Others | Others | Others |
| 2791 | LMNA | RNA | Others | Others | Others |
| 2792 | LMNB1 | RNA | Others | Others | Others |
| 2793 | LNX1 | RNA | Others | Others | Others |
| 2794 | LOX | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 2795 | LOXL1 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 2796 | LOXL2 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 2797 | LOXL4 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 2798 | LPA | RNA | Others | Others | Others |
| 2799 | LPAR1 | RNA | Myelination | Neural Connectivity | CNS |
| 2800 | LPAR5 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2801 | LPAR6 | RNA | Others | Others | Others |
| 2802 | LPCAT1 | RNA | Others | Others | Others |
| 2803 | LPIN1 | RNA | Others | Others | Others |
| 2804 | LPL | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2805 | LPO | RNA | Oxydative Stress | Others | Inflammation |
| 2806 | LRG1 | RNA | Others | Others | Others |
| 2807 | LRP1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2808 | LRP2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 2809 | LRP5 | RNA | Others | Others | Others |
| 2810 | LRP6 | RNA | Others | Others | Others |
| 2811 | LRR1 | RNA | Others | Others | Others |
| 2812 | LRRC25 | RNA | Others | Others | Others |
| 2813 | LRRC3 | RNA | Others | Others | Others |
| 2814 | LRRC32 | RNA | Others | Others | Others |
| 2815 | LRRC4 | RNA | Others | Neural Connectivity | CNS |
| 2816 | LRRC41 | RNA | Others | Others | Others |
| 2817 | LRRK2 | RNA | Epigenic and Transcriptional Regulation | Neural Connectivity | Epigenic and Nuclear Signaling |
| 2818 | LRRK2 | RNA | Epigenic and Transcriptional Regulation | Neural Connectivity | CNS |
| 2819 | LRRN3 | RNA | Others | Others | Others |
| 2820 | LSM2 | RNA | Others | Others | Others |
| 2821 | LSM7 | RNA | Others | Others | Others |
| 2822 | LSR | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 2823 | LST1 | RNA | Others | Others | Others |
| 2824 | LTA | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2825 | LTA4H | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2826 | LTB | RNA | NF-kappaB Signaling | Others | CNS |
| 2827 | LTB4R | RNA | Others | Others | Others |
| 2828 | LTB4R2 | RNA | Others | Others | Others |
| 2829 | LTBP1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 2830 | LTBP4 | RNA | Cellular Differentiation | Others | Oncology |
| 2831 | LTBR | RNA | HIF1 Signaling | Others | Inflammation |
| 2832 | LTC4S | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2833 | LTF | RNA | Others | Others | Others |
| 2834 | LTK | RNA | Others | Others | Others |
| 2835 | LUM | RNA | Others | Others | Others |
| 2836 | LY6E | RNA | Others | Others | Others |
| 2837 | LY86 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2838 | LY9 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2839 | LY96 | RNA | Apoptosis | Others | Oncology |
| 2840 | LYN | RNA | Others | Others | Others |
| 2841 | LYPLA1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 2842 | LYZ | RNA | Others | Others | Others |
| 2843 | MAD2L1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2844 | MAD2L2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2845 | MAF | RNA | EMT | Others | Oncology |
| 2846 | MAFB | RNA | Others | Others | Others |
| 2847 | MAFF | RNA | Others | Others | Others |
| 2848 | MAFG | RNA | Others | Others | Others |
| 2849 | MAFK | RNA | Others | Others | Others |
| 2850 | MAG | RNA | Myelination | Others | CNS |
| 2851 | MAGEA1 | RNA | Others | Others | Others |
| 2852 | MAGEA12 | RNA | Others | Others | Others |
| 2853 | MAGEA3 | RNA | Others | Others | Others |
| 2854 | MAGEA3/A6 | RNA | Others | Others | Others |
| 2855 | MAGEA4 | RNA | Others | Others | Others |
| 2856 | MAGEB2 | RNA | Others | Others | Others |
| 2857 | MAGEC1 | RNA | Others | Others | Others |
| 2858 | MAGEC2 | RNA | Others | Others | Others |
| 2859 | MAGED1 | RNA | Others | Others | Others |
| 2860 | MAGEE1 | RNA | Others | Others | Others |
| 2861 | MAGI2 | RNA | Others | Others | Others |
| 2862 | MAL | RNA | Myelination | Others | CNS |
| 2863 | MALL | RNA | Others | Others | Others |
| 2864 | MALT1 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 2865 | MAML1 | RNA | Others | Others | Others |
| 2866 | MAML2 | RNA | Notch | Others | Immuno-Oncology |
| 2867 | MAML3 | RNA | Others | Others | Others |
| 2868 | MAN2B1 | RNA | Others | Others | Others |
| 2869 | MAP1LC3A | RNA | Others | Others | Others |
| 2870 | MAP1LC3B | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 2871 | MAP2 | RNA | Others | Others | Others |
| 2872 | MAP2K1 | RNA | Nutrient Capture and Catabolic Pathways | Transmitter Release | Metabolic Diseases |
| 2873 | MAP2K1 | RNA | Nutrient Capture and Catabolic Pathways | Transmitter Release | CNS |
| 2874 | MAP2K2 | RNA | Nutrient Capture and Catabolic Pathways | Transmitter Response and Reuptake | Metabolic Diseases |
| 2875 | MAP2K2 | RNA | Nutrient Capture and Catabolic Pathways | Transmitter Response and Reuptake | CNS |
| 2876 | MAP2K3 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2877 | MAP2K4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2878 | MAP2K6 | RNA | Others | Others | Others |
| 2879 | MAP2K7 | RNA | Others | Others | Others |
| 2880 | MAP3K1 | RNA | Others | Others | Others |
| 2881 | MAP3K12 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 2882 | MAP3K13 | RNA | Others | Others | Others |
| 2883 | MAP3K14 | RNA | Others | Others | Others |
| 2884 | MAP3K20 | RNA | Others | Others | Others |
| 2885 | MAP3K3 | RNA | Others | Others | Others |
| 2886 | MAP3K5 | RNA | MAPK | Others | Cardiovascular |
| 2887 | MAP3K7 | RNA | Angiogenesis | Others | Cardiovascular |
| 2888 | MAP3K8 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 2889 | MAP3K9 | RNA | Others | Others | Others |
| 2890 | MAP4K1 | RNA | Others | Others | Others |
| 2891 | MAP4K2 | RNA | Others | Others | Others |
| 2892 | MAP4K4 | RNA | Others | Others | Others |
| 2893 | MAPK1 | RNA | Biosynthesis and Anabolic Pathways | Transmitter Release | CNS |
| 2894 | MAPK10 | RNA | AP1 Signaling | Transmitter Release | Cardiovascular |
| 2895 | MAPK10 | RNA | AP1 Signaling | Transmitter Release | CNS |
| 2896 | MAPK11 | RNA | AP1 Signaling | Others | Cardiovascular |
| 2897 | MAPK12 | RNA | Others | Others | Others |
| 2898 | MAPK13 | RNA | VEGFR Signaling | Others | Cardiovascular |
| 2899 | MAPK14 | RNA | AP1 Signaling | Others | Cardiovascular |
| 2900 | MAPK15 | RNA | Others | Others | Others |
| 2901 | MAPK3 | RNA | Cellular Differentiation | Transmitter Release | Oncology |
| 2902 | MAPK3 | RNA | Cellular Differentiation | Transmitter Release | CNS |
| 2903 | MAPK7 | RNA | Others | Others | Others |
| 2904 | MAPK8 | RNA | AP1 Signaling | Transmitter Release | Cardiovascular |
| 2905 | MAPK8 | RNA | AP1 Signaling | Transmitter Release | CNS |
| 2906 | MAPK8IP1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2907 | MAPK8IP2 | RNA | MAPK | Others | Cardiovascular |
| 2908 | MAPK9 | RNA | AP1 Signaling | Transmitter Release | Cardiovascular |
| 2909 | MAPK9 | RNA | AP1 Signaling | Transmitter Release | CNS |
| 2910 | MAPKAP1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2911 | MAPKAPK2 | RNA | Others | Others | Others |
| 2912 | MAPKAPK3 | RNA | Others | Others | Others |
| 2913 | MAPKAPK5 | RNA | Others | Others | Others |
| 2914 | MAPT | RNA | ER Signaling | Neuronal Cytoskeleton | Oncology |
| 2915 | MAPT | RNA | ER Signaling | Neuronal Cytoskeleton | CNS |
| 2916 | MARCKS | RNA | Others | Others | Others |
| 2917 | MARCO | RNA | Others | Others | Others |
| 2918 | MASP1 | RNA | Others | Others | Others |
| 2919 | MASP2 | RNA | Others | Others | Others |
| 2920 | MAT1A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2921 | MAT2A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2922 | MAVS | RNA | Others | Others | Others |
| 2923 | MAX | RNA | Others | Others | Others |
| 2924 | MB21D1 | RNA | Others | Others | Others |
| 2925 | MBD2 | RNA | Others | Others | Others |
| 2926 | MBD3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 2927 | MBL2 | RNA | Others | Others | Others |
| 2928 | MBNL1 | RNA | Others | Others | Others |
| 2929 | MBNL3 | RNA | Others | Others | Others |
| 2930 | MBP | RNA | Myelination | Vesicle Trafficking | CNS |
| 2931 | MBTPS2 | RNA | Others | Others | Others |
| 2932 | MCAM | RNA | Angiogenesis | Others | Cardiovascular |
| 2933 | MCAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2934 | MCL1 | RNA | Others | Others | Others |
| 2935 | MCM2 | RNA | Cell Cycle | Others | Oncology |
| 2936 | MCM3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2937 | MCM4 | RNA | Cell Cycle | Others | Oncology |
| 2938 | MCM5 | RNA | Others | Others | Others |
| 2939 | MCM6 | RNA | Others | Others | Others |
| 2940 | MCM7 | RNA | Others | Others | Others |
| 2941 | MDC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2942 | MDFIC | RNA | Others | Others | Others |
| 2943 | MDH2 | RNA | Others | Others | Others |
| 2944 | MDM2 | RNA | Cell Cycle | Others | Oncology |
| 2945 | MDM4 | RNA | Others | Others | Others |
| 2946 | ME2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2947 | MEAF6 | RNA | Others | Others | Others |
| 2948 | MECOM | RNA | Others | Others | Others |
| 2949 | MECP2 | RNA | Others | Vesicle Trafficking | CNS |
| 2950 | MED1 | RNA | Angiogenesis | Others | Cardiovascular |
| 2951 | MED12 | RNA | Others | Others | Others |
| 2952 | MED23 | RNA | Others | Others | Others |
| 2953 | MEF2A | RNA | Others | Others | Others |
| 2954 | MEF2BNB-MEF2B | RNA | Others | Others | Others |
| 2955 | MEF2C | RNA | Others | Others | Others |
| 2956 | MEF2D | RNA | Others | Others | Others |
| 2957 | MEFV | RNA | Others | Others | Others |
| 2958 | MEG3 | RNA | Cell Proliferation | Others | CNS |
| 2959 | MELK | RNA | Proliferation | Others | Oncology |
| 2960 | MEN1 | RNA | Others | Others | Others |
| 2961 | MEOX2 | RNA | Angiogenesis | Others | Cardiovascular |
| 2962 | MERTK | RNA | Others | Others | Others |
| 2963 | MET | RNA | Cell Proliferation | Others | CNS |
| 2964 | MFAP3 | RNA | Others | Others | Others |
| 2965 | MFAP4 | RNA | Others | Others | Others |
| 2966 | MFGE8 | RNA | Others | Others | Others |
| 2967 | MFN2 | RNA | Others | Others | Others |
| 2968 | MFNG | RNA | Notch | Others | Immuno-Oncology |
| 2969 | MGA | RNA | Myc | Others | Oncology |
| 2970 | MGAM | RNA | Others | Others | Others |
| 2971 | MGAT5 | RNA | Others | Others | Others |
| 2972 | MGMT | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2973 | MGP | RNA | Others | Others | Others |
| 2974 | MGST3 | RNA | Cell Stress | Others | CNS |
| 2975 | MIA | RNA | Others | Others | Others |
| 2976 | MIB1 | RNA | Others | Others | Others |
| 2977 | MICA | RNA | Others | Others | Others |
| 2978 | MICB | RNA | Others | Others | Others |
| 2979 | MID1IP1 | RNA | Others | Others | Others |
| 2980 | MIF | RNA | Others | Others | Others |
| 2981 | MINOS1 | RNA | Others | Others | Others |
| 2982 | MIS18A | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2983 | MISP | RNA | Others | Others | Others |
| 2984 | MKI67 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 2985 | MKNK1 | RNA | Others | Others | Others |
| 2986 | MLANA | RNA | Others | Others | Others |
| 2987 | MLF1 | RNA | Others | Others | Others |
| 2988 | MLH1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2989 | MLKL | RNA | Others | Others | Others |
| 2990 | MLLT3 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 2991 | MLLT4 | RNA | RAS | Others | Oncology |
| 2992 | MLPH | RNA | Others | Others | Others |
| 2993 | MLST8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 2994 | MLXIPL | RNA | Others | Others | Others |
| 2995 | MLYCD | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 2996 | MME | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 2997 | MMP1 | RNA | Cellular Differentiation | Others | Oncology |
| 2998 | MMP10 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 2999 | MMP11 | RNA | Others | Others | Others |
| 3000 | MMP12 | RNA | Cell Proliferation | Others | CNS |
| 3001 | MMP13 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 3002 | MMP14 | RNA | Angiogenesis | Others | Cardiovascular |
| 3003 | MMP16 | RNA | Others | Others | Others |
| 3004 | MMP17 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 3005 | MMP19 | RNA | Others | Others | Others |
| 3006 | MMP2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3007 | MMP24 | RNA | Cellular Differentiation | Others | Oncology |
| 3008 | MMP3 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3009 | MMP7 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 3010 | MMP8 | RNA | Others | Others | Others |
| 3011 | MMP9 | RNA | Angiogenesis | Others | Cardiovascular |
| 3012 | MMRN1 | RNA | Others | Others | Others |
| 3013 | MMRN2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3014 | MMUT | RNA | Others | Others | Others |
| 3015 | MNAT1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3016 | MNDA | RNA | Others | Others | Others |
| 3017 | MNX1 | RNA | Others | Others | Others |
| 3018 | MOB1B | RNA | Others | Others | Others |
| 3019 | MOBP | RNA | Others | Others | Others |
| 3020 | MOG | RNA | Myelination | Others | CNS |
| 3021 | MPC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3022 | MPC2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3023 | MPDZ | RNA | Others | Others | Others |
| 3024 | MPEG1 | RNA | Others | Others | Others |
| 3025 | MPG | RNA | Others | Others | Others |
| 3026 | MPL | RNA | Others | Others | Others |
| 3027 | MPO | RNA | Cell Stress | Others | CNS |
| 3028 | MPPED1 | RNA | Others | Others | Others |
| 3029 | MPV17 | RNA | Others | Others | Others |
| 3030 | MPZ | RNA | Others | Vesicle Trafficking | CNS |
| 3031 | MPZL1 | RNA | Others | Others | Others |
| 3032 | MR1 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 3033 | MRAS | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3034 | MRC1 | RNA | Others | Others | Others |
| 3035 | MRE11 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3036 | MRM2 | RNA | Others | Others | Others |
| 3037 | MRPL19 | RNA | Others | Others | Others |
| 3038 | MRPS5 | RNA | Others | Others | Others |
| 3039 | MRPS7 | RNA | Others | Others | Others |
| 3040 | MS4A1 | RNA | Others | Others | Others |
| 3041 | MS4A2 | RNA | Others | Others | Others |
| 3042 | MS4A4A | RNA | Others | Others | Others |
| 3043 | MS4A6A | RNA | Others | Others | Others |
| 3044 | MS4A7 | RNA | Others | Others | Others |
| 3045 | MSH2 | RNA | Cell Stress | Others | CNS |
| 3046 | MSH6 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3047 | MSLN | RNA | Others | Others | Others |
| 3048 | MSN | RNA | Others | Others | Others |
| 3049 | MSR1 | RNA | Others | Others | Others |
| 3050 | MSRA | RNA | Others | Others | Others |
| 3051 | MSRB2 | RNA | Cell Stress | Others | CNS |
| 3052 | MST1R | RNA | Others | Others | Others |
| 3053 | MT1G | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3054 | MT2A | RNA | Others | Others | Others |
| 3055 | MT3 | RNA | Cell Proliferation | Others | CNS |
| 3056 | MTA1 | RNA | Others | Others | Others |
| 3057 | MTA2 | RNA | Others | Others | Others |
| 3058 | MTBP | RNA | Cell Proliferation | Others | CNS |
| 3059 | MTCP1 | RNA | Others | Others | Others |
| 3060 | MTDH | RNA | Others | Others | Others |
| 3061 | MTF1 | RNA | Cell Stress | Others | CNS |
| 3062 | MTF2 | RNA | Others | Others | Others |
| 3063 | MTHFD1 | RNA | Others | Others | Others |
| 3064 | MTHFD1L | RNA | Others | Others | Others |
| 3065 | MTHFD2 | RNA | mTOR Signaling | Others | Oncology |
| 3066 | MTHFR | RNA | Others | Others | Others |
| 3067 | MTHFS | RNA | Others | Others | Others |
| 3068 | MTMR14 | RNA | Others | Others | Others |
| 3069 | MTMR3 | RNA | Others | Others | Others |
| 3070 | MTMR4 | RNA | Others | Others | Others |
| 3071 | MTOR | RNA | Autophagy | Others | Cardiovascular |
| 3072 | MTR | RNA | Others | Others | Others |
| 3073 | MUC1 | RNA | EMT | Others | Oncology |
| 3074 | MUC16 | RNA | Others | Others | Others |
| 3075 | MUC4 | RNA | Others | Others | Others |
| 3076 | MUC5B | RNA | Others | Others | Others |
| 3077 | MUS81 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3078 | MUTYH | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3079 | MVP | RNA | Others | Others | Others |
| 3080 | MX1 | RNA | Cytotoxicity | Others | Oncology |
| 3081 | MX2 | RNA | Others | Others | Others |
| 3082 | MXI1 | RNA | Others | Others | Others |
| 3083 | MYB | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3084 | MYBL1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3085 | MYBL2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3086 | MYC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3087 | MYCL | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3088 | MYCN | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3089 | MYCT1 | RNA | Angiogenesis | Others | Cardiovascular |
| 3090 | MYD88 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3091 | MYH10 | RNA | Others | Others | Others |
| 3092 | MYH11 | RNA | Others | Others | Others |
| 3093 | MYL2 | RNA | Others | Others | Others |
| 3094 | MYL9 | RNA | Others | Others | Others |
| 3095 | MYLK | RNA | Others | Others | Others |
| 3096 | MYO1D | RNA | Others | Others | Others |
| 3097 | MYO5C | RNA | Others | Others | Others |
| 3098 | MYORG | RNA | Others | Others | Others |
| 3099 | MYRF | RNA | Myelination | Others | CNS |
| 3100 | MYSM1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3101 | MZB1 | RNA | Others | Others | Others |
| 3102 | NAA15 | RNA | Angiogenesis | Others | Cardiovascular |
| 3103 | NAA20 | RNA | Others | Others | Others |
| 3104 | NAA50 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3105 | NAALAD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3106 | NADK | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3107 | NADK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3108 | NAE1 | RNA | Others | Others | Others |
| 3109 | NAGLU | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3110 | NAMPT | RNA | Others | Others | Others |
| 3111 | NANOG | RNA | Others | Others | Others |
| 3112 | NAP1L3 | RNA | Others | Others | Others |
| 3113 | NAPSA | RNA | Others | Others | Others |
| 3114 | NASP | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 3115 | NAT1 | RNA | ER Signaling | Others | Oncology |
| 3116 | NAT8L | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3117 | NBL1 | RNA | Others | Others | Others |
| 3118 | NBN | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3119 | NCAM1 | RNA | Matrix Remodeling and Metastases | Vesicle Trafficking | CNS |
| 3120 | NCAPD2 | RNA | Others | Others | Others |
| 3121 | NCAPG | RNA | Cell Cycle | Others | Oncology |
| 3122 | NCAPG2 | RNA | Others | Others | Others |
| 3123 | NCAPH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3124 | NCAPH2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3125 | NCEH1 | RNA | Others | Others | Others |
| 3126 | NCF1 | RNA | Oxydative Stress | Others | Inflammation |
| 3127 | NCF2 | RNA | Others | Others | Others |
| 3128 | NCF4 | RNA | Others | Others | Others |
| 3129 | NCK1 | RNA | PDGF Signaling | Others | Oncology |
| 3130 | NCK2 | RNA | Others | Others | Others |
| 3131 | NCKAP1L | RNA | Others | Others | Others |
| 3132 | NCL | RNA | Angiogenesis | Others | Cardiovascular |
| 3133 | NCOA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3134 | NCOR1 | RNA | Androgen Signaling | Others | Oncology |
| 3135 | NCOR2 | RNA | Others | Others | Others |
| 3136 | NCR1 | RNA | Others | Others | Others |
| 3137 | NCR2 | RNA | Others | Others | Others |
| 3138 | NCR3 | RNA | Others | Others | Others |
| 3139 | NCSTN | RNA | Others | Others | Others |
| 3140 | NDC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3141 | NDC80 | RNA | Others | Others | Others |
| 3142 | NDNF | RNA | Others | Others | Others |
| 3143 | NDP | RNA | Cell Proliferation | Others | CNS |
| 3144 | NDRG1 | RNA | Others | Others | Others |
| 3145 | NDUFA1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3146 | NDUFA11 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3147 | NDUFA12 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3148 | NDUFA13 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3149 | NDUFA2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3150 | NDUFA3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3151 | NDUFA4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3152 | NDUFA4L2 | RNA | Others | Others | Others |
| 3153 | NDUFA6 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3154 | NDUFA7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3155 | NDUFAB1 | RNA | Others | Others | Others |
| 3156 | NDUFB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3157 | NDUFB10 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3158 | NDUFB11 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3159 | NDUFB2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3160 | NDUFB4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3161 | NDUFB5 | RNA | Others | Others | Others |
| 3162 | NDUFB6 | RNA | Others | Others | Others |
| 3163 | NDUFB7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3164 | NDUFB8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3165 | NDUFB9 | RNA | Others | Others | Others |
| 3166 | NDUFC1 | RNA | Others | Others | Others |
| 3167 | NDUFS3 | RNA | Others | Others | Others |
| 3168 | NDUFS5 | RNA | Others | Others | Others |
| 3169 | NDUFS7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3170 | NDUFS8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3171 | NECTIN1 | RNA | Others | Others | Others |
| 3172 | NECTIN2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3173 | NEDD8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3174 | NEFH | RNA | Oxydative Stress | Others | Inflammation |
| 3175 | NEFL | RNA | Others | Others | Others |
| 3176 | NEGR1 | RNA | Others | Others | Others |
| 3177 | NEIL1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3178 | NEIL2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3179 | NEIL3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3180 | NEK2 | RNA | Cell Cycle | Others | Oncology |
| 3181 | NELFA | RNA | Others | Others | Others |
| 3182 | NELL2 | RNA | Others | Others | Others |
| 3183 | NEO1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3184 | NES | RNA | Others | Others | Others |
| 3185 | NETO2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3186 | NEU1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3187 | NF1 | RNA | Apoptosis | Transmitter Response and Reuptake | Oncology |
| 3188 | NF1 | RNA | Apoptosis | Transmitter Response and Reuptake | CNS |
| 3189 | NF2 | RNA | Cell Proliferation | Others | CNS |
| 3190 | NFAM1 | RNA | Others | Others | Others |
| 3191 | NFAT5 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3192 | NFATC1 | RNA | MAPK | Others | Cardiovascular |
| 3193 | NFATC2 | RNA | Cell Proliferation | Others | CNS |
| 3194 | NFATC2IP | RNA | Others | Others | Others |
| 3195 | NFATC3 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 3196 | NFATC4 | RNA | Others | Others | Others |
| 3197 | NFE2L1 | RNA | Others | Others | Others |
| 3198 | NFE2L2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3199 | NFIL3 | RNA | Angiogenesis | Others | Cardiovascular |
| 3200 | NFKB1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3201 | NFKB2 | RNA | MAPK | Others | Cardiovascular |
| 3202 | NFKBIA | RNA | Costimulatory Signaling | Transmitter Response and Reuptake | Immuno-Oncology |
| 3203 | NFKBIA | RNA | Costimulatory Signaling | Transmitter Response and Reuptake | CNS |
| 3204 | NFKBIB | RNA | Others | Others | Others |
| 3205 | NFKBIE | RNA | NF-kappaB Signaling | Others | CNS |
| 3206 | NFKBIZ | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3207 | NFS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3208 | NGF | RNA | RAS | Others | Oncology |
| 3209 | NGFR | RNA | MAPK | Vesicle Trafficking | Cardiovascular |
| 3210 | NGFR | RNA | MAPK | Vesicle Trafficking | CNS |
| 3211 | NGLY1 | RNA | Others | Others | Others |
| 3212 | NID1 | RNA | Others | Others | Others |
| 3213 | NID2 | RNA | Cellular Differentiation | Others | Oncology |
| 3214 | NINJ2 | RNA | Others | Others | Others |
| 3215 | NKD1 | RNA | Others | Others | Others |
| 3216 | NKG7 | RNA | Cytotoxicity | Others | Oncology |
| 3217 | NKIRAS2 | RNA | Others | Others | Others |
| 3218 | NKX2-1 | RNA | Others | Others | Others |
| 3219 | NKX3-1 | RNA | Androgen Signaling | Others | Oncology |
| 3220 | NKX6-2 | RNA | Myelination | Others | CNS |
| 3221 | NLGN1 | RNA | Others | Others | Others |
| 3222 | NLGN2 | RNA | Others | Others | Others |
| 3223 | NLGN4X | RNA | Others | Vesicle Trafficking | CNS |
| 3224 | NLRC4 | RNA | Others | Others | Others |
| 3225 | NLRC5 | RNA | Others | Others | Others |
| 3226 | NLRP1 | RNA | Others | Others | Others |
| 3227 | NLRP3 | RNA | Others | Others | Others |
| 3228 | NMB | RNA | Others | Others | Others |
| 3229 | NME1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3230 | NME2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3231 | NME4 | RNA | Others | Others | Others |
| 3232 | NME5 | RNA | Oxydative Stress | Others | Inflammation |
| 3233 | NMNAT2 | RNA | Others | Others | Others |
| 3234 | NMT1 | RNA | Others | Others | Others |
| 3235 | NOD1 | RNA | Others | Others | Others |
| 3236 | NOD2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3237 | NODAL | RNA | Cell Proliferation | Others | CNS |
| 3238 | NOG | RNA | Others | Others | Others |
| 3239 | NOL3 | RNA | Oxydative Stress | Others | Inflammation |
| 3240 | NOL7 | RNA | Others | Others | Others |
| 3241 | NOS1 | RNA | Biosynthesis and Anabolic Pathways | Transmitter Response and Reuptake | CNS |
| 3242 | NOS2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3243 | NOS2A | RNA | Others | Others | Others |
| 3244 | NOS3 | RNA | Angiogenesis | Transmitter Response and Reuptake | Cardiovascular |
| 3245 | NOS3 | RNA | Angiogenesis | Transmitter Response and Reuptake | CNS |
| 3246 | NOSTRIN | RNA | Others | Others | Others |
| 3247 | NOTCH1 | RNA | Cellular Differentiation | Others | Oncology |
| 3248 | NOTCH2 | RNA | Notch | Others | Immuno-Oncology |
| 3249 | NOTCH3 | RNA | Notch | Others | Immuno-Oncology |
| 3250 | NOTCH4 | RNA | Others | Others | Others |
| 3251 | NOVA1 | RNA | Others | Vesicle Trafficking | CNS |
| 3252 | NOX1 | RNA | Cell Stress | Others | CNS |
| 3253 | NOX3 | RNA | Cell Stress | Others | CNS |
| 3254 | NOX4 | RNA | Cell Stress | Others | CNS |
| 3255 | NOX5 | RNA | Angiogenesis | Others | Cardiovascular |
| 3256 | NPAS4 | RNA | Others | Vesicle Trafficking | CNS |
| 3257 | NPC1 | RNA | Others | Others | Others |
| 3258 | NPC2 | RNA | Others | Others | Others |
| 3259 | NPEPPS | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3260 | NPHP4 | RNA | Others | Others | Others |
| 3261 | NPL | RNA | Others | Others | Others |
| 3262 | NPM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3263 | NPM2 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 3264 | NPNT | RNA | Others | Others | Others |
| 3265 | NPR1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3266 | NPR2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3267 | NPRL2 | RNA | Others | Others | Others |
| 3268 | NPRL3 | RNA | Others | Others | Others |
| 3269 | NPTN | RNA | Others | Transmitter Response and Reuptake | CNS |
| 3270 | NPTX1 | RNA | Others | Others | Others |
| 3271 | NPY | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake | CNS |
| 3272 | NQO1 | RNA | Cell Stress | Vesicle Trafficking | CNS |
| 3273 | NR1H2 | RNA | Others | Others | Others |
| 3274 | NR1H3 | RNA | Others | Others | Others |
| 3275 | NR1H4 | RNA | Others | Others | Others |
| 3276 | NR2F1 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3277 | NR3C1 | RNA | Cell Proliferation | Others | CNS |
| 3278 | NR4A1 | RNA | Cell Proliferation | Others | CNS |
| 3279 | NR4A2 | RNA | Oxydative Stress | Others | Inflammation |
| 3280 | NR4A3 | RNA | Cell Proliferation | Others | CNS |
| 3281 | NRAS | RNA | Autophagy | Others | Cardiovascular |
| 3282 | NRBF2 | RNA | Others | Others | Others |
| 3283 | NRCAM | RNA | Angiogenesis | Others | Cardiovascular |
| 3284 | NRDE2 | RNA | Others | Others | Others |
| 3285 | NRF1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3286 | NRG1 | RNA | Myelination | Others | CNS |
| 3287 | NRGN | RNA | Others | Others | Others |
| 3288 | NRIP3 | RNA | Others | Others | Others |
| 3289 | NRL | RNA | AP1 Signaling | Others | Cardiovascular |
| 3290 | NRM | RNA | Others | Others | Others |
| 3291 | NRP1 | RNA | Angiogenesis | Others | Cardiovascular |
| 3292 | NRP2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3293 | NRXN1 | RNA | Angiogenesis | Vesicle Trafficking | Cardiovascular |
| 3294 | NRXN1 | RNA | Angiogenesis | Vesicle Trafficking | CNS |
| 3295 | NRXN3 | RNA | Angiogenesis | Others | Cardiovascular |
| 3296 | NSD1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3297 | NSD2 | RNA | Others | Others | Others |
| 3298 | NSD3 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3299 | NSF | RNA | Transmitter Synthesis | Vesicle Trafficking | CNS |
| 3300 | NT5E | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3301 | NTF3 | RNA | Myelination | Vesicle Trafficking | CNS |
| 3302 | NTHL1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3303 | NTNG1 | RNA | Others | Others | Others |
| 3304 | NTNG2 | RNA | Others | Others | Others |
| 3305 | NTRK1 | RNA | Cell Proliferation | Vesicle Trafficking | CNS |
| 3306 | NTRK2 | RNA | MAPK | Others | Cardiovascular |
| 3307 | NTS | RNA | Others | Others | Others |
| 3308 | NUBP1 | RNA | Others | Others | Others |
| 3309 | NUDT1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3310 | NUDT2 | RNA | Others | Others | Others |
| 3311 | NUF2 | RNA | Cell Cycle | Others | Oncology |
| 3312 | NUMB | RNA | Others | Others | Others |
| 3313 | NUMBL | RNA | Notch | Others | Immuno-Oncology |
| 3314 | NUP107 | RNA | Others | Others | Others |
| 3315 | NUP205 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3316 | NUP54 | RNA | Others | Others | Others |
| 3317 | NUP62 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3318 | NUPR1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3319 | NWD1 | RNA | Others | Others | Others |
| 3320 | OAS1 | RNA | Cytotoxicity | Others | Oncology |
| 3321 | OAS2 | RNA | Cytotoxicity | Others | Oncology |
| 3322 | OAS3 | RNA | Cytotoxicity | Others | Oncology |
| 3323 | OASL | RNA | Others | Others | Others |
| 3324 | OAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3325 | OAZ1 | RNA | Others | Others | Others |
| 3326 | OCIAD2 | RNA | Others | Others | Others |
| 3327 | OCLN | RNA | EMT | Others | Oncology |
| 3328 | ODC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3329 | OGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3330 | OGDHL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3331 | OGG1 | RNA | Others | Others | Others |
| 3332 | OGN | RNA | Cell Proliferation | Others | CNS |
| 3333 | OGT | RNA | Others | Others | Others |
| 3334 | OLFM3 | RNA | Others | Others | Others |
| 3335 | OLFML2B | RNA | EMT | Others | Oncology |
| 3336 | OLFML3 | RNA | Others | Others | Others |
| 3337 | OLIG2 | RNA | Myelination | Others | CNS |
| 3338 | OLR1 | RNA | Others | Others | Others |
| 3339 | OMA1 | RNA | Others | Others | Others |
| 3340 | OPA1 | RNA | Others | Others | Others |
| 3341 | OPALIN | RNA | Others | Others | Others |
| 3342 | OPN3 | RNA | Others | Others | Others |
| 3343 | OPTN | RNA | Others | Others | Others |
| 3344 | ORAI1 | RNA | Others | Others | Others |
| 3345 | ORC2 | RNA | Others | Others | Others |
| 3346 | ORC4 | RNA | Others | Others | Others |
| 3347 | ORC6 | RNA | Others | Others | Others |
| 3348 | OS9 | RNA | Others | Others | Others |
| 3349 | OSBPL5 | RNA | Others | Others | Others |
| 3350 | OSGIN1 | RNA | Others | Others | Others |
| 3351 | OSM | RNA | Others | Others | Others |
| 3352 | OSMR | RNA | Others | Others | Others |
| 3353 | OTC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3354 | OTOA | RNA | Others | Others | Others |
| 3355 | OTUD7B | RNA | Others | Others | Others |
| 3356 | OTULIN | RNA | Others | Others | Others |
| 3357 | OVOL2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3358 | OXER1 | RNA | Others | Others | Others |
| 3359 | OXR1 | RNA | Oxydative Stress | Others | Inflammation |
| 3360 | OXSM | RNA | Others | Others | Others |
| 3361 | P2RX4 | RNA | Others | Others | Others |
| 3362 | P2RX7 | RNA | Others | Vesicle Trafficking | CNS |
| 3363 | P2RY12 | RNA | Others | Others | Others |
| 3364 | P2RY13 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3365 | P3H1 | RNA | Others | Others | Others |
| 3366 | P3H2 | RNA | Cellular Differentiation | Others | Oncology |
| 3367 | P3H3 | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 3368 | P4HA1 | RNA | Others | Others | Others |
| 3369 | P4HA2 | RNA | HIF1 Signaling | Others | Inflammation |
| 3370 | P4HB | RNA | Collagen Biosynthesis & Modification | Others | CNS |
| 3371 | PA2G4 | RNA | Myc | Others | Oncology |
| 3372 | PACSIN1 | RNA | Others | Others | Others |
| 3373 | PADI2 | RNA | Others | Others | Others |
| 3374 | PADI4 | RNA | Others | Others | Others |
| 3375 | PAH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3376 | PAK1 | RNA | Others | Others | Others |
| 3377 | PAK2 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 3378 | PAK3 | RNA | RAS | Others | Oncology |
| 3379 | PAK5 | RNA | Others | Others | Others |
| 3380 | PAK7 | RNA | RAS | Others | Oncology |
| 3381 | PALB2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3382 | PALM | RNA | Others | Others | Others |
| 3383 | PALMD | RNA | Angiogenesis | Others | Cardiovascular |
| 3384 | PANX1 | RNA | Others | Others | Others |
| 3385 | PARD3 | RNA | Hippo Signaling | Others | CNS |
| 3386 | PARK2 | RNA | Others | Others | Others |
| 3387 | PARK7 | RNA | Oxydative Stress | Vesicle Trafficking | Inflammation |
| 3388 | PARK7 | RNA | Oxydative Stress | Vesicle Trafficking | CNS |
| 3389 | PARP1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3390 | PARP12 | RNA | Others | Others | Others |
| 3391 | PARP2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3392 | PARP3 | RNA | Others | Others | Others |
| 3393 | PARP4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3394 | PARP9 | RNA | Others | Others | Others |
| 3395 | PARVA | RNA | Others | Others | Others |
| 3396 | PASD1 | RNA | Others | Others | Others |
| 3397 | PAX3 | RNA | Others | Others | Others |
| 3398 | PAX5 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3399 | PAX8 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3400 | PBK | RNA | Others | Others | Others |
| 3401 | PBRM1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3402 | PBX1 | RNA | Others | Others | Others |
| 3403 | PBX3 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3404 | PC | RNA | Metabolism Stress | Others | Metabolic Diseases |
| 3405 | PCCA | RNA | Others | Others | Others |
| 3406 | PCCB | RNA | Others | Others | Others |
| 3407 | PCGF2 | RNA | Others | Others | Others |
| 3408 | PCK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3409 | PCK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3410 | PCLAF | RNA | Cell Stress | Others | CNS |
| 3411 | PCNA | RNA | Cell Cycle | Others | Oncology |
| 3412 | PCOLCE | RNA | Others | Others | Others |
| 3413 | PCSK2 | RNA | Others | Others | Others |
| 3414 | PCTP | RNA | Others | Others | Others |
| 3415 | PDCD1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3416 | PDCD10 | RNA | Angiogenesis | Others | Cardiovascular |
| 3417 | PDCD1LG2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3418 | PDCD2 | RNA | Others | Others | Others |
| 3419 | PDCL3 | RNA | Angiogenesis | Others | Cardiovascular |
| 3420 | PDE1B | RNA | Transmitter Synthesis | Others | CNS |
| 3421 | PDE2A | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3422 | PDE3B | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3423 | PDE4D | RNA | Others | Others | Others |
| 3424 | PDE9A | RNA | Others | Others | Others |
| 3425 | PDGFA | RNA | Angiogenesis | Others | Cardiovascular |
| 3426 | PDGFB | RNA | Angiogenesis | Others | Cardiovascular |
| 3427 | PDGFC | RNA | Cell Proliferation | Others | CNS |
| 3428 | PDGFD | RNA | RAS | Others | Oncology |
| 3429 | PDGFRA | RNA | MAPK | Others | Cardiovascular |
| 3430 | PDGFRB | RNA | Cell Proliferation | Others | CNS |
| 3431 | PDHA1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3432 | PDHB | RNA | Others | Others | Others |
| 3433 | PDK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3434 | PDK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3435 | PDK3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3436 | PDK4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3437 | PDLIM5 | RNA | Androgen Signaling | Others | Oncology |
| 3438 | PDP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3439 | PDPK1 | RNA | Carbohydrate Metabolism | Others | CNS |
| 3440 | PDPN | RNA | Cell Proliferation | Others | CNS |
| 3441 | PDZK1IP1 | RNA | Others | Others | Others |
| 3442 | PEBP1 | RNA | Cell Stress | Others | CNS |
| 3443 | PEBP4 | RNA | Others | Others | Others |
| 3444 | PECAM1 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 3445 | PELI1 | RNA | Others | Others | Others |
| 3446 | PELI2 | RNA | Others | Others | Others |
| 3447 | PEMT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3448 | PEX14 | RNA | Others | Others | Others |
| 3449 | PF4 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 3450 | PF4V1 | RNA | Others | Others | Others |
| 3451 | PFDN2 | RNA | ER Signaling | Others | Oncology |
| 3452 | PFKFB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3453 | PFKFB3 | RNA | HIF1 Signaling | Others | Inflammation |
| 3454 | PFKFB4 | RNA | Others | Others | Others |
| 3455 | PFKL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3456 | PFKM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3457 | PFKP | RNA | HIF1 Signaling | Others | Inflammation |
| 3458 | PFN1 | RNA | Others | Others | Others |
| 3459 | PGAM1 | RNA | Carbohydrate Metabolism | Others | CNS |
| 3460 | PGAM2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3461 | PGD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3462 | PGF | RNA | RAS | Others | Oncology |
| 3463 | PGK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3464 | PGLYRP2 | RNA | Others | Others | Others |
| 3465 | PGLYRP3 | RNA | Others | Others | Others |
| 3466 | PGM1 | RNA | Others | Others | Others |
| 3467 | PGM2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3468 | PGPEP1 | RNA | Angiogenesis | Others | Cardiovascular |
| 3469 | PGR | RNA | ER Signaling | Others | Oncology |
| 3470 | PHB | RNA | Androgen Signaling | Others | Oncology |
| 3471 | PHC3 | RNA | Others | Others | Others |
| 3472 | PHF19 | RNA | Others | Others | Others |
| 3473 | PHF2 | RNA | Others | Others | Others |
| 3474 | PHF21A | RNA | Others | Others | Others |
| 3475 | PHF6 | RNA | Others | Others | Others |
| 3476 | PHGDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3477 | PHLPP1 | RNA | Others | Others | Others |
| 3478 | PHYKPL | RNA | Others | Others | Others |
| 3479 | PIAS1 | RNA | Others | Others | Others |
| 3480 | PIAS2 | RNA | Others | Others | Others |
| 3481 | PIAS4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3482 | PIDD1 | RNA | Others | Others | Others |
| 3483 | PIGR | RNA | Others | Others | Others |
| 3484 | PIK3AP1 | RNA | Others | Others | Others |
| 3485 | PIK3C2A | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3486 | PIK3C2G | RNA | Others | Others | Others |
| 3487 | PIK3C3 | RNA | Others | Others | Others |
| 3488 | PIK3CA | RNA | Angiogenesis | Others | Cardiovascular |
| 3489 | PIK3CB | RNA | Carbohydrate Metabolism | Others | CNS |
| 3490 | PIK3CD | RNA | Autophagy | Others | Cardiovascular |
| 3491 | PIK3CG | RNA | Angiogenesis | Others | Cardiovascular |
| 3492 | PIK3R1 | RNA | Autophagy | Others | Cardiovascular |
| 3493 | PIK3R2 | RNA | Autophagy | Others | Cardiovascular |
| 3494 | PIK3R3 | RNA | JAK-STAT | Others | CNS |
| 3495 | PIK3R4 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3496 | PIK3R5 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 3497 | PIK3R6 | RNA | Angiogenesis | Others | Cardiovascular |
| 3498 | PILRA | RNA | Others | Others | Others |
| 3499 | PILRB | RNA | Others | Others | Others |
| 3500 | PIM1 | RNA | JAK-STAT | Others | CNS |
| 3501 | PIN1 | RNA | Others | Others | Others |
| 3502 | PINK1 | RNA | Oxydative Stress | Others | Inflammation |
| 3503 | PIP | RNA | Others | Others | Others |
| 3504 | PITX2 | RNA | Others | Others | Others |
| 3505 | PKHD1 | RNA | Others | Others | Others |
| 3506 | PKLR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3507 | PKM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3508 | PKMYT1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3509 | PKN1 | RNA | Cellular Differentiation | Others | Oncology |
| 3510 | PKN2 | RNA | Others | Others | Others |
| 3511 | PKNOX1 | RNA | Angiogenesis | Others | Cardiovascular |
| 3512 | PKP3 | RNA | Others | Others | Others |
| 3513 | PLA1A | RNA | MAPK | Others | Cardiovascular |
| 3514 | PLA2G10 | RNA | RAS | Others | Oncology |
| 3515 | PLA2G15 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3516 | PLA2G16 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3517 | PLA2G1B | RNA | Others | Others | Others |
| 3518 | PLA2G2A | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3519 | PLA2G2D | RNA | Others | Others | Others |
| 3520 | PLA2G2E | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3521 | PLA2G2F | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3522 | PLA2G3 | RNA | MAPK | Others | Cardiovascular |
| 3523 | PLA2G4A | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3524 | PLA2G4B | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3525 | PLA2G4C | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3526 | PLA2G4D | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3527 | PLA2G4E | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3528 | PLA2G4F | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3529 | PLA2G5 | RNA | RAS | Others | Oncology |
| 3530 | PLA2G6 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3531 | PLAT | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3532 | PLAU | RNA | Cell Proliferation | Others | CNS |
| 3533 | PLAUR | RNA | Cell Proliferation | Others | CNS |
| 3534 | PLCB1 | RNA | Wnt Signaling | Others | CNS |
| 3535 | PLCB2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3536 | PLCB3 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3537 | PLCB4 | RNA | Wnt Signaling | Others | CNS |
| 3538 | PLCE1 | RNA | MAPK | Others | Cardiovascular |
| 3539 | PLCG1 | RNA | PI3K-AKT | Others | Oncology |
| 3540 | PLCG2 | RNA | RAS | Others | Oncology |
| 3541 | PLCL2 | RNA | Others | Others | Others |
| 3542 | PLD1 | RNA | MAPK | Others | Cardiovascular |
| 3543 | PLD2 | RNA | Others | Others | Others |
| 3544 | PLD3 | RNA | Others | Others | Others |
| 3545 | PLEK | RNA | Others | Others | Others |
| 3546 | PLEK2 | RNA | Others | Others | Others |
| 3547 | PLEKHA1 | RNA | Others | Others | Others |
| 3548 | PLEKHB1 | RNA | Others | Others | Others |
| 3549 | PLEKHB2 | RNA | Others | Others | Others |
| 3550 | PLEKHM1 | RNA | Others | Others | Others |
| 3551 | PLEKHO1 | RNA | Others | Others | Others |
| 3552 | PLEKHO2 | RNA | Others | Others | Others |
| 3553 | PLG | RNA | Others | Others | Others |
| 3554 | PLIN4 | RNA | Others | Others | Others |
| 3555 | PLK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3556 | PLLP | RNA | Myelination | Others | CNS |
| 3557 | PLOD2 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 3558 | PLP1 | RNA | Others | Others | Others |
| 3559 | PLPP4 | RNA | Others | Others | Others |
| 3560 | PLS1 | RNA | Others | Others | Others |
| 3561 | PLSCR1 | RNA | Others | Others | Others |
| 3562 | PLTP | RNA | Others | Others | Others |
| 3563 | PLXDC1 | RNA | Angiogenesis | Others | Cardiovascular |
| 3564 | PLXDC2 | RNA | Others | Others | Others |
| 3565 | PLXNB3 | RNA | Others | Others | Others |
| 3566 | PLXNC1 | RNA | Others | Others | Others |
| 3567 | PLXND1 | RNA | Angiogenesis | Others | Cardiovascular |
| 3568 | PMAIP1 | RNA | p53 Signaling | Others | Oncology |
| 3569 | PMCH | RNA | Others | Others | Others |
| 3570 | PMEL | RNA | Others | Others | Others |
| 3571 | PML | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3572 | PMP22 | RNA | Cell Proliferation | Others | CNS |
| 3573 | PMS2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3574 | PNKD | RNA | Transmitter Synthesis | Others | CNS |
| 3575 | PNMA1 | RNA | Others | Others | Others |
| 3576 | PNOC | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3577 | PNP | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3578 | PNPLA3 | RNA | Others | Others | Others |
| 3579 | PNPLA6 | RNA | Angiogenesis | Others | Cardiovascular |
| 3580 | POLB | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3581 | POLD1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3582 | POLD4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3583 | POLE | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3584 | POLE2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3585 | POLQ | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3586 | POLR1C | RNA | Others | Others | Others |
| 3587 | POLR1D | RNA | Others | Others | Others |
| 3588 | POLR2A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3589 | POLR2B | RNA | Others | Others | Others |
| 3590 | POLR2D | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3591 | POLR2H | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3592 | POLR2J | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3593 | POLR2K | RNA | Others | Others | Others |
| 3594 | POLR2L | RNA | Others | Others | Others |
| 3595 | POLR3D | RNA | Others | Others | Others |
| 3596 | POLR3H | RNA | Others | Others | Others |
| 3597 | POMC | RNA | Others | Others | Others |
| 3598 | POPDC3 | RNA | EMT | Others | Oncology |
| 3599 | POSTN | RNA | Others | Others | Others |
| 3600 | POU2AF1 | RNA | Others | Others | Others |
| 3601 | POU2F2 | RNA | Others | Others | Others |
| 3602 | POU5F1 | RNA | Others | Others | Others |
| 3603 | PPAN | RNA | Myc | Others | Oncology |
| 3604 | PPARA | RNA | Others | Others | Others |
| 3605 | PPARD | RNA | Others | Others | Others |
| 3606 | PPARG | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3607 | PPARGC1A | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3608 | PPARGC1B | RNA | Others | Others | Others |
| 3609 | PPAT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3610 | PPBP | RNA | Others | Others | Others |
| 3611 | PPFIA4 | RNA | Others | Others | Others |
| 3612 | PPFIBP2 | RNA | Others | Others | Others |
| 3613 | PPIA | RNA | Others | Others | Others |
| 3614 | PPL | RNA | Others | Others | Others |
| 3615 | PPM1A | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3616 | PPM1F | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3617 | PPM1L | RNA | Others | Others | Others |
| 3618 | PPP1CB | RNA | Others | Others | Others |
| 3619 | PPP1R12B | RNA | Others | Others | Others |
| 3620 | PPP1R16B | RNA | Others | Others | Others |
| 3621 | PPP2CA | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3622 | PPP2CB | RNA | PI3K-AKT | Others | Oncology |
| 3623 | PPP2R1A | RNA | PI3K-AKT | Others | Oncology |
| 3624 | PPP2R1B | RNA | Others | Others | Others |
| 3625 | PPP2R2B | RNA | Others | Others | Others |
| 3626 | PPP2R2C | RNA | PI3K-AKT | Others | Oncology |
| 3627 | PPP2R3A | RNA | Others | Others | Others |
| 3628 | PPP2R5A | RNA | Others | Others | Others |
| 3629 | PPP2R5B | RNA | Others | Others | Others |
| 3630 | PPP2R5C | RNA | Carbohydrate Metabolism | Others | CNS |
| 3631 | PPP2R5D | RNA | Others | Others | Others |
| 3632 | PPP2R5E | RNA | Carbohydrate Metabolism | Others | CNS |
| 3633 | PPP3CA | RNA | Others | Others | Others |
| 3634 | PPP3CB | RNA | Others | Others | Others |
| 3635 | PPP3CC | RNA | Others | Others | Others |
| 3636 | PPP3R1 | RNA | Others | Others | Others |
| 3637 | PPP3R2 | RNA | Others | Others | Others |
| 3638 | PPT1 | RNA | Others | Others | Others |
| 3639 | PPT2 | RNA | Others | Others | Others |
| 3640 | PQBP1 | RNA | Others | Others | Others |
| 3641 | PRAME | RNA | Others | Others | Others |
| 3642 | PRAP1 | RNA | Others | Others | Others |
| 3643 | PRC1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3644 | PRCP | RNA | Others | Others | Others |
| 3645 | PRDM1 | RNA | Others | Others | Others |
| 3646 | PRDM16 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3647 | PRDX1 | RNA | Cell Stress | Others | CNS |
| 3648 | PRDX2 | RNA | Others | Others | Others |
| 3649 | PRDX5 | RNA | Cell Stress | Others | CNS |
| 3650 | PRDX6 | RNA | Others | Others | Others |
| 3651 | PRELP | RNA | Cellular Differentiation | Others | Oncology |
| 3652 | PREP | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3653 | PREX1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3654 | PRF1 | RNA | Cytotoxicity | Others | Oncology |
| 3655 | PRG2 | RNA | Others | Others | Others |
| 3656 | PRICKLE3 | RNA | Others | Others | Others |
| 3657 | PRIM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3658 | PRIM2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3659 | PRKAA1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3660 | PRKAA2 | RNA | Autophagy | Others | Cardiovascular |
| 3661 | PRKAB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3662 | PRKAB2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3663 | PRKACA | RNA | Hedgehog | Others | CNS |
| 3664 | PRKACB | RNA | Autophagy | Others | Cardiovascular |
| 3665 | PRKACG | RNA | RAS | Others | Oncology |
| 3666 | PRKAG1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3667 | PRKAG2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3668 | PRKAG3 | RNA | Others | Others | Others |
| 3669 | PRKAR1A | RNA | Others | Others | Others |
| 3670 | PRKAR1B | RNA | Others | Others | Others |
| 3671 | PRKAR2A | RNA | Others | Others | Others |
| 3672 | PRKAR2B | RNA | Others | Others | Others |
| 3673 | PRKCA | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3674 | PRKCB | RNA | Cellular Differentiation | Others | Oncology |
| 3675 | PRKCD | RNA | Others | Others | Others |
| 3676 | PRKCE | RNA | Others | Others | Others |
| 3677 | PRKCG | RNA | Cellular Differentiation | Others | Oncology |
| 3678 | PRKCQ | RNA | Others | Others | Others |
| 3679 | PRKCSH | RNA | Others | Others | Others |
| 3680 | PRKCZ | RNA | Others | Others | Others |
| 3681 | PRKDC | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3682 | PRKN | RNA | Cell Stress | Others | CNS |
| 3683 | PRKX | RNA | Hedgehog | Others | CNS |
| 3684 | PRL | RNA | Others | Others | Others |
| 3685 | PRLR | RNA | Cytotoxicity | Others | Oncology |
| 3686 | PRM1 | RNA | Others | Others | Others |
| 3687 | PRMT5 | RNA | Others | Others | Others |
| 3688 | PRMT8 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 3689 | PRNP | RNA | Oxydative Stress | Others | Inflammation |
| 3690 | PROCR | RNA | Others | Others | Others |
| 3691 | PRODH2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3692 | PROK2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3693 | PROM1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3694 | PROS1 | RNA | Others | Others | Others |
| 3695 | PRPF3 | RNA | Others | Others | Others |
| 3696 | PRPF31 | RNA | Others | Others | Others |
| 3697 | PRPF38A | RNA | Others | Others | Others |
| 3698 | PRPS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3699 | PRR15L | RNA | Others | Others | Others |
| 3700 | PRR5 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3701 | PRSS22 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 3702 | PRSS8 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 3703 | PRUNE1 | RNA | Others | Others | Others |
| 3704 | PSAP | RNA | Others | Others | Others |
| 3705 | PSAT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3706 | PSEN1 | RNA | Amyloid Processing | Others | CNS |
| 3707 | PSEN2 | RNA | Others | Others | Others |
| 3708 | PSENEN | RNA | Others | Others | Others |
| 3709 | PSIP1 | RNA | Others | Others | Others |
| 3710 | PSMA1 | RNA | Others | Others | Others |
| 3711 | PSMA2 | RNA | Others | Others | Others |
| 3712 | PSMA3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3713 | PSMA6 | RNA | Others | Others | Others |
| 3714 | PSMA7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3715 | PSMB1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3716 | PSMB10 | RNA | Apoptosis | Others | Oncology |
| 3717 | PSMB3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3718 | PSMB5 | RNA | Apoptosis | Others | Oncology |
| 3719 | PSMB7 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 3720 | PSMB8 | RNA | Apoptosis | Others | Oncology |
| 3721 | PSMB9 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 3722 | PSMC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3723 | PSMC2 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 3724 | PSMC3 | RNA | Others | Others | Others |
| 3725 | PSMC4 | RNA | Apoptosis | Others | Oncology |
| 3726 | PSMC6 | RNA | Others | Others | Others |
| 3727 | PSMD13 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3728 | PSMD6 | RNA | Others | Others | Others |
| 3729 | PSMD7 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 3730 | PSME2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3731 | PSPH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3732 | PSTPIP1 | RNA | Others | Others | Others |
| 3733 | PTAFR | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3734 | PTCD1 | RNA | Others | Others | Others |
| 3735 | PTCD2 | RNA | Others | Others | Others |
| 3736 | PTCH1 | RNA | Hedgehog | Others | CNS |
| 3737 | PTCH2 | RNA | Others | Others | Others |
| 3738 | PTCRA | RNA | Others | Others | Others |
| 3739 | PTDSS1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3740 | PTDSS2 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 3741 | PTEN | RNA | Angiogenesis | Others | Cardiovascular |
| 3742 | PTGDR2 | RNA | Others | Others | Others |
| 3743 | PTGDS | RNA | EMT | Others | Oncology |
| 3744 | PTGER1 | RNA | Others | Others | Others |
| 3745 | PTGER2 | RNA | Others | Others | Others |
| 3746 | PTGER3 | RNA | ER Signaling | Others | Oncology |
| 3747 | PTGER4 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3748 | PTGES | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3749 | PTGFR | RNA | Others | Others | Others |
| 3750 | PTGIR | RNA | Others | Others | Others |
| 3751 | PTGIS | RNA | Others | Others | Others |
| 3752 | PTGR1 | RNA | Others | Others | Others |
| 3753 | PTGS1 | RNA | Cell Stress | Others | CNS |
| 3754 | PTGS2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3755 | PTK2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3756 | PTK2B | RNA | Angiogenesis | Others | Cardiovascular |
| 3757 | PTK6 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3758 | PTMS | RNA | Others | Others | Others |
| 3759 | PTPA | RNA | Others | Others | Others |
| 3760 | PTPN1 | RNA | Others | Others | Others |
| 3761 | PTPN11 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3762 | PTPN12 | RNA | Others | Others | Others |
| 3763 | PTPN18 | RNA | Others | Others | Others |
| 3764 | PTPN2 | RNA | Others | Others | Others |
| 3765 | PTPN22 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 3766 | PTPN4 | RNA | Others | Others | Others |
| 3767 | PTPN5 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3768 | PTPN6 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 3769 | PTPN7 | RNA | Others | Others | Others |
| 3770 | PTPRB | RNA | Angiogenesis | Others | Cardiovascular |
| 3771 | PTPRC | RNA | Cell Proliferation | Others | CNS |
| 3772 | PTPRC_all (common probe) | RNA | TCR Signaling | Others | Immuno-Oncology |
| 3773 | PTPRJ | RNA | Others | Others | Others |
| 3774 | PTPRK | RNA | Others | Others | Others |
| 3775 | PTPRM | RNA | Cell Proliferation | Others | CNS |
| 3776 | PTPRN2 | RNA | Others | Others | Others |
| 3777 | PTPRR | RNA | Others | Others | Others |
| 3778 | PTPRS | RNA | Others | Others | Others |
| 3779 | PTRF | RNA | Others | Others | Others |
| 3780 | PTTG1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3781 | PTTG2 | RNA | Others | Others | Others |
| 3782 | PTX3 | RNA | Others | Others | Others |
| 3783 | PUDP | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3784 | PUM1 | RNA | Others | Others | Others |
| 3785 | PURA | RNA | Others | Others | Others |
| 3786 | PVALB | RNA | Others | Others | Others |
| 3787 | PVR | RNA | Others | Others | Others |
| 3788 | PVRIG | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3789 | PXDN | RNA | Others | Others | Others |
| 3790 | PXN | RNA | Others | Others | Others |
| 3791 | PYCARD | RNA | EMT | Others | Oncology |
| 3792 | PYCR1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3793 | PYCR2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3794 | PYCR3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3795 | PYGM | RNA | Others | Others | Others |
| 3796 | QKI | RNA | Vasculogenesis | Others | Cardiovascular |
| 3797 | RAB25 | RNA | Cell Proliferation | Others | CNS |
| 3798 | RAB2A | RNA | Carbohydrate Metabolism | Others | CNS |
| 3799 | RAB31 | RNA | Others | Others | Others |
| 3800 | RAB3A | RNA | Transmitter Synthesis | Others | CNS |
| 3801 | RAB3C | RNA | Others | Others | Others |
| 3802 | RAB5C | RNA | Others | Others | Others |
| 3803 | RAB6B | RNA | Others | Others | Others |
| 3804 | RAB7A | RNA | Others | Others | Others |
| 3805 | RAB7B | RNA | Others | Others | Others |
| 3806 | RAC1 | RNA | Cellular Differentiation | Others | Oncology |
| 3807 | RAC2 | RNA | Cell Proliferation | Others | CNS |
| 3808 | RAC3 | RNA | MAPK | Others | Cardiovascular |
| 3809 | RACK1 | RNA | Others | Others | Others |
| 3810 | RAD1 | RNA | Others | Others | Others |
| 3811 | RAD17 | RNA | Others | Others | Others |
| 3812 | RAD21 | RNA | Others | Others | Others |
| 3813 | RAD23B | RNA | Others | Others | Others |
| 3814 | RAD50 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3815 | RAD51 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3816 | RAD51AP1 | RNA | Cell Stress | Others | CNS |
| 3817 | RAD51B | RNA | Others | Others | Others |
| 3818 | RAD51C | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3819 | RAD52 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3820 | RAD54B | RNA | Others | Others | Others |
| 3821 | RAD54L | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3822 | RAD9A | RNA | Others | Others | Others |
| 3823 | RAE1 | RNA | Others | Others | Others |
| 3824 | RAF1 | RNA | Cell Proliferation | Others | CNS |
| 3825 | RAG1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3826 | RAG2 | RNA | Others | Others | Others |
| 3827 | RAI1 | RNA | Others | Others | Others |
| 3828 | RALA | RNA | Others | Others | Others |
| 3829 | RALB | RNA | Others | Others | Others |
| 3830 | RAMP1 | RNA | Angiogenesis | Others | Cardiovascular |
| 3831 | RAMP2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3832 | RAN | RNA | Others | Others | Others |
| 3833 | RANBP2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3834 | RAP1A | RNA | Others | Others | Others |
| 3835 | RAP1B | RNA | Others | Others | Others |
| 3836 | RAPGEF1 | RNA | Others | Others | Others |
| 3837 | RAPGEF2 | RNA | Others | Others | Others |
| 3838 | RAPGEF3 | RNA | Others | Others | Others |
| 3839 | RARA | RNA | Others | Others | Others |
| 3840 | RARB | RNA | Others | Others | Others |
| 3841 | RARG | RNA | Others | Others | Others |
| 3842 | RARRES3 | RNA | Others | Others | Others |
| 3843 | RASA1 | RNA | PDGF Signaling | Others | Oncology |
| 3844 | RASA4 | RNA | RAS | Others | Oncology |
| 3845 | RASAL1 | RNA | MAPK | Others | Cardiovascular |
| 3846 | RASGRF1 | RNA | MAPK | Others | Cardiovascular |
| 3847 | RASGRF2 | RNA | MAPK | Others | Cardiovascular |
| 3848 | RASGRP1 | RNA | MAPK | Others | Cardiovascular |
| 3849 | RASGRP2 | RNA | RAS | Others | Oncology |
| 3850 | RASGRP3 | RNA | Others | Others | Others |
| 3851 | RASGRP4 | RNA | Others | Others | Others |
| 3852 | RASSF5 | RNA | Others | Others | Others |
| 3853 | RB1 | RNA | Androgen Signaling | Others | Oncology |
| 3854 | RB1CC1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3855 | RBBP5 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3856 | RBCK1 | RNA | Others | Others | Others |
| 3857 | RBFOX3 | RNA | Others | Others | Others |
| 3858 | RBKS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3859 | RBL1 | RNA | Cell Cycle | Others | Oncology |
| 3860 | RBL2 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 3861 | RBM45 | RNA | Others | Others | Others |
| 3862 | RBM47 | RNA | Others | Others | Others |
| 3863 | RBP4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3864 | RBPJ | RNA | Angiogenesis | Others | Cardiovascular |
| 3865 | RBX1 | RNA | Cell Cycle | Others | Oncology |
| 3866 | RDH10 | RNA | Others | Others | Others |
| 3867 | RDH14 | RNA | Others | Others | Others |
| 3868 | RDH5 | RNA | Others | Others | Others |
| 3869 | RDX | RNA | Others | Others | Others |
| 3870 | REL | RNA | Others | Others | Others |
| 3871 | RELA | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3872 | RELB | RNA | MAPK | Others | Cardiovascular |
| 3873 | RELN | RNA | Cellular Differentiation | Others | Oncology |
| 3874 | REN | RNA | Others | Others | Others |
| 3875 | REPS1 | RNA | Others | Others | Others |
| 3876 | REST | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3877 | RET | RNA | Others | Others | Others |
| 3878 | RETN | RNA | Others | Others | Others |
| 3879 | RFC2 | RNA | Cell Cycle | Others | Oncology |
| 3880 | RFC3 | RNA | Cell Cycle | Others | Oncology |
| 3881 | RFC4 | RNA | Cell Cycle | Others | Oncology |
| 3882 | RGCC | RNA | Others | Others | Others |
| 3883 | RGL1 | RNA | Others | Others | Others |
| 3884 | RGMA | RNA | Others | Others | Others |
| 3885 | RGMB | RNA | Others | Others | Others |
| 3886 | RGN | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3887 | RGS16 | RNA | Others | Others | Others |
| 3888 | RGS2 | RNA | Others | Others | Others |
| 3889 | RGS7 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3890 | RHEB | RNA | Others | Others | Others |
| 3891 | RHO | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3892 | RHOA | RNA | Cellular Differentiation | Others | Oncology |
| 3893 | RHOB | RNA | Others | Others | Others |
| 3894 | RHOG | RNA | Others | Others | Others |
| 3895 | RICTOR | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3896 | RIMKLA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3897 | RIMKLB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3898 | RIMS1 | RNA | Transmitter Synthesis | Others | CNS |
| 3899 | RIN1 | RNA | RAS | Others | Oncology |
| 3900 | RING1 | RNA | Others | Others | Others |
| 3901 | RIPK1 | RNA | Apoptosis | Others | Oncology |
| 3902 | RIPK2 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 3903 | RIPK3 | RNA | Apoptosis | Others | Oncology |
| 3904 | RIT2 | RNA | Others | Others | Others |
| 3905 | RNA | RNA | Others | Others | Others |
| 3906 | RNASE2 | RNA | Angiogenesis | Others | Cardiovascular |
| 3907 | RNASEH2A | RNA | Others | Others | Others |
| 3908 | RNASEL | RNA | Others | Others | Others |
| 3909 | RNF103 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 3910 | RNF111 | RNA | Others | Others | Others |
| 3911 | RNF114 | RNA | Others | Others | Others |
| 3912 | RNF126 | RNA | Others | Others | Others |
| 3913 | RNF135 | RNA | Others | Others | Others |
| 3914 | RNF152 | RNA | Others | Others | Others |
| 3915 | RNF31 | RNA | Others | Others | Others |
| 3916 | RNF43 | RNA | Others | Others | Others |
| 3917 | RNF8 | RNA | Others | Others | Others |
| 3918 | RNH1 | RNA | Others | Others | Others |
| 3919 | RNLS | RNA | Others | Others | Others |
| 3920 | ROBO4 | RNA | Angiogenesis | Others | Cardiovascular |
| 3921 | ROCK1 | RNA | Apoptosis | Others | Oncology |
| 3922 | ROCK2 | RNA | TGF Beta Signaling | Others | Oncology |
| 3923 | ROPN1 | RNA | Others | Others | Others |
| 3924 | ROR2 | RNA | Others | Others | Others |
| 3925 | RORA | RNA | Angiogenesis | Others | Cardiovascular |
| 3926 | RORB | RNA | Cell Proliferation | Others | CNS |
| 3927 | RORC | RNA | Others | Others | Others |
| 3928 | RORg | RNA | Others | Others | Others |
| 3929 | RORgt | RNA | Others | Others | Others |
| 3930 | RPA1 | RNA | Others | Others | Others |
| 3931 | RPA3 | RNA | Cell Cycle | Others | Oncology |
| 3932 | RPIA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3933 | RPL23 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3934 | RPL28 | RNA | Others | Others | Others |
| 3935 | RPL29 | RNA | Others | Others | Others |
| 3936 | RPL3 | RNA | Others | Others | Others |
| 3937 | RPL36AL | RNA | Others | Others | Others |
| 3938 | RPL4 | RNA | Others | Others | Others |
| 3939 | RPL7A | RNA | Angiogenesis | Others | Cardiovascular |
| 3940 | RPL9 | RNA | Others | Others | Others |
| 3941 | RPLP0 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3942 | RPS10 | RNA | Others | Others | Others |
| 3943 | RPS2 | RNA | Others | Others | Others |
| 3944 | RPS21 | RNA | Others | Others | Others |
| 3945 | RPS27A | RNA | Cellular Differentiation | Others | Oncology |
| 3946 | RPS3 | RNA | Others | Others | Others |
| 3947 | RPS6 | RNA | Others | Others | Others |
| 3948 | RPS6KA1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3949 | RPS6KA2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3950 | RPS6KA3 | RNA | Others | Others | Others |
| 3951 | RPS6KA5 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 3952 | RPS6KA6 | RNA | Others | Others | Others |
| 3953 | RPS6KB1 | RNA | Autophagy | Others | Cardiovascular |
| 3954 | RPS6KB2 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 3955 | RPS9 | RNA | Others | Others | Others |
| 3956 | RPTOR | RNA | Autophagy | Others | Cardiovascular |
| 3957 | RRAD | RNA | Others | Others | Others |
| 3958 | RRAGC | RNA | mTOR Signaling | Others | Oncology |
| 3959 | RRAS | RNA | Others | Others | Others |
| 3960 | RRAS2 | RNA | RAS | Others | Oncology |
| 3961 | RRM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3962 | RRM2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 3963 | RSAD2 | RNA | Others | Others | Others |
| 3964 | RTN4 | RNA | Angiogenesis | Others | Cardiovascular |
| 3965 | RTN4RL1 | RNA | Others | Others | Others |
| 3966 | RUNX1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3967 | RUNX1T1 | RNA | Others | Others | Others |
| 3968 | RUNX2 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3969 | RUNX3 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 3970 | RUVBL1 | RNA | Cell Cycle | Others | Oncology |
| 3971 | RXRG | RNA | Others | Others | Others |
| 3972 | RYBP | RNA | Others | Others | Others |
| 3973 | RYR1 | RNA | Others | Others | Others |
| 3974 | RYR2 | RNA | Others | Others | Others |
| 3975 | RYR3 | RNA | Others | Others | Others |
| 3976 | S100A1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3977 | S100A10 | RNA | Others | Others | Others |
| 3978 | S100A12 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 3979 | S100A14 | RNA | EMT | Others | Oncology |
| 3980 | S100A4 | RNA | Others | Others | Others |
| 3981 | S100A7 | RNA | Angiogenesis | Others | Cardiovascular |
| 3982 | S100A8 | RNA | Others | Others | Others |
| 3983 | S100A9 | RNA | Others | Others | Others |
| 3984 | S100B | RNA | Others | Others | Others |
| 3985 | S1PR1 | RNA | Angiogenesis | Others | Cardiovascular |
| 3986 | S1PR3 | RNA | Others | Others | Others |
| 3987 | S1PR4 | RNA | Others | Others | Others |
| 3988 | S1PR5 | RNA | Others | Others | Others |
| 3989 | SAA1 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 3990 | SACS | RNA | Others | Others | Others |
| 3991 | SALL1 | RNA | Others | Others | Others |
| 3992 | SAMD9 | RNA | Others | Others | Others |
| 3993 | SAMHD1 | RNA | Others | Others | Others |
| 3994 | SAMSN1 | RNA | Others | Others | Others |
| 3995 | SAP130 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 3996 | SAR1B | RNA | Others | Others | Others |
| 3997 | SART1 | RNA | Others | Others | Others |
| 3998 | SAV1 | RNA | Hippo Signaling | Others | CNS |
| 3999 | SBNO2 | RNA | Others | Others | Others |
| 4000 | SCAMP2 | RNA | Others | Others | Others |
| 4001 | SCARA5 | RNA | Others | Others | Others |
| 4002 | SCARB2 | RNA | Others | Others | Others |
| 4003 | SCD | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4004 | SCG2 | RNA | Angiogenesis | Others | Cardiovascular |
| 4005 | SCIN | RNA | Others | Others | Others |
| 4006 | SCN1A | RNA | Others | Others | Others |
| 4007 | SCN2A | RNA | Myelination | Others | CNS |
| 4008 | SCNN1A | RNA | Others | Others | Others |
| 4009 | SCP2 | RNA | Others | Others | Others |
| 4010 | sCTLA4 (soluble form) | RNA | TCR Signaling | Others | Immuno-Oncology |
| 4011 | SCUBE2 | RNA | ER Signaling | Others | Oncology |
| 4012 | SDC1 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 4013 | SDC3 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 4014 | SDC4 | RNA | Others | Others | Others |
| 4015 | SDHA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4016 | SDHB | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4017 | SDHC | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4018 | SDS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4019 | SDSL | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4020 | SEC13 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4021 | SEC22B | RNA | Others | Others | Others |
| 4022 | SEC23A | RNA | Others | Others | Others |
| 4023 | SEC24C | RNA | Others | Others | Others |
| 4024 | SEC61B | RNA | Others | Others | Others |
| 4025 | SEH1L | RNA | Others | Others | Others |
| 4026 | SEL1L | RNA | Others | Others | Others |
| 4027 | SELE | RNA | Others | Others | Others |
| 4028 | SELENBP1 | RNA | Others | Others | Others |
| 4029 | SELENOK | RNA | Cell Stress | Others | CNS |
| 4030 | SELENOS | RNA | Others | Others | Others |
| 4031 | SELL | RNA | Others | Others | Others |
| 4032 | SELP | RNA | Others | Others | Others |
| 4033 | SELPLG | RNA | Others | Others | Others |
| 4034 | SEM1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4035 | SEMA3E | RNA | Others | Others | Others |
| 4036 | SEMA4D | RNA | Others | Others | Others |
| 4037 | SEMG1 | RNA | Others | Others | Others |
| 4038 | SERBP1 | RNA | ER Signaling | Others | Oncology |
| 4039 | SERINC1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4040 | SERINC2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4041 | SERINC3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4042 | SERINC4 | RNA | Others | Others | Others |
| 4043 | SERINC5 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4044 | SERPINA1 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 4045 | SERPINA3 | RNA | Others | Others | Others |
| 4046 | SERPINB2 | RNA | Others | Others | Others |
| 4047 | SERPINB5 | RNA | Angiogenesis | Others | Cardiovascular |
| 4048 | SERPINB6 | RNA | Others | Others | Others |
| 4049 | SERPINB9 | RNA | Others | Others | Others |
| 4050 | SERPINE1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4051 | SERPINF1 | RNA | Cell Proliferation | Others | CNS |
| 4052 | SERPINF2 | RNA | Others | Others | Others |
| 4053 | SERPING1 | RNA | Others | Others | Others |
| 4054 | SERPINH1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4055 | SESN1 | RNA | Others | Others | Others |
| 4056 | SESN2 | RNA | Others | Others | Others |
| 4057 | SESN3 | RNA | Others | Others | Others |
| 4058 | SET | RNA | Cell Proliferation | Others | CNS |
| 4059 | SETBP1 | RNA | Others | Others | Others |
| 4060 | SETD1A | RNA | Others | Others | Others |
| 4061 | SETD1B | RNA | Others | Others | Others |
| 4062 | SETD2 | RNA | Angiogenesis | Others | Cardiovascular |
| 4063 | SETD7 | RNA | Others | Others | Others |
| 4064 | SETDB1 | RNA | Others | Others | Others |
| 4065 | SF3A1 | RNA | Others | Others | Others |
| 4066 | SF3A2 | RNA | Others | Others | Others |
| 4067 | SF3A3 | RNA | Others | Others | Others |
| 4068 | SF3B1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4069 | SF3B2 | RNA | Others | Others | Others |
| 4070 | SF3B4 | RNA | Others | Others | Others |
| 4071 | SFN | RNA | Cell Cycle | Others | Oncology |
| 4072 | SFRP1 | RNA | Cell Proliferation | Others | CNS |
| 4073 | SFRP2 | RNA | Cell Proliferation | Others | CNS |
| 4074 | SFRP4 | RNA | Wnt Signaling | Others | CNS |
| 4075 | SFTPA1 | RNA | Others | Others | Others |
| 4076 | SFTPD | RNA | Others | Others | Others |
| 4077 | SFXN1 | RNA | Others | Others | Others |
| 4078 | SGK1 | RNA | Metabolism Stress | Others | Metabolic Diseases |
| 4079 | SGK2 | RNA | Others | Others | Others |
| 4080 | SGK3 | RNA | Others | Others | Others |
| 4081 | SGO2 | RNA | Others | Others | Others |
| 4082 | SGPL1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 4083 | SH2B2 | RNA | Others | Others | Others |
| 4084 | SH2B3 | RNA | Others | Others | Others |
| 4085 | SH2D1A | RNA | Others | Others | Others |
| 4086 | SH2D1B | RNA | Others | Others | Others |
| 4087 | SH2D3A | RNA | Others | Others | Others |
| 4088 | SH3BP2 | RNA | Others | Others | Others |
| 4089 | SH3PXD2A | RNA | Others | Others | Others |
| 4090 | SH3TC2 | RNA | Myelination | Others | CNS |
| 4091 | SH3YL1 | RNA | Others | Others | Others |
| 4092 | SHANK2 | RNA | Others | Others | Others |
| 4093 | SHANK3 | RNA | Others | Others | Others |
| 4094 | SHB | RNA | Angiogenesis | Others | Cardiovascular |
| 4095 | SHC1 | RNA | RAS | Others | Oncology |
| 4096 | SHC2 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 4097 | SHC3 | RNA | RAS | Others | Oncology |
| 4098 | SHC4 | RNA | MAPK | Others | Cardiovascular |
| 4099 | SHE | RNA | Angiogenesis | Others | Cardiovascular |
| 4100 | SHH | RNA | Others | Others | Others |
| 4101 | SHMT1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4102 | SHMT2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4103 | SIDT1 | RNA | Others | Others | Others |
| 4104 | SIGIRR | RNA | Others | Others | Others |
| 4105 | SIGLEC1 | RNA | Others | Others | Others |
| 4106 | SIGLEC5 | RNA | Others | Others | Others |
| 4107 | SIGLEC6 | RNA | Others | Others | Others |
| 4108 | SIGLEC8 | RNA | Others | Others | Others |
| 4109 | SIGLEC9 | RNA | Others | Others | Others |
| 4110 | SIK1 | RNA | Others | Others | Others |
| 4111 | SIL1 | RNA | Others | Others | Others |
| 4112 | SIN3A | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4113 | SIPA1 | RNA | Others | Others | Others |
| 4114 | SIRPA | RNA | Cytotoxicity | Others | Oncology |
| 4115 | SIRPB2 | RNA | Others | Others | Others |
| 4116 | SIRT1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4117 | SIRT2 | RNA | Myelination | Others | CNS |
| 4118 | SIRT4 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 4119 | SIRT7 | RNA | Others | Others | Others |
| 4120 | SIX1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 4121 | SKA1 | RNA | Cell Cycle | Others | Oncology |
| 4122 | SKA3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4123 | SKI | RNA | Others | Others | Others |
| 4124 | SKIL | RNA | Others | Others | Others |
| 4125 | SKP1 | RNA | Proliferation | Others | Oncology |
| 4126 | SKP2 | RNA | Cell Cycle | Others | Oncology |
| 4127 | SLA | RNA | Others | Others | Others |
| 4128 | SLAMF1 | RNA | Others | Others | Others |
| 4129 | SLAMF6 | RNA | Others | Others | Others |
| 4130 | SLAMF7 | RNA | Others | Others | Others |
| 4131 | SLAMF8 | RNA | Others | Others | Others |
| 4132 | SLAMF9 | RNA | Others | Others | Others |
| 4133 | SLC10A6 | RNA | Others | Others | Others |
| 4134 | SLC11A1 | RNA | Others | Others | Others |
| 4135 | SLC12A5 | RNA | Others | Others | Others |
| 4136 | SLC12A6 | RNA | Angiogenesis | Others | Cardiovascular |
| 4137 | SLC16A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4138 | SLC16A11 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4139 | SLC16A13 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4140 | SLC16A2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4141 | SLC16A3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4142 | SLC16A6 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4143 | SLC16A7 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4144 | SLC16A8 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4145 | SLC17A6 | RNA | Transmitter Synthesis | Others | CNS |
| 4146 | SLC17A7 | RNA | Others | Others | Others |
| 4147 | SLC18A2 | RNA | Transmitter Synthesis | Others | CNS |
| 4148 | SLC18A3 | RNA | Transmitter Synthesis | Others | CNS |
| 4149 | SLC1A1 | RNA | Carbohydrate Metabolism | Others | CNS |
| 4150 | SLC1A2 | RNA | Carbohydrate Metabolism | Others | CNS |
| 4151 | SLC1A3 | RNA | Others | Others | Others |
| 4152 | SLC1A5 | RNA | Metabolism Stress | Others | Metabolic Diseases |
| 4153 | SLC25A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4154 | SLC25A10 | RNA | Others | Others | Others |
| 4155 | SLC25A13 | RNA | Others | Others | Others |
| 4156 | SLC25A20 | RNA | Others | Others | Others |
| 4157 | SLC25A6 | RNA | Others | Others | Others |
| 4158 | SLC27A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4159 | SLC27A3 | RNA | Others | Others | Others |
| 4160 | SLC2A1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4161 | SLC2A11 | RNA | Others | Others | Others |
| 4162 | SLC2A12 | RNA | Others | Others | Others |
| 4163 | SLC2A14 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4164 | SLC2A2 | RNA | Others | Others | Others |
| 4165 | SLC2A3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4166 | SLC2A3/14 | RNA | Others | Others | Others |
| 4167 | SLC2A5 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4168 | SLC2A6 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4169 | SLC2A8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4170 | SLC32A1 | RNA | Transmitter Synthesis | Others | CNS |
| 4171 | SLC35A3 | RNA | Others | Others | Others |
| 4172 | SLC37A1 | RNA | Others | Others | Others |
| 4173 | SLC37A4 | RNA | Others | Others | Others |
| 4174 | SLC39A6 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4175 | SLC3A1 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4176 | SLC3A2 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4177 | SLC44A1 | RNA | Others | Others | Others |
| 4178 | SLC44A4 | RNA | EMT | Others | Oncology |
| 4179 | SLC4A10 | RNA | Others | Others | Others |
| 4180 | SLC4A1AP | RNA | Others | Others | Others |
| 4181 | SLC6A1 | RNA | Others | Others | Others |
| 4182 | SLC6A12 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4183 | SLC6A18 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4184 | SLC6A19 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4185 | SLC6A3 | RNA | Transmitter Synthesis | Others | CNS |
| 4186 | SLC6A4 | RNA | Transmitter Synthesis | Others | CNS |
| 4187 | SLC7A11 | RNA | Cell Stress | Others | CNS |
| 4188 | SLC7A5 | RNA | Metabolism Stress | Others | Metabolic Diseases |
| 4189 | SLC7A9 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4190 | SLC8A1 | RNA | Oxydative Stress | Others | Inflammation |
| 4191 | SLC9A6 | RNA | Others | Others | Others |
| 4192 | SLCO2B1 | RNA | Others | Others | Others |
| 4193 | SLFN11 | RNA | Others | Others | Others |
| 4194 | SLIT2 | RNA | Hippo Signaling | Others | CNS |
| 4195 | SLPI | RNA | EMT | Others | Oncology |
| 4196 | SLU7 | RNA | Others | Others | Others |
| 4197 | SMAD1 | RNA | Cell Proliferation | Others | CNS |
| 4198 | SMAD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4199 | SMAD3 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4200 | SMAD4 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4201 | SMAD5 | RNA | Proliferation | Others | Oncology |
| 4202 | SMAD6 | RNA | Others | Others | Others |
| 4203 | SMAD7 | RNA | Hippo Signaling | Others | CNS |
| 4204 | SMAD9 | RNA | Others | Others | Others |
| 4205 | SMAP1 | RNA | Others | Others | Others |
| 4206 | SMARCA4 | RNA | Others | Others | Others |
| 4207 | SMARCA5 | RNA | Others | Others | Others |
| 4208 | SMARCB1 | RNA | Others | Others | Others |
| 4209 | SMARCC2 | RNA | Others | Others | Others |
| 4210 | SMARCD1 | RNA | Others | Others | Others |
| 4211 | SMC1A | RNA | Others | Others | Others |
| 4212 | SMC1B | RNA | Proliferation | Others | Oncology |
| 4213 | SMC2 | RNA | Others | Others | Others |
| 4214 | SMC3 | RNA | Cell Cycle | Others | Oncology |
| 4215 | SMN1 | RNA | Others | Others | Others |
| 4216 | SMO | RNA | Hedgehog | Others | CNS |
| 4217 | SMOC1 | RNA | Others | Others | Others |
| 4218 | SMPD3 | RNA | Others | Others | Others |
| 4219 | SMPD4 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 4220 | SMS | RNA | Androgen Signaling | Others | Oncology |
| 4221 | SMURF1 | RNA | Others | Others | Others |
| 4222 | SMURF2 | RNA | Proliferation | Others | Oncology |
| 4223 | SMYD1 | RNA | Others | Others | Others |
| 4224 | SNAI1 | RNA | Cellular Differentiation | Others | Oncology |
| 4225 | SNAI2 | RNA | Cellular Differentiation | Others | Oncology |
| 4226 | SNAI3 | RNA | Others | Others | Others |
| 4227 | SNAP91 | RNA | Others | Others | Others |
| 4228 | SNCA | RNA | Oxydative Stress | Others | Inflammation |
| 4229 | SNCAIP | RNA | Transmitter Synthesis | Others | CNS |
| 4230 | SNCB | RNA | Transmitter Synthesis | Others | CNS |
| 4231 | SNF8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4232 | SNRPA | RNA | Others | Others | Others |
| 4233 | SNRPF | RNA | Others | Others | Others |
| 4234 | SOCS1 | RNA | JAK-STAT | Others | CNS |
| 4235 | SOCS2 | RNA | JAK-STAT | Others | CNS |
| 4236 | SOCS3 | RNA | JAK-STAT | Others | CNS |
| 4237 | SOCS4 | RNA | Others | Others | Others |
| 4238 | SOCS5 | RNA | Others | Others | Others |
| 4239 | SOD1 | RNA | Carbohydrate Metabolism | Others | CNS |
| 4240 | SOD2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4241 | SOD3 | RNA | Cell Stress | Others | CNS |
| 4242 | SORBS1 | RNA | Others | Others | Others |
| 4243 | SORCS3 | RNA | Others | Others | Others |
| 4244 | SORD | RNA | Androgen Signaling | Others | Oncology |
| 4245 | SORL1 | RNA | Others | Others | Others |
| 4246 | SORT1 | RNA | Others | Others | Others |
| 4247 | SOS1 | RNA | EGFR Signaling | Others | Oncology |
| 4248 | SOS2 | RNA | RAS | Others | Oncology |
| 4249 | SOST | RNA | Others | Others | Others |
| 4250 | SOX10 | RNA | Others | Others | Others |
| 4251 | SOX11 | RNA | Wnt Signaling | Others | CNS |
| 4252 | SOX17 | RNA | Angiogenesis | Others | Cardiovascular |
| 4253 | SOX2 | RNA | Hippo Signaling | Others | CNS |
| 4254 | SOX4 | RNA | Others | Others | Others |
| 4255 | SOX7 | RNA | Others | Others | Others |
| 4256 | SOX9 | RNA | Cell Proliferation | Others | CNS |
| 4257 | SP1 | RNA | TGF Beta Signaling | Others | Oncology |
| 4258 | SP100 | RNA | Others | Others | Others |
| 4259 | SP3 | RNA | Others | Others | Others |
| 4260 | SPA17 | RNA | Others | Others | Others |
| 4261 | SPACA3 | RNA | Others | Others | Others |
| 4262 | SPAG9 | RNA | AP1 Signaling | Others | Cardiovascular |
| 4263 | SPANXB1 | RNA | Others | Others | Others |
| 4264 | SPARC | RNA | Cell Proliferation | Others | CNS |
| 4265 | SPARCL1 | RNA | Others | Others | Others |
| 4266 | SPAST | RNA | Others | Others | Others |
| 4267 | SPC25 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4268 | SPDEF | RNA | Androgen Signaling | Others | Oncology |
| 4269 | SPHK1 | RNA | Others | Others | Others |
| 4270 | SPHK2 | RNA | Cell Proliferation | Others | CNS |
| 4271 | SPI1 | RNA | Others | Others | Others |
| 4272 | SPIB | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4273 | SPINK1 | RNA | Others | Others | Others |
| 4274 | SPINK5 | RNA | Others | Others | Others |
| 4275 | SPINT1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4276 | SPINT2 | RNA | Met Signaling | Others | Oncology |
| 4277 | SPN | RNA | Others | Others | Others |
| 4278 | SPO11 | RNA | Others | Others | Others |
| 4279 | SPOCK3 | RNA | Others | Others | Others |
| 4280 | SPOP | RNA | Others | Others | Others |
| 4281 | SPOPL | RNA | Others | Others | Others |
| 4282 | SPP1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4283 | SPPL2B | RNA | Others | Others | Others |
| 4284 | SPRED1 | RNA | Others | Others | Others |
| 4285 | SPRY1 | RNA | JAK-STAT | Others | CNS |
| 4286 | SPRY2 | RNA | JAK-STAT | Others | CNS |
| 4287 | SPRY4 | RNA | Cytotoxicity | Others | Oncology |
| 4288 | SPTAN1 | RNA | Others | Others | Others |
| 4289 | SPTBN2 | RNA | Others | Others | Others |
| 4290 | SQLE | RNA | mTOR Signaling | Others | Oncology |
| 4291 | SQSTM1 | RNA | mTOR Signaling | Others | Oncology |
| 4292 | SRC | RNA | Cell Proliferation | Others | CNS |
| 4293 | SRD5A2 | RNA | Others | Others | Others |
| 4294 | SREBF1 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 4295 | SREBF2 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4296 | SRF | RNA | Angiogenesis | Others | Cardiovascular |
| 4297 | SRGN | RNA | Others | Others | Others |
| 4298 | SRI | RNA | Others | Others | Others |
| 4299 | SRM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4300 | SRP54 | RNA | Others | Others | Others |
| 4301 | SRPK2 | RNA | Angiogenesis | Others | Cardiovascular |
| 4302 | SRPX | RNA | Others | Others | Others |
| 4303 | SRPX2 | RNA | Angiogenesis | Others | Cardiovascular |
| 4304 | SRR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4305 | SRSF2 | RNA | Others | Others | Others |
| 4306 | SRSF4 | RNA | Others | Others | Others |
| 4307 | SRXN1 | RNA | Others | Others | Others |
| 4308 | SSR1 | RNA | Others | Others | Others |
| 4309 | SSR2 | RNA | Others | Others | Others |
| 4310 | SSR4 | RNA | Others | Others | Others |
| 4311 | SSRP1 | RNA | p53 Signaling | Others | Oncology |
| 4312 | SSTR2 | RNA | Cell Proliferation | Others | CNS |
| 4313 | SSX1 | RNA | Others | Others | Others |
| 4314 | SSX4 | RNA | Others | Others | Others |
| 4315 | ST14 | RNA | Others | Others | Others |
| 4316 | ST3GAL6 | RNA | Others | Others | Others |
| 4317 | ST6GAL1 | RNA | Others | Others | Others |
| 4318 | ST6GALNAC2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4319 | ST8SIA6 | RNA | Others | Others | Others |
| 4320 | STAB1 | RNA | Others | Others | Others |
| 4321 | STAB2 | RNA | Angiogenesis | Others | Cardiovascular |
| 4322 | STAG2 | RNA | Cell Cycle | Others | Oncology |
| 4323 | STAM | RNA | Others | Others | Others |
| 4324 | STAM2 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4325 | STAMBPL1 | RNA | Others | Others | Others |
| 4326 | STAT1 | RNA | Cell Proliferation | Others | CNS |
| 4327 | STAT2 | RNA | Cytokine and Chemokine Signaling | Others | Immuno-Oncology |
| 4328 | STAT3 | RNA | Cell Proliferation | Others | CNS |
| 4329 | STAT4 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4330 | STAT5A | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4331 | STAT5B | RNA | Others | Others | Others |
| 4332 | STAT6 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4333 | STC1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4334 | STC2 | RNA | Others | Others | Others |
| 4335 | STEAP4 | RNA | Others | Others | Others |
| 4336 | STIM1 | RNA | Others | Others | Others |
| 4337 | STING1 | RNA | Others | Others | Others |
| 4338 | STIP1 | RNA | mTOR Signaling | Others | Oncology |
| 4339 | STK11 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4340 | STK11IP | RNA | Others | Others | Others |
| 4341 | STK26 | RNA | Others | Others | Others |
| 4342 | STK3 | RNA | Hippo Signaling | Others | CNS |
| 4343 | STK4 | RNA | Hippo Signaling | Others | CNS |
| 4344 | STMN1 | RNA | Others | Others | Others |
| 4345 | STRADB | RNA | Others | Others | Others |
| 4346 | STRAP | RNA | Others | Others | Others |
| 4347 | STT3B | RNA | Others | Others | Others |
| 4348 | STX18 | RNA | Others | Others | Others |
| 4349 | STX1A | RNA | Transmitter Synthesis | Others | CNS |
| 4350 | STX1B | RNA | Transmitter Synthesis | Others | CNS |
| 4351 | STX2 | RNA | Oxydative Stress | Others | Inflammation |
| 4352 | SUCLA2 | RNA | Carbohydrate Metabolism | Others | CNS |
| 4353 | SUFU | RNA | Others | Others | Others |
| 4354 | SUGT1 | RNA | Others | Others | Others |
| 4355 | SULF1 | RNA | Cell Proliferation | Others | CNS |
| 4356 | SUMO1 | RNA | Others | Others | Others |
| 4357 | SUPT16H | RNA | p53 Signaling | Others | Oncology |
| 4358 | SUV39H1 | RNA | Others | Others | Others |
| 4359 | SUV39H2 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 4360 | SUZ12 | RNA | Others | Others | Others |
| 4361 | SV2B | RNA | Cellular Differentiation | Others | Oncology |
| 4362 | SYCP1 | RNA | Others | Others | Others |
| 4363 | SYK | RNA | Angiogenesis | Others | Cardiovascular |
| 4364 | SYN2 | RNA | Others | Others | Others |
| 4365 | SYNE1 | RNA | Others | Others | Others |
| 4366 | SYNJ1 | RNA | Others | Others | Others |
| 4367 | SYP | RNA | Others | Others | Others |
| 4368 | SYT1 | RNA | Transmitter Synthesis | Others | CNS |
| 4369 | SYT13 | RNA | Others | Others | Others |
| 4370 | SYT17 | RNA | Others | Others | Others |
| 4371 | SYT4 | RNA | Others | Others | Others |
| 4372 | SYT7 | RNA | Others | Others | Others |
| 4373 | SYTL4 | RNA | ER Signaling | Others | Oncology |
| 4374 | TAB1 | RNA | Others | Others | Others |
| 4375 | TAB2 | RNA | Others | Others | Others |
| 4376 | TAB3 | RNA | Others | Others | Others |
| 4377 | TACSTD2 | RNA | Cell Proliferation | Others | CNS |
| 4378 | TAF10 | RNA | Others | Others | Others |
| 4379 | TAF3 | RNA | Others | Others | Others |
| 4380 | TAF4 | RNA | Others | Others | Others |
| 4381 | TAF4B | RNA | Others | Others | Others |
| 4382 | TAF6L | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4383 | TAF9 | RNA | Others | Others | Others |
| 4384 | TAGAP | RNA | Others | Others | Others |
| 4385 | TAL1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4386 | TALDO1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4387 | TANK | RNA | Others | Others | Others |
| 4388 | TAOK2 | RNA | Others | Others | Others |
| 4389 | TAP1 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 4390 | TAP2 | RNA | Antigen Processing | Others | Immuno-Oncology |
| 4391 | TAPBP | RNA | Antigen Processing | Others | Immuno-Oncology |
| 4392 | TAPBPL | RNA | Others | Others | Others |
| 4393 | TARBP2 | RNA | Others | Others | Others |
| 4394 | TARDBP | RNA | Others | Others | Others |
| 4395 | TARP | RNA | Others | Others | Others |
| 4396 | TARP/TRGC1/2 | RNA | Others | Others | Others |
| 4397 | TATDN1 | RNA | Others | Others | Others |
| 4398 | TAX1BP1 | RNA | Others | Others | Others |
| 4399 | TAZ | RNA | Hippo Signaling | Others | CNS |
| 4400 | TBC1D10B | RNA | Others | Others | Others |
| 4401 | TBC1D4 | RNA | Others | Others | Others |
| 4402 | TBC1D9 | RNA | ER Signaling | Others | Oncology |
| 4403 | TBK1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4404 | TBL1XR1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4405 | TBP | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4406 | TBPL1 | RNA | Others | Others | Others |
| 4407 | TBR1 | RNA | Others | Others | Others |
| 4408 | TBRG4 | RNA | Myc | Others | Oncology |
| 4409 | TBX1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4410 | TBX21 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4411 | TBX4 | RNA | Angiogenesis | Others | Cardiovascular |
| 4412 | TBXA2R | RNA | Others | Others | Others |
| 4413 | TBXAS1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4414 | TCEAL1 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4415 | TCEB1 | RNA | Others | Others | Others |
| 4416 | TCEB2 | RNA | Others | Others | Others |
| 4417 | TCERG1 | RNA | Others | Others | Others |
| 4418 | TCF20 | RNA | Others | Others | Others |
| 4419 | TCF3 | RNA | Others | Others | Others |
| 4420 | TCF4 | RNA | EMT | Others | Oncology |
| 4421 | TCF7 | RNA | Others | Others | Others |
| 4422 | TCF7L1 | RNA | Wnt Signaling | Others | CNS |
| 4423 | TCF7L2 | RNA | Others | Others | Others |
| 4424 | TCIRG1 | RNA | Transmitter Synthesis | Others | CNS |
| 4425 | TCL1A | RNA | PI3K-AKT | Others | Oncology |
| 4426 | TCL1B | RNA | Others | Others | Others |
| 4427 | TCN2 | RNA | Others | Others | Others |
| 4428 | TCOF1 | RNA | Myc | Others | Oncology |
| 4429 | TDGF1 | RNA | Cell Proliferation | Others | CNS |
| 4430 | TDO2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4431 | TDRD1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4432 | TEAD1 | RNA | Hippo Signaling | Others | CNS |
| 4433 | TEAD2 | RNA | Hippo Signaling | Others | CNS |
| 4434 | TECR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4435 | TEK | RNA | Angiogenesis | Others | Cardiovascular |
| 4436 | TELO2 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4437 | TENM2 | RNA | Others | Others | Others |
| 4438 | TERF2IP | RNA | Others | Others | Others |
| 4439 | TERT | RNA | Myc | Others | Oncology |
| 4440 | TET1 | RNA | Others | Others | Others |
| 4441 | TET2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4442 | TF | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4443 | TFAM | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4444 | TFB2M | RNA | Others | Others | Others |
| 4445 | TFDP1 | RNA | Cell Cycle | Others | Oncology |
| 4446 | TFE3 | RNA | Others | Others | Others |
| 4447 | TFEB | RNA | Autophagy | Others | Cardiovascular |
| 4448 | TFF1 | RNA | ER Signaling | Others | Oncology |
| 4449 | TFF3 | RNA | Others | Others | Others |
| 4450 | TFG | RNA | Others | Others | Others |
| 4451 | TFPI2 | RNA | Others | Others | Others |
| 4452 | TFRC | RNA | Hypoxia | Others | Cardiovascular |
| 4453 | TG | RNA | Others | Others | Others |
| 4454 | TGFA | RNA | Others | Others | Others |
| 4455 | TGFB1 | RNA | Cell Proliferation | Others | CNS |
| 4456 | TGFB1I1 | RNA | Others | Others | Others |
| 4457 | TGFB2 | RNA | Angiogenesis | Others | Cardiovascular |
| 4458 | TGFB3 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 4459 | TGFBI | RNA | Angiogenesis | Others | Cardiovascular |
| 4460 | TGFBR1 | RNA | MAPK | Others | Cardiovascular |
| 4461 | TGFBR2 | RNA | Cell Proliferation | Others | CNS |
| 4462 | TGIF2 | RNA | Others | Others | Others |
| 4463 | TGM1 | RNA | Others | Others | Others |
| 4464 | TGM2 | RNA | Hippo Signaling | Others | CNS |
| 4465 | TH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4466 | THBD | RNA | Others | Others | Others |
| 4467 | THBS1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4468 | THBS2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 4469 | THBS3 | RNA | Others | Others | Others |
| 4470 | THBS4 | RNA | Cell Proliferation | Others | CNS |
| 4471 | THEM4 | RNA | Others | Others | Others |
| 4472 | THOP1 | RNA | Others | Others | Others |
| 4473 | THY1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4474 | TIAM1 | RNA | RAS | Others | Oncology |
| 4475 | TICAM1 | RNA | Apoptosis | Others | Oncology |
| 4476 | TICAM2 | RNA | Others | Others | Others |
| 4477 | TIE1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4478 | TIFA | RNA | Others | Others | Others |
| 4479 | TIGAR | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4480 | TIGIT | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4481 | TIMELESS | RNA | Cell Stress | Others | CNS |
| 4482 | TIMM17A | RNA | Others | Others | Others |
| 4483 | TIMM23 | RNA | Others | Others | Others |
| 4484 | TIMP1 | RNA | Cell Proliferation | Others | CNS |
| 4485 | TIMP2 | RNA | Cell Proliferation | Others | CNS |
| 4486 | TIMP4 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 4487 | TIRAP | RNA | Others | Others | Others |
| 4488 | TJP1 | RNA | Hippo Signaling | Others | CNS |
| 4489 | TJP2 | RNA | Others | Others | Others |
| 4490 | TJP3 | RNA | Others | Others | Others |
| 4491 | TK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4492 | TK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4493 | TKT | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4494 | TLE3 | RNA | ER Signaling | Others | Oncology |
| 4495 | TLE4 | RNA | Others | Others | Others |
| 4496 | TLK2 | RNA | Others | Others | Others |
| 4497 | TLN1 | RNA | Others | Others | Others |
| 4498 | TLR1 | RNA | Others | Others | Others |
| 4499 | TLR10 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4500 | TLR2 | RNA | PI3K-AKT | Others | Oncology |
| 4501 | TLR3 | RNA | Apoptosis | Others | Oncology |
| 4502 | TLR4 | RNA | Apoptosis | Others | Oncology |
| 4503 | TLR5 | RNA | Others | Others | Others |
| 4504 | TLR6 | RNA | Others | Others | Others |
| 4505 | TLR7 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4506 | TLR8 | RNA | Others | Others | Others |
| 4507 | TLR9 | RNA | Others | Others | Others |
| 4508 | TLX1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 4509 | TM4SF1 | RNA | Others | Others | Others |
| 4510 | TM6SF2 | RNA | Others | Others | Others |
| 4511 | TMC6 | RNA | Others | Others | Others |
| 4512 | TMC7 | RNA | Others | Others | Others |
| 4513 | TMCC3 | RNA | Others | Others | Others |
| 4514 | TMED2 | RNA | Others | Others | Others |
| 4515 | TMEFF2 | RNA | Others | Others | Others |
| 4516 | TMEM100 | RNA | Angiogenesis | Others | Cardiovascular |
| 4517 | TMEM119 | RNA | Others | Others | Others |
| 4518 | TMEM140 | RNA | Others | Others | Others |
| 4519 | TMEM144 | RNA | Others | Others | Others |
| 4520 | TMEM163 | RNA | Others | Others | Others |
| 4521 | TMEM173 | RNA | Others | Others | Others |
| 4522 | TMEM176A | RNA | Others | Others | Others |
| 4523 | TMEM204 | RNA | Others | Others | Others |
| 4524 | TMEM206 | RNA | Others | Others | Others |
| 4525 | TMEM30B | RNA | Cellular Differentiation | Others | Oncology |
| 4526 | TMEM37 | RNA | Others | Others | Others |
| 4527 | TMEM45B | RNA | Others | Others | Others |
| 4528 | TMEM64 | RNA | Others | Others | Others |
| 4529 | TMEM88B | RNA | Others | Others | Others |
| 4530 | TMPRSS2 | RNA | Androgen Signaling | Others | Oncology |
| 4531 | TMPRSS4 | RNA | EMT | Others | Oncology |
| 4532 | TMPRSS6 | RNA | Angiogenesis | Others | Cardiovascular |
| 4533 | TMUB2 | RNA | Others | Others | Others |
| 4534 | TNC | RNA | Cell Proliferation | Others | CNS |
| 4535 | TNF | RNA | Apoptosis | Others | Oncology |
| 4536 | TNFAIP3 | RNA | Others | Others | Others |
| 4537 | TNFAIP6 | RNA | Angiogenesis | Others | Cardiovascular |
| 4538 | TNFRSF10A | RNA | Others | Others | Others |
| 4539 | TNFRSF10B | RNA | Apoptosis | Others | Oncology |
| 4540 | TNFRSF10C | RNA | Others | Others | Others |
| 4541 | TNFRSF10D | RNA | Others | Others | Others |
| 4542 | TNFRSF11A | RNA | NF-kappaB Signaling | Others | CNS |
| 4543 | TNFRSF11B | RNA | NF-kappaB Signaling | Others | CNS |
| 4544 | TNFRSF12A | RNA | Angiogenesis | Others | Cardiovascular |
| 4545 | TNFRSF13B | RNA | Others | Others | Others |
| 4546 | TNFRSF13C | RNA | Others | Others | Others |
| 4547 | TNFRSF14 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4548 | TNFRSF17 | RNA | NF-kappaB Signaling | Others | CNS |
| 4549 | TNFRSF18 | RNA | NF-kappaB Signaling | Others | CNS |
| 4550 | TNFRSF1A | RNA | MAPK | Others | Cardiovascular |
| 4551 | TNFRSF1B | RNA | NF-kappaB Signaling | Others | CNS |
| 4552 | TNFRSF25 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4553 | TNFRSF4 | RNA | NF-kappaB Signaling | Others | CNS |
| 4554 | TNFRSF8 | RNA | Others | Others | Others |
| 4555 | TNFRSF9 | RNA | TNF Superfamily | Others | Oncology |
| 4556 | TNFSF10 | RNA | Apoptosis | Others | Oncology |
| 4557 | TNFSF11 | RNA | TNF Superfamily | Others | Oncology |
| 4558 | TNFSF12 | RNA | Angiogenesis | Others | Cardiovascular |
| 4559 | TNFSF13 | RNA | Cell Proliferation | Others | CNS |
| 4560 | TNFSF13B | RNA | NF-kappaB Signaling | Others | CNS |
| 4561 | TNFSF14 | RNA | TNF Superfamily | Others | Oncology |
| 4562 | TNFSF15 | RNA | Others | Others | Others |
| 4563 | TNFSF18 | RNA | NF-kappaB Signaling | Others | CNS |
| 4564 | TNFSF4 | RNA | NF-kappaB Signaling | Others | CNS |
| 4565 | TNFSF8 | RNA | TNF Superfamily | Others | Oncology |
| 4566 | TNFSF9 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4567 | TNKS | RNA | Apoptosis | Others | Oncology |
| 4568 | TNKS2 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4569 | TNMD | RNA | Cell Proliferation | Others | CNS |
| 4570 | TNN | RNA | PI3K-AKT | Others | Oncology |
| 4571 | TNR | RNA | Others | Others | Others |
| 4572 | TNS1 | RNA | Hippo Signaling | Others | CNS |
| 4573 | TNS4 | RNA | Met Signaling | Others | Oncology |
| 4574 | TNXB | RNA | Cellular Differentiation | Others | Oncology |
| 4575 | TOLLIP | RNA | Others | Others | Others |
| 4576 | TOM1L1 | RNA | Others | Others | Others |
| 4577 | TOMM6 | RNA | Others | Others | Others |
| 4578 | TOP2A | RNA | Cell Cycle | Others | Oncology |
| 4579 | TOPBP1 | RNA | Others | Others | Others |
| 4580 | TOR1A | RNA | Oxydative Stress | Others | Inflammation |
| 4581 | TOX | RNA | Others | Others | Others |
| 4582 | TOX2 | RNA | Others | Others | Others |
| 4583 | TOX3 | RNA | Others | Others | Others |
| 4584 | TOX4 | RNA | Others | Others | Others |
| 4585 | TP53 | RNA | Apoptosis | Others | Oncology |
| 4586 | TP53BP2 | RNA | Others | Others | Others |
| 4587 | TP53INP2 | RNA | Others | Others | Others |
| 4588 | TP63 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4589 | TP73 | RNA | Hippo Signaling | Others | CNS |
| 4590 | TPD52 | RNA | Androgen Signaling | Others | Oncology |
| 4591 | TPH1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4592 | TPI1 | RNA | HIF1 Signaling | Others | Inflammation |
| 4593 | TPM1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4594 | TPM2 | RNA | Others | Others | Others |
| 4595 | TPO | RNA | Others | Others | Others |
| 4596 | TPP1 | RNA | Others | Others | Others |
| 4597 | TPP2 | RNA | Others | Others | Others |
| 4598 | TPR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4599 | TPSAB1 | RNA | Others | Others | Others |
| 4600 | TPSAB1/B2 | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 4601 | TPSB2 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 4602 | TPSD1 | RNA | Matrix Remodeling and Metastases | Others | CNS |
| 4603 | TPTE | RNA | Others | Others | Others |
| 4604 | TPX2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4605 | TRAC | RNA | Others | Others | Others |
| 4606 | TRADD | RNA | Others | Others | Others |
| 4607 | TRAF1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4608 | TRAF2 | RNA | Others | Others | Others |
| 4609 | TRAF3 | RNA | Others | Others | Others |
| 4610 | TRAF4 | RNA | Others | Others | Others |
| 4611 | TRAF5 | RNA | Others | Others | Others |
| 4612 | TRAF6 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4613 | TRAF7 | RNA | Others | Others | Others |
| 4614 | TRAM1 | RNA | Others | Others | Others |
| 4615 | TRAT1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4616 | TRAV10 | RNA | Others | Others | Others |
| 4617 | TRAV11 | RNA | Others | Others | Others |
| 4618 | TRAV1-1 | RNA | Others | Others | Others |
| 4619 | TRAV1-2 | RNA | Others | Others | Others |
| 4620 | TRAV12-1 | RNA | Others | Others | Others |
| 4621 | TRAV12-2 | RNA | Others | Others | Others |
| 4622 | TRAV12-3 | RNA | Others | Others | Others |
| 4623 | TRAV13-1 | RNA | Others | Others | Others |
| 4624 | TRAV13-2 | RNA | Others | Others | Others |
| 4625 | TRAV14 | RNA | Others | Others | Others |
| 4626 | TRAV16 | RNA | Others | Others | Others |
| 4627 | TRAV17 | RNA | Others | Others | Others |
| 4628 | TRAV18 | RNA | Others | Others | Others |
| 4629 | TRAV19 | RNA | Others | Others | Others |
| 4630 | TRAV2 | RNA | Others | Others | Others |
| 4631 | TRAV20 | RNA | Others | Others | Others |
| 4632 | TRAV21 | RNA | Others | Others | Others |
| 4633 | TRAV22 | RNA | Others | Others | Others |
| 4634 | TRAV23 | RNA | Others | Others | Others |
| 4635 | TRAV24 | RNA | Others | Others | Others |
| 4636 | TRAV25 | RNA | Others | Others | Others |
| 4637 | TRAV26-1 | RNA | Others | Others | Others |
| 4638 | TRAV26-2 | RNA | Others | Others | Others |
| 4639 | TRAV27 | RNA | Others | Others | Others |
| 4640 | TRAV29 | RNA | Others | Others | Others |
| 4641 | TRAV3 | RNA | Others | Others | Others |
| 4642 | TRAV30 | RNA | Others | Others | Others |
| 4643 | TRAV34 | RNA | Others | Others | Others |
| 4644 | TRAV35 | RNA | Others | Others | Others |
| 4645 | TRAV36 | RNA | Others | Others | Others |
| 4646 | TRAV38-1 | RNA | Others | Others | Others |
| 4647 | TRAV38-2 | RNA | Others | Others | Others |
| 4648 | TRAV39 | RNA | Others | Others | Others |
| 4649 | TRAV4 | RNA | Others | Others | Others |
| 4650 | TRAV40 | RNA | Others | Others | Others |
| 4651 | TRAV41 | RNA | Others | Others | Others |
| 4652 | TRAV5 | RNA | Others | Others | Others |
| 4653 | TRAV6 | RNA | Others | Others | Others |
| 4654 | TRAV7 | RNA | Others | Others | Others |
| 4655 | TRAV8-1 | RNA | Others | Others | Others |
| 4656 | TRAV8-2 | RNA | Others | Others | Others |
| 4657 | TRAV8-3 | RNA | Others | Others | Others |
| 4658 | TRAV8-6 | RNA | Others | Others | Others |
| 4659 | TRAV9-1 | RNA | Others | Others | Others |
| 4660 | TRAV9-2 | RNA | Others | Others | Others |
| 4661 | TRBC1/2 | RNA | Others | Others | Others |
| 4662 | TRBV10-1 | RNA | Others | Others | Others |
| 4663 | TRBV10-2 | RNA | Others | Others | Others |
| 4664 | TRBV10-3 | RNA | Others | Others | Others |
| 4665 | TRBV11-1 | RNA | Others | Others | Others |
| 4666 | TRBV11-2 | RNA | Others | Others | Others |
| 4667 | TRBV11-3 | RNA | Others | Others | Others |
| 4668 | TRBV12-3 | RNA | Others | Others | Others |
| 4669 | TRBV12-5 | RNA | Others | Others | Others |
| 4670 | TRBV13 | RNA | Others | Others | Others |
| 4671 | TRBV14 | RNA | Others | Others | Others |
| 4672 | TRBV15 | RNA | Others | Others | Others |
| 4673 | TRBV16 | RNA | Others | Others | Others |
| 4674 | TRBV18 | RNA | Others | Others | Others |
| 4675 | TRBV19 | RNA | Others | Others | Others |
| 4676 | TRBV2 | RNA | Others | Others | Others |
| 4677 | TRBV20-1 | RNA | Others | Others | Others |
| 4678 | TRBV24-1 | RNA | Others | Others | Others |
| 4679 | TRBV25-1 | RNA | Others | Others | Others |
| 4680 | TRBV27 | RNA | Others | Others | Others |
| 4681 | TRBV28 | RNA | Others | Others | Others |
| 4682 | TRBV29-1 | RNA | Others | Others | Others |
| 4683 | TRBV30 | RNA | Others | Others | Others |
| 4684 | TRBV3-1 | RNA | Others | Others | Others |
| 4685 | TRBV4-1 | RNA | Others | Others | Others |
| 4686 | TRBV4-2 | RNA | Others | Others | Others |
| 4687 | TRBV4-3 | RNA | Others | Others | Others |
| 4688 | TRBV5-1 | RNA | Others | Others | Others |
| 4689 | TRBV5-4 | RNA | Others | Others | Others |
| 4690 | TRBV5-5 | RNA | Others | Others | Others |
| 4691 | TRBV5-6 | RNA | Others | Others | Others |
| 4692 | TRBV5-8 | RNA | Others | Others | Others |
| 4693 | TRBV6-1 | RNA | Others | Others | Others |
| 4694 | TRBV6-2 | RNA | Others | Others | Others |
| 4695 | TRBV6-4 | RNA | Others | Others | Others |
| 4696 | TRBV6-5 | RNA | Others | Others | Others |
| 4697 | TRBV6-6 | RNA | Others | Others | Others |
| 4698 | TRBV6-8 | RNA | Others | Others | Others |
| 4699 | TRBV6-9 | RNA | Others | Others | Others |
| 4700 | TRBV7-2 | RNA | Others | Others | Others |
| 4701 | TRBV7-3 | RNA | Others | Others | Others |
| 4702 | TRBV7-4 | RNA | Others | Others | Others |
| 4703 | TRBV7-6 | RNA | Others | Others | Others |
| 4704 | TRBV7-7 | RNA | Others | Others | Others |
| 4705 | TRBV7-8 | RNA | Others | Others | Others |
| 4706 | TRBV7-9 | RNA | Others | Others | Others |
| 4707 | TRBV9 | RNA | Others | Others | Others |
| 4708 | TRDC | RNA | Others | Others | Others |
| 4709 | TRDV1 | RNA | Others | Others | Others |
| 4710 | TRDV2 | RNA | Others | Others | Others |
| 4711 | TRDV3 | RNA | Others | Others | Others |
| 4712 | TREM1 | RNA | Others | Others | Others |
| 4713 | TREM2 | RNA | Others | Others | Others |
| 4714 | TREX1 | RNA | Others | Others | Others |
| 4715 | TRGC1 | RNA | Others | Others | Others |
| 4716 | TRGC2 | RNA | Others | Others | Others |
| 4717 | TRGV2 | RNA | Others | Others | Others |
| 4718 | TRGV3/5 | RNA | Others | Others | Others |
| 4719 | TRGV4 | RNA | Others | Others | Others |
| 4720 | TRGV8 | RNA | Others | Others | Others |
| 4721 | TRGV9 | RNA | Others | Others | Others |
| 4722 | TRIB3 | RNA | Others | Others | Others |
| 4723 | TRIM10 | RNA | Others | Others | Others |
| 4724 | TRIM14 | RNA | Others | Others | Others |
| 4725 | TRIM2 | RNA | Others | Others | Others |
| 4726 | TRIM21 | RNA | Others | Others | Others |
| 4727 | TRIM22 | RNA | Others | Others | Others |
| 4728 | TRIM25 | RNA | Others | Others | Others |
| 4729 | TRIM26 | RNA | Others | Others | Others |
| 4730 | TRIM28 | RNA | Others | Others | Others |
| 4731 | TRIM29 | RNA | Others | Others | Others |
| 4732 | TRIM31 | RNA | Others | Others | Others |
| 4733 | TRIM33 | RNA | Others | Others | Others |
| 4734 | TRIM34 | RNA | Others | Others | Others |
| 4735 | TRIM35 | RNA | Others | Others | Others |
| 4736 | TRIM36 | RNA | Others | Others | Others |
| 4737 | TRIM37 | RNA | Others | Others | Others |
| 4738 | TRIM39 | RNA | Others | Others | Others |
| 4739 | TRIM46 | RNA | Others | Others | Others |
| 4740 | TRIM47 | RNA | Others | Others | Others |
| 4741 | TRIM48 | RNA | Others | Others | Others |
| 4742 | TRIM5 | RNA | Others | Others | Others |
| 4743 | TRIM56 | RNA | Others | Others | Others |
| 4744 | TRIM6 | RNA | Others | Others | Others |
| 4745 | TRIM68 | RNA | Others | Others | Others |
| 4746 | TRIM8 | RNA | Others | Others | Others |
| 4747 | TRIM9 | RNA | Others | Others | Others |
| 4748 | TRIP13 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4749 | TROVE2 | RNA | Others | Others | Others |
| 4750 | TRPA1 | RNA | Others | Others | Others |
| 4751 | TRPC1 | RNA | Others | Others | Others |
| 4752 | TRPC6 | RNA | Others | Others | Others |
| 4753 | TRPM2 | RNA | Oxydative Stress | Others | Inflammation |
| 4754 | TRPM4 | RNA | Others | Others | Others |
| 4755 | TRPM7 | RNA | Others | Others | Others |
| 4756 | TRPV1 | RNA | Others | Others | Others |
| 4757 | TRRAP | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4758 | TSC1 | RNA | Others | Others | Others |
| 4759 | TSC2 | RNA | Others | Others | Others |
| 4760 | TSHR | RNA | Cell Proliferation | Others | CNS |
| 4761 | TSLP | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4762 | TSPAN1 | RNA | EMT | Others | Oncology |
| 4763 | TSPAN18 | RNA | Others | Others | Others |
| 4764 | TSPAN7 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 4765 | TSPO | RNA | Others | Others | Others |
| 4766 | TTC30A | RNA | Others | Others | Others |
| 4767 | TTC31 | RNA | Others | Others | Others |
| 4768 | TTK | RNA | Cell Cycle | Others | Oncology |
| 4769 | TTN | RNA | Others | Others | Others |
| 4770 | TTPA | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4771 | TTR | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4772 | TTYH1 | RNA | Others | Others | Others |
| 4773 | TUBA4A | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4774 | TUBB | RNA | Others | Others | Others |
| 4775 | TUBB3 | RNA | Others | Others | Others |
| 4776 | TUBB4A | RNA | Others | Others | Others |
| 4777 | TUBG1 | RNA | Cell Cycle | Others | Oncology |
| 4778 | TUSC2 | RNA | Others | Others | Others |
| 4779 | TWF1 | RNA | Others | Others | Others |
| 4780 | TWIST1 | RNA | Cellular Differentiation | Others | Oncology |
| 4781 | TWIST2 | RNA | Cell Proliferation | Others | CNS |
| 4782 | TWISTNB | RNA | Others | Others | Others |
| 4783 | TXK | RNA | Others | Others | Others |
| 4784 | TXN | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4785 | TXN2 | RNA | Cell Stress | Others | CNS |
| 4786 | TXNDC5 | RNA | Others | Others | Others |
| 4787 | TXNIP | RNA | Cell Proliferation | Others | CNS |
| 4788 | TXNL1 | RNA | Oxydative Stress | Others | Inflammation |
| 4789 | TXNRD1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4790 | TXNRD2 | RNA | Others | Others | Others |
| 4791 | TYK2 | RNA | Others | Others | Others |
| 4792 | TYMP | RNA | Angiogenesis | Others | Cardiovascular |
| 4793 | TYMS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4794 | TYROBP | RNA | Others | Others | Others |
| 4795 | U2AF1 | RNA | Others | Others | Others |
| 4796 | U2AF2 | RNA | Others | Others | Others |
| 4797 | UBA5 | RNA | Others | Others | Others |
| 4798 | UBA52 | RNA | Others | Others | Others |
| 4799 | UBA7 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4800 | UBB | RNA | Apoptosis | Others | Oncology |
| 4801 | UBC | RNA | Others | Others | Others |
| 4802 | UBE2C | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4803 | UBE2D1 | RNA | Others | Others | Others |
| 4804 | UBE2D2 | RNA | Others | Others | Others |
| 4805 | UBE2F | RNA | Others | Others | Others |
| 4806 | UBE2I | RNA | Others | Others | Others |
| 4807 | UBE2K | RNA | Others | Others | Others |
| 4808 | UBE2L3 | RNA | Others | Others | Others |
| 4809 | UBE2L6 | RNA | Others | Others | Others |
| 4810 | UBE2N | RNA | Others | Others | Others |
| 4811 | UBE2S | RNA | Others | Others | Others |
| 4812 | UBE2T | RNA | Cell Stress | Others | CNS |
| 4813 | UBE2V1 | RNA | Others | Others | Others |
| 4814 | UBE3A | RNA | Others | Others | Others |
| 4815 | UBE4B | RNA | Others | Others | Others |
| 4816 | UBQLN1 | RNA | Oxydative Stress | Others | Inflammation |
| 4817 | UCHL1 | RNA | Others | Others | Others |
| 4818 | UCHL5 | RNA | mTOR Signaling | Others | Oncology |
| 4819 | UCK1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4820 | UCK2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4821 | UCKL1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4822 | UCP1 | RNA | Others | Others | Others |
| 4823 | UGCG | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 4824 | UGDH | RNA | Androgen Signaling | Others | Oncology |
| 4825 | UGT8 | RNA | Lipid Metabolism | Others | Metabolic Diseases |
| 4826 | UHRF1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4827 | ULBP2 | RNA | Others | Others | Others |
| 4828 | ULBP3 | RNA | Others | Others | Others |
| 4829 | ULK1 | RNA | Others | Others | Others |
| 4830 | ULK2 | RNA | Others | Others | Others |
| 4831 | UMPS | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4832 | UNC13A | RNA | Transmitter Synthesis | Others | CNS |
| 4833 | UNC93B1 | RNA | Others | Others | Others |
| 4834 | UNG | RNA | Others | Others | Others |
| 4835 | UPP1 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4836 | UPP2 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4837 | UQCR10 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4838 | UQCR11 | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4839 | UQCRB | RNA | Others | Others | Others |
| 4840 | UQCRFS1 | RNA | Others | Others | Others |
| 4841 | UQCRH | RNA | Others | Others | Others |
| 4842 | UQCRQ | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4843 | USP15 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4844 | USP18 | RNA | Others | Others | Others |
| 4845 | USP21 | RNA | Others | Others | Others |
| 4846 | USP30 | RNA | Others | Others | Others |
| 4847 | USP39 | RNA | Others | Others | Others |
| 4848 | USP8 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4849 | USP9Y | RNA | Others | Others | Others |
| 4850 | UTS2 | RNA | Others | Others | Others |
| 4851 | UTY | RNA | Others | Others | Others |
| 4852 | VAMP2 | RNA | Others | Others | Others |
| 4853 | VAMP3 | RNA | Others | Others | Others |
| 4854 | VAMP7 | RNA | Others | Others | Others |
| 4855 | VAMP8 | RNA | Others | Others | Others |
| 4856 | VASH1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4857 | VAV1 | RNA | TCR Signaling | Others | Immuno-Oncology |
| 4858 | VAV2 | RNA | Angiogenesis | Others | Cardiovascular |
| 4859 | VAV3 | RNA | Angiogenesis | Others | Cardiovascular |
| 4860 | VCAM1 | RNA | Cell Proliferation | Others | CNS |
| 4861 | VCAN | RNA | Angiogenesis | Others | Cardiovascular |
| 4862 | VCL | RNA | Others | Others | Others |
| 4863 | VCP | RNA | Others | Others | Others |
| 4864 | VDAC1 | RNA | Others | Others | Others |
| 4865 | VEGFA | RNA | Angiogenesis | Others | Cardiovascular |
| 4866 | VEGFB | RNA | Angiogenesis | Others | Cardiovascular |
| 4867 | VEGFC | RNA | Angiogenesis | Others | Cardiovascular |
| 4868 | VEGFD | RNA | MAPK | Others | Cardiovascular |
| 4869 | VEZF1 | RNA | Angiogenesis | Others | Cardiovascular |
| 4870 | VHL | RNA | Cell Proliferation | Others | CNS |
| 4871 | VIM | RNA | EMT | Others | Oncology |
| 4872 | VIP | RNA | Carbohydrate Metabolism | Others | CNS |
| 4873 | VIT | RNA | EMT | Others | Oncology |
| 4874 | VPS13A | RNA | Others | Others | Others |
| 4875 | VPS28 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4876 | VPS33B | RNA | Others | Others | Others |
| 4877 | VPS4A | RNA | Others | Others | Others |
| 4878 | VPS4B | RNA | Others | Others | Others |
| 4879 | VRK3 | RNA | Others | Others | Others |
| 4880 | VSIG4 | RNA | Cell Proliferation | Others | CNS |
| 4881 | VSIR | RNA | Others | Others | Others |
| 4882 | VTCN1 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4883 | VTN | RNA | Others | Others | Others |
| 4884 | VWA1 | RNA | Others | Others | Others |
| 4885 | VWA2 | RNA | Others | Others | Others |
| 4886 | VWF | RNA | ECM Remodeling | Others | Metabolic Diseases |
| 4887 | WARS | RNA | Angiogenesis | Others | Cardiovascular |
| 4888 | WAS | RNA | Others | Others | Others |
| 4889 | WASF2 | RNA | VEGFR Signaling | Others | Cardiovascular |
| 4890 | WASHC4 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4891 | WDR45 | RNA | Nutrient Capture and Catabolic Pathways | Others | Metabolic Diseases |
| 4892 | WDR5 | RNA | Others | Others | Others |
| 4893 | WDR76 | RNA | Others | Others | Others |
| 4894 | WDR77 | RNA | ER Signaling | Others | Oncology |
| 4895 | WEE1 | RNA | Cell Cycle | Others | Oncology |
| 4896 | WFS1 | RNA | Others | Others | Others |
| 4897 | WHSC1 | RNA | Others | Others | Others |
| 4898 | WHSC1L1 | RNA | Chromatin Modification | Others | Epigenic and Nuclear Signaling |
| 4899 | WIF1 | RNA | Wnt Signaling | Others | CNS |
| 4900 | WIPF1 | RNA | Cellular Differentiation | Others | Oncology |
| 4901 | WIPI1 | RNA | Others | Others | Others |
| 4902 | WNT1 | RNA | Signaling Affecting Cellular Metabolism | Others | Metabolic Diseases |
| 4903 | WNT10A | RNA | Hedgehog | Others | CNS |
| 4904 | WNT10B | RNA | Others | Others | Others |
| 4905 | WNT11 | RNA | Hedgehog | Others | CNS |
| 4906 | WNT16 | RNA | Others | Others | Others |
| 4907 | WNT2 | RNA | Hedgehog | Others | CNS |
| 4908 | WNT2B | RNA | Hedgehog | Others | CNS |
| 4909 | WNT3 | RNA | Others | Others | Others |
| 4910 | WNT3A | RNA | Hedgehog | Others | CNS |
| 4911 | WNT4 | RNA | Hedgehog | Others | CNS |
| 4912 | WNT5A | RNA | Cell Proliferation | Others | CNS |
| 4913 | WNT5B | RNA | Cellular Differentiation | Others | Oncology |
| 4914 | WNT6 | RNA | Hedgehog | Others | CNS |
| 4915 | WNT7A | RNA | Others | Others | Others |
| 4916 | WNT7B | RNA | Hedgehog | Others | CNS |
| 4917 | WRAP53 | RNA | Cell Cycle | Others | Oncology |
| 4918 | WRN | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4919 | WT1 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 4920 | WWC1 | RNA | Hippo Signaling | Others | CNS |
| 4921 | WWTR1 | RNA | Hippo Signaling | Others | CNS |
| 4922 | XAB2 | RNA | Others | Others | Others |
| 4923 | XAF1 | RNA | Others | Others | Others |
| 4924 | XBP1 | RNA | mTOR Signaling | Others | Oncology |
| 4925 | XCL1 | RNA | Others | Others | Others |
| 4926 | XCL1/2 | RNA | Adenosine Pathway | Others | Immuno-Oncology |
| 4927 | XCL2 | RNA | Others | Others | Others |
| 4928 | XCR1 | RNA | Others | Others | Others |
| 4929 | XDH | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4930 | XIAP | RNA | Others | Others | Others |
| 4931 | XK | RNA | Myelination | Others | CNS |
| 4932 | XPA | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4933 | XRCC2 | RNA | Cell Stress | Others | CNS |
| 4934 | XRCC3 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4935 | XRCC4 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4936 | XRCC6 | RNA | Others | Others | Others |
| 4937 | YAP1 | RNA | Hippo Signaling | Others | CNS |
| 4938 | YES1 | RNA | Others | Others | Others |
| 4939 | YTHDF2 | RNA | Others | Others | Others |
| 4940 | YWHAB | RNA | Others | Others | Others |
| 4941 | YWHAE | RNA | Others | Others | Others |
| 4942 | YWHAG | RNA | Others | Others | Others |
| 4943 | YWHAQ | RNA | Others | Others | Others |
| 4944 | YWHAZ | RNA | Biosynthesis and Anabolic Pathways | Others | CNS |
| 4945 | YY1 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4946 | ZAK | RNA | Others | Others | Others |
| 4947 | ZAP70 | RNA | Costimulatory Signaling | Others | Immuno-Oncology |
| 4948 | ZBP1 | RNA | Others | Others | Others |
| 4949 | ZBTB16 | RNA | Transcriptional Misregulation | Others | Epigenic and Nuclear Signaling |
| 4950 | ZBTB20 | RNA | Others | Others | Others |
| 4951 | ZBTB32 | RNA | DNA Damage Repair | Others | Epigenic and Nuclear Signaling |
| 4952 | ZC3H12A | RNA | Angiogenesis | Others | Cardiovascular |
| 4953 | ZC3H14 | RNA | Others | Others | Others |
| 4954 | ZCCHC24 | RNA | Others | Others | Others |
| 4955 | ZDHHC2 | RNA | Others | Others | Others |
| 4956 | ZEB1 | RNA | Cell Proliferation | Others | CNS |
| 4957 | ZEB2 | RNA | Cell Proliferation | Others | CNS |
| 4958 | ZFP36L2 | RNA | Others | Others | Others |
| 4959 | ZFPM2 | RNA | EMT | Others | Oncology |
| 4960 | ZFYVE16 | RNA | Others | Others | Others |
| 4961 | ZFYVE9 | RNA | Proliferation | Others | Oncology |
| 4962 | ZIC2 | RNA | Hedgehog | Others | CNS |
| 4963 | ZKSCAN5 | RNA | Others | Others | Others |
| 4964 | ZMYM2 | RNA | Epigenic and Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4965 | ZNF100 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4966 | ZNF136 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4967 | ZNF143 | RNA | Others | Others | Others |
| 4968 | ZNF205 | RNA | Others | Others | Others |
| 4969 | ZNF24 | RNA | Myelination | Others | CNS |
| 4970 | ZNF253 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4971 | ZNF254 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4972 | ZNF346 | RNA | Others | Others | Others |
| 4973 | ZNF367 | RNA | Others | Others | Others |
| 4974 | ZNF384 | RNA | Others | Others | Others |
| 4975 | ZNF385A | RNA | Others | Others | Others |
| 4976 | ZNF43 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4977 | ZNF610 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4978 | ZNF675 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4979 | ZNF682 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4980 | ZNF683 | RNA | Others | Others | Others |
| 4981 | ZNF708 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4982 | ZNF85 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4983 | ZNF91 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4984 | ZNF93 | RNA | Transcriptional Regulation | Others | Epigenic and Nuclear Signaling |
| 4985 | Alanine | Amino-acid & Metabolites | Others | Others | Others |
| 4986 | 3-MT | Amino-acid & Metabolites | Others | Others | Others |
| 4987 | Adenosine | Amino-acid & Metabolites | Others | Others | Others |
| 4988 | ADP | Amino-acid & Metabolites | Others | Others | Others |
| 4989 | AMP | Amino-acid & Metabolites | Others | Others | Others |
| 4990 | AMPc | Amino-acid & Metabolites | Others | Others | Others |
| 4991 | Arginine | Amino-acid & Metabolites | Others | Others | Others |
| 4992 | Asparagine | Amino-acid & Metabolites | Others | Others | Others |
| 4993 | Aspartate | Amino-acid & Metabolites | Others | Others | Others |
| 4994 | ATP | Amino-acid & Metabolites | Others | Others | Others |
| 4995 | Citrate | Amino-acid & Metabolites | Others | Others | Others |
| 4996 | Dopamine | Amino-acid & Metabolites | Others | Others | Others |
| 4997 | Fructose 1 P | Amino-acid & Metabolites | Others | Others | Others |
| 4998 | Fumarate | Amino-acid & Metabolites | Others | Others | Others |
| 4999 | GDP | Amino-acid & Metabolites | Others | Others | Others |
| 5000 | Glucose | Amino-acid & Metabolites | Others | Others | Others |
| 5001 | Glucose 6P | Amino-acid & Metabolites | Others | Others | Others |
| 5002 | glutamate | Amino-acid & Metabolites | Others | Others | Others |
| 5003 | Glutamine | Amino-acid & Metabolites | Others | Others | Others |
| 5004 | Glycine | Amino-acid & Metabolites | Others | Others | Others |
| 5005 | GMP | Amino-acid & Metabolites | Others | Others | Others |
| 5006 | GTP | Amino-acid & Metabolites | Others | Others | Others |
| 5007 | Guanine | Amino-acid & Metabolites | Others | Others | Others |
| 5008 | guanosine | Amino-acid & Metabolites | Others | Others | Others |
| 5009 | HIAA (5-hydroxy-Indole-3-acetic acid) | Amino-acid & Metabolites | Others | Others | Others |
| 5010 | Hypoxanthine | Amino-acid & Metabolites | Others | Others | Others |
| 5011 | IMP | Amino-acid & Metabolites | Others | Others | Others |
| 5012 | Inosine | Amino-acid & Metabolites | Others | Others | Others |
| 5013 | kynurenic acid | Amino-acid & Metabolites | Others | Others | Others |
| 5014 | Lactate | Amino-acid & Metabolites | Others | Others | Others |
| 5015 | L-DOPA | Amino-acid & Metabolites | Others | Others | Others |
| 5016 | Leucine (Isoleucine) | Amino-acid & Metabolites | Others | Others | Others |
| 5017 | Lysine | Amino-acid & Metabolites | Others | Others | Others |
| 5018 | malate | Amino-acid & Metabolites | Others | Others | Others |
| 5019 | MTA adenosine | Amino-acid & Metabolites | Others | Others | Others |
| 5020 | ornithine | Amino-acid & Metabolites | Others | Others | Others |
| 5021 | Phenylalanine | Amino-acid & Metabolites | Others | Others | Others |
| 5022 | Proline | Amino-acid & Metabolites | Others | Others | Others |
| 5023 | Pyruvate | Amino-acid & Metabolites | Others | Others | Others |
| 5024 | Serine | Amino-acid & Metabolites | Others | Others | Others |
| 5025 | Serotonin | Amino-acid & Metabolites | Others | Others | Others |
| 5026 | Spermidine | Amino-acid & Metabolites | Others | Others | Others |
| 5027 | Taurine | Amino-acid & Metabolites | Others | Others | Others |
| 5028 | Theronine | Amino-acid & Metabolites | Others | Others | Others |
| 5029 | Tryptamine | Amino-acid & Metabolites | Others | Others | Others |
| 5030 | Tryptophan | Amino-acid & Metabolites | Others | Others | Others |
| 5031 | uric acid | Amino-acid & Metabolites | Others | Others | Others |
| 5032 | Valine | Amino-acid & Metabolites | Others | Others | Others |
| 5033 | xanthine | Amino-acid & Metabolites | Others | Others | Others |
| 5034 | PE(19:0/0:0) | Lipid | Others | Others | Others |
| 5035 | Apigenin 7-glucuronide-4′-(6 »-malonylglucoside) | Lipid | Others | Others | Others |
| 5036 | Anguvetin | Lipid | Others | Others | Others |
| 5037 | Anastatin A | Lipid | Others | Others | Others |
| 5038 | Anandamide (20:l, n-9) | Lipid | Others | Others | Others |
| 5039 | Amaronol B | Lipid | Others | Others | Others |
| 5040 | alhpa-tocopheronolactone | Lipid | Others | Others | Others |
| 5041 | algestone | Lipid | Others | Others | Others |
| 5042 | Agavegenin A | Lipid | Others | Others | Others |
| 5043 | Adrenic acid | Lipid | Others | Others | Others |
| 5044 | Acylcarnitine C18:0 | Lipid | Others | Others | Others |
| 5045 | 9Z,12Z,15Z,18Z-Tetracosatetraenoic acid | Lipid | Others | Others | Others |
| 5046 | 9Z,11E,13-Tetradecatrienal | Lipid | Others | Others | Others |
| 5047 | 9S,10S,11R-trihydroxy-12Z-octadecenoic acid | Lipid | Others | Others | Others |
| 5048 | 9-oxo-2E-decenoic acid | Lipid | Others | Others | Others |
| 5049 | 9-deoxy-9-methylene-16,16-dimethyl -PGE2 | Lipid | Others | Others | Others |
| 5050 | 9,11alpha-epoxypregn-4-ene-3,20-dione | Lipid | Others | Others | Others |
| 5051 | 9,11alpha-epoxy-6alpha-acetoxy-cholest-7-en-3beta,5alpha,19-triol | Lipid | Others | Others | Others |
| 5052 | 8′-apo-beta-carotenol | Lipid | Others | Others | Others |
| 5053 | 8,9,10,11-Tetrafluoro-8E,10E-dodecadien-1-ol | Lipid | Others | Others | Others |
| 5054 | 8,8-Dimethyl-2-phenyl-4H,8H-benzo[1,2-b:3,4-b’]dipyran-4-one | Lipid | Others | Others | Others |
| 5055 | 8,11,14-Docosatriynoic acid | Lipid | Others | Others | Others |
| 5056 | 7-O-Methyllicoricidin | Lipid | Others | Others | Others |
| 5057 | 7-methyl-3-oxooctanoyl-CoA | Lipid | Others | Others | Others |
| 5058 | 6Z,9Z-Docosadiene | Lipid | Others | Others | Others |
| 5059 | 6-fluorovitamin D3 / 6-fluorocholecalciferol | Lipid | Others | Others | Others |
| 5060 | 6beta-Hydroxyasiatic acid | Lipid | Others | Others | Others |
| 5061 | 5-oxo-7-octenoic acid | Lipid | Others | Others | Others |
| 5062 | 5beta-scymnol sulfate | Lipid | Others | Others | Others |
| 5063 | 5alpha-Tetrahydrocorticosterone | Lipid | Others | Others | Others |
| 5064 | 4E,14Z-Sphingadiene | Lipid | Others | Others | Others |
| 5065 | 4,7-dioxo-octanoic acid | Lipid | Others | Others | Others |
| 5066 | 4,4′-Diaponeurosporene | Lipid | Others | Others | Others |
| 5067 | 4,2′,3′,4′,6′-Pentahydroxy-5′-neryldihydrochalcone | Lipid | Others | Others | Others |
| 5068 | 3-oxoglycyrrhetinic acid | Lipid | Others | Others | Others |
| 5069 | 3-O-Methylanhydrotuberosin | Lipid | Others | Others | Others |
| 5070 | 3-O-(2-O-(2E-decenoyl)-alpha-L-rhamnopyranosyl)-3-hydroxydecanoic acid | Lipid | Others | Others | Others |
| 5071 | 3-Deoxyvitamin D3 | Lipid | Others | Others | Others |
| 5072 | 38:5(23Z,26Z,29Z,32Z,35Z) | Lipid | Others | Others | Others |
| 5073 | 32,35-anhydrobacteriohopan-11-ene-tetrol | Lipid | Others | Others | Others |
| 5074 | 3,5-Di-O-methyl-8-prenylafzelechin-4beta-ol | Lipid | Others | Others | Others |
| 5075 | 3,5,7,9,11-dodecapentaenoic acid | Lipid | Others | Others | Others |
| 5076 | 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione | Lipid | Others | Others | Others |
| 5077 | 3,4,17-trihydroxy-9,10-seco-androsta-1,3,5(10)-triene-9-one | Lipid | Others | Others | Others |
| 5078 | 3,17-dioxoandrost-4-en-19-al | Lipid | Others | Others | Others |
| 5079 | 2S-aminoheptanoic acid | Lipid | Others | Others | Others |
| 5080 | 2-Methyldocosane | Lipid | Others | Others | Others |
| 5081 | 2-Methylacetophenone | Lipid | Others | Others | Others |
| 5082 | 2-demethylmenaquinone-8 | Lipid | Others | Others | Others |
| 5083 | 2-Amino-3-methylbutanoic acid | Lipid | Others | Others | Others |
| 5084 | 26,26,26-trifluoro-25-hydroxy-27-norvitamin D3 / 26,26,26-trifluoro-25-hydroxy-27-norcholecalciferol | Lipid | Others | Others | Others |
| 5085 | 24,24-difluoro-1alpha,25-dihydroxy-24a-homovitamin D3 / 24,24-difluoro-1alpha,25-dihydroxy-24a-homocholecalciferol | Lipid | Others | Others | Others |
| 5086 | 22:6 Cholesteryl ester | Lipid | Others | Others | Others |
| 5087 | 20-COOH-leukotriene E4 | Lipid | Others | Others | Others |
| 5088 | 20:1 Campesteryl ester | Lipid | Others | Others | Others |
| 5089 | 1-tetradecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | Others | Others | Others |
| 5090 | 1-Hexadecylglycerol | Lipid | Others | Others | Others |
| 5091 | 1-hexadecanyl-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | Others | Others | Others |
| 5092 | 1alpha,25-dihydroxy-2beta-(6-hydroxyhexyl)vitamin D3 / 1alpha,25-dihydroxy-2beta-(6-hydroxyhexyl)cholecalciferol | Lipid | Others | Others | Others |
| 5093 | 1alpha,25-dihydroxy-2beta-(3-hydroxypropyl)vitamin D3 / 1alpha,25-dihydroxy-2beta-(3-hydroxypropyl)cholecalciferol | Lipid | Others | Others | Others |
| 5094 | 1alpha,22-dihydroxy-23,24,25,26,27-pentanorvitamin D3 / 1alpha,22-dihydroxy-23,24,25,26,27-pentanorcholecalciferol | Lipid | Others | Others | Others |
| 5095 | 18-Oxocortisol | Lipid | Others | Others | Others |
| 5096 | 18:3-Glc-Stigmasterol | Lipid | Others | Others | Others |
| 5097 | 18:0-Glc-Campesterol | Lipid | Others | Others | Others |
| 5098 | 17,18-dehydro-clavulone I | Lipid | Others | Others | Others |
| 5099 | 16:0-Glc-Campesterol | Lipid | Others | Others | Others |
| 5100 | 16,17-epoxy-DHA | Lipid | Others | Others | Others |
| 5101 | 15-methyl-15R-PGF2alpha | Lipid | Others | Others | Others |
| 5102 | 12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid | Lipid | Others | Others | Others |
| 5103 | 12-hydroxyjasmonic acid 12-O-beta-D-glucoside | Lipid | Others | Others | Others |
| 5104 | 11,12-dihydroxy arachidic acid | Lipid | Others | Others | Others |
| 5105 | 10-[5]-ladderane-decanoic acid | Lipid | Others | Others | Others |
| 5106 | 1,2-Dihydro-5-hydroxy-2-(1-hydroxy-1-methylethyl)-4-(isobutyryl)-6-phenylfurano[2,3-h][1]benzopyran-8-one | Lipid | Others | Others | Others |
| 5107 | 1-(8-[5]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | Others | Others | Others |
| 5108 | 1-(8-[5]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | Others | Others | Others |
| 5109 | 1-(8-[3]-ladderane-octanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | Others | Others | Others |
| 5110 | 1-(8-[3]-ladderane-octanoyl-2-(8-[3]-ladderane-octanyl)-sn-glycerol | Lipid | Others | Others | Others |
| 5111 | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | Others | Others | Others |
| 5112 | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | Others | Others | Others |
| 5113 | 1-(2E,6E-phytadienyl)-2-(2E,6E-phytadienyl)-sn-glycero-3-phosphocholine | Lipid | Others | Others | Others |
| 5114 | (E,E)-2,4-Decadienoic isobutylamide | Lipid | Others | Others | Others |
| 5115 | (7Z,10Z,13Z,16Z,19Z)-docosapentaenoylcarnitine | Lipid | Others | Others | Others |
| 5116 | (6S)-vitamin D2 6,19-sulfur dioxide adduct / (6S)-ergocalciferol 6,19-sulfur dioxide adduct | Lipid | Others | Others | Others |
| 5117 | (6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3 / (6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrocholecalciferol | Lipid | Others | Others | Others |
| 5118 | (5E,10Z)-19-fluoro-1alpha-hydroxyvitamin-D3 / (5E,10Z)-19-fluoro-1alpha-hydroxycholecalciferol | Lipid | Others | Others | Others |
| 5119 | (5E,10E)-19-fluoro-1alpha,25-dihydroxyvitamin D3 / (5E,10E)-19-fluoro-1alpha,25-dihydroxycholecalciferol | Lipid | Others | Others | Others |
| 5120 | (3′-sulfo)Galbeta-Cer(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
| 5121 | (3′-sulfo)Galbeta-Cer(d18:1/24:1(15Z)(2OH)) | Lipid | Others | Others | Others |
| 5122 | (3′-sulfo)Galbeta-Cer(d18:1/24:0) | Lipid | Others | Others | Others |
| 5123 | (3′-sulfo)Galbeta-Cer(d18:1/24:0(2OH)) | Lipid | Others | Others | Others |
| 5124 | (3′-sulfo)Galbeta-Cer(d18:1/22:0) | Lipid | Others | Others | Others |
| 5125 | (3′-sulfo)Galbeta-Cer(d18:1/22:0(2OH)) | Lipid | Others | Others | Others |
| 5126 | (3′-sulfo)Galbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
| 5127 | (3′-sulfo)Galbeta-Cer(d18:1/20:0(2OH)) | Lipid | Others | Others | Others |
| 5128 | (3′-sulfo)Galbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
| 5129 | (3′-sulfo)Galbeta-Cer(d18:1/18:0(2OH)) | Lipid | Others | Others | Others |
| 5130 | (3′-sulfo)Galbeta-Cer(d18:1/16:0) | Lipid | Others | Others | Others |
| 5131 | (24R)-1alpha,24-dihydroxy-22-oxa-20-epivitamin D3 / (24R)-1alpha,24-dihydroxy-22-oxa-20-epicholecalciferol | Lipid | Others | Others | Others |
| 5132 | (23R,25S)-1alpha,25-dihydroxyvitamin D3 26,23-lactone / (23R,25S)-1alpha,25-dihydroxycholecalciferol 26,23-lactone | Lipid | Others | Others | Others |
| 5133 | (-)N-(2R-hydroxy-propyl) alpha,alpha-dimethylarachidonoyl amine | Lipid | Others | Others | Others |
| 5134 | (-)-Fusidic acid | Lipid | Others | Others | Others |
| 5135 | (-)-Asbestinine 2 | Lipid | Others | Others | Others |
| 5136 | Butyl 4′-O-butanoyl-6-O-hexadecanoyl-neohesperidoside | Lipid | Others | Others | Others |
| 5137 | C17 Sphinganine | Lipid | Others | Others | Others |
| 5138 | Cauliflorin A | Lipid | Others | Others | Others |
| 5139 | Cer(d14:1(4E)/26:0(2OH)) | Lipid | Others | Others | Others |
| 5140 | Cer(d14:2(4E,6E)/22:0) | Lipid | Others | Others | Others |
| 5141 | Cer(d16:1(4E)/22:0(2OH)) | Lipid | Others | Others | Others |
| 5142 | Cer(d18:0/18:1(9Z)) | Lipid | Others | Others | Others |
| 5143 | Cer(d18:1/20:0) | Lipid | Others | Others | Others |
| 5144 | Cer(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
| 5145 | Cer(d18:2/22:0) | Lipid | Others | Others | Others |
| 5146 | Cer(m18:0/22:0) | Lipid | Others | Others | Others |
| 5147 | CerP(d18:1/16:0) | Lipid | Others | Others | Others |
| 5148 | CerP(d18:1/18:0) | Lipid | Others | Others | Others |
| 5149 | CerP(d18:1/22:0) | Lipid | Others | Others | Others |
| 5150 | CerP(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
| 5151 | CerP(d18:1/8:0) | Lipid | Others | Others | Others |
| 5152 | Cholestanyl glucoside | Lipid | Others | Others | Others |
| 5153 | cholesterol sulfate | Lipid | Others | Others | Others |
| 5154 | CL(1′-[18:1(9Z)/18:2(9Z,12Z)],3′-[20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)]) | Lipid | Others | Others | Others |
| 5155 | CL(1′-[18:2(9Z,12Z)/0:0],3′-[18:2(9Z,12Z)/0:0]) | Lipid | Others | Others | Others |
| 5156 | CL(1′-[20:0/18:0],3′-[20:0/18:0]) | Lipid | Others | Others | Others |
| 5157 | CL(1′-[20:0/18:1(9Z)],3′-[18:2(9Z,12Z)/20:0]) | Lipid | Others | Others | Others |
| 5158 | CL(1′-[20:0/18:1(9Z)],3′-[20:0/20:0]) | Lipid | Others | Others | Others |
| 5159 | CL(1′-[20:0/18:1(9Z)],3′-[20:4(5Z,8Z,11Z,14Z)/20:0]) | Lipid | Others | Others | Others |
| 5160 | CL(1′-[20:0/20:0],3′-[18:2(9Z,12Z)/20:0]) | Lipid | Others | Others | Others |
| 5161 | CL(1′-[20:4(5Z,8Z,11Z,14Z)/20:0],3′-[20:0/18:2(9Z,12Z)]) | Lipid | Others | Others | Others |
| 5162 | CL(1′-[20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)],3′-[20:4(5Z,8Z,11Z,14Z)/18:1(9Z)]) | Lipid | Others | Others | Others |
| 5163 | CL(1′-[22:1(13Z)/22:1(13Z)],3′-[22:1(13Z)/14:1(9Z)])[rac] | Lipid | Others | Others | Others |
| 5164 | CoA(24:6(6Z,9Z,12Z,15Z,18Z,21Z)(3OH)) | Lipid | Others | Others | Others |
| 5165 | CPA(16:0) | Lipid | Others | Others | Others |
| 5166 | CPA(18:0) | Lipid | Others | Others | Others |
| 5167 | CPA(18:1(9Z)) | Lipid | Others | Others | Others |
| 5168 | Cucurbitacin I | Lipid | Others | Others | Others |
| 5169 | Delphinidin 3-(2 »-galloylgalactoside) | Lipid | Others | Others | Others |
| 5170 | DG(14:0/18:0/0:0)[iso2] | Lipid | Others | Others | Others |
| 5171 | DG(14:0/20:1(11Z)/0:0)[iso2] | Lipid | Others | Others | Others |
| 5172 | DG(16:0/18:2(9Z,12Z)/0:0)[iso2] | Lipid | Others | Others | Others |
| 5173 | DG(17:1(9Z)/19:0/0:0)[iso2] | Lipid | Others | Others | Others |
| 5174 | DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)[iso2] | Lipid | Others | Others | Others |
| 5175 | DG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)[iso2] | Lipid | Others | Others | Others |
| 5176 | DG(19:0/22:0/0:0)[iso2] | Lipid | Others | Others | Others |
| 5177 | DG(19:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)[iso2] | Lipid | Others | Others | Others |
| 5178 | DG(P-14:0/18:1(9Z)) | Lipid | Others | Others | Others |
| 5179 | DGTS(16:0/16:0) | Lipid | Others | Others | Others |
| 5180 | Dinorlithocholic acid | Lipid | Others | Others | Others |
| 5181 | Dioctyl hexanedioate | Lipid | Others | Others | Others |
| 5182 | Diospolysaponin A | Lipid | Others | Others | Others |
| 5183 | DL-Acetylcarnitine | Lipid | Others | Others | Others |
| 5184 | Docosanamide | Lipid | Others | Others | Others |
| 5185 | Ecalcidene | Lipid | Others | Others | Others |
| 5186 | Elaidic carnitine | Lipid | Others | Others | Others |
| 5187 | Eriotriochin | Lipid | Others | Others | Others |
| 5188 | Erybraedin E | Lipid | Others | Others | Others |
| 5189 | Estradiol dipropionate | Lipid | Others | Others | Others |
| 5190 | Etioline | Lipid | Others | Others | Others |
| 5191 | Exiguaflavanone J | Lipid | Others | Others | Others |
| 5192 | Falcarindiol | Lipid | Others | Others | Others |
| 5193 | Fluoxymesterone | Lipid | Others | Others | Others |
| 5194 | Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Lipid | Others | Others | Others |
| 5195 | fumagillin | Lipid | Others | Others | Others |
| 5196 | Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
| 5197 | Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
| 5198 | Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Lipid | Others | Others | Others |
| 5199 | Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
| 5200 | GalCer(d18:1/18:0) | Lipid | Others | Others | Others |
| 5201 | GalCer(d18:1/24:0) | Lipid | Others | Others | Others |
| 5202 | GalCer(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
| 5203 | GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
| 5204 | GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
| 5205 | Gangetin | Lipid | Others | Others | Others |
| 5206 | Gibberellin A51 | Lipid | Others | Others | Others |
| 5207 | Ginkgolide A | Lipid | Others | Others | Others |
| 5208 | GlcCer(d14:1(4E)/24:1(15Z)(2OH)) | Lipid | Others | Others | Others |
| 5209 | GlcCer(d14:1/24:0) | Lipid | Others | Others | Others |
| 5210 | GlcCer(d15:1/20:0) | Lipid | Others | Others | Others |
| 5211 | GlcCer(d16:1(4E)/22:0(2OH)) | Lipid | Others | Others | Others |
| 5212 | GlcCer(d16:1/24:0) | Lipid | Others | Others | Others |
| 5213 | GlcCer(d16:2(4E,6E)/24:0(2OH)) | Lipid | Others | Others | Others |
| 5214 | GlcCer(d16:2(4E,6E)/24:0) | Lipid | Others | Others | Others |
| 5215 | GlcCer(d18:1/23:0) | Lipid | Others | Others | Others |
| 5216 | GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
| 5217 | Grandiflorone | Lipid | Others | Others | Others |
| 5218 | Hexacosanedioic acid | Lipid | Others | Others | Others |
| 5219 | Homomurideoxycholic acid | Lipid | Others | Others | Others |
| 5220 | Homo-omega-muricholic acid | Lipid | Others | Others | Others |
| 5221 | Hydrocortisone caproate | Lipid | Others | Others | Others |
| 5222 | Isorhamnetin 3-(6 »-malonylglucoside) | Lipid | Others | Others | Others |
| 5223 | Kaempferol 3-rhamnosyl-(1->2)-[glucosyl-(1->3)-(4 »’-p-coumaroylrhamnosyl)-(1->6)-galactoside] | Lipid | Others | Others | Others |
| 5224 | Kushenol D | Lipid | Others | Others | Others |
| 5225 | LacCer(d18:0/18:0) | Lipid | Others | Others | Others |
| 5226 | LacCer(d18:0/20:0) | Lipid | Others | Others | Others |
| 5227 | LacCer(d18:0/22:0) | Lipid | Others | Others | Others |
| 5228 | LacCer(d18:1/12:0) | Lipid | Others | Others | Others |
| 5229 | LacCer(d18:1/14:0) | Lipid | Others | Others | Others |
| 5230 | Lespedezaflavanone F | Lipid | Others | Others | Others |
| 5231 | Leucadenone B | Lipid | Others | Others | Others |
| 5232 | LysoPC(20:4(8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
| 5233 | LysoPE(0:0/16:0) | Lipid | Others | Others | Others |
| 5234 | LysoPE(0:0/18:0) | Lipid | Others | Others | Others |
| 5235 | LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5236 | Manbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
| 5237 | Manniflavanone | Lipid | Others | Others | Others |
| 5238 | Megalomicin B | Lipid | Others | Others | Others |
| 5239 | methyl 4-[2-(2-formyl-vinyl)-3-hydroxy-5-oxo-cyclopentyl]-butanoate | Lipid | Others | Others | Others |
| 5240 | methyl 5-hydroperoxy-6,8,9,11-bisepidioxy-12,14-eicosadienoate | Lipid | Others | Others | Others |
| 5241 | MG(16:0/0:0/0:0) | Lipid | Others | Others | Others |
| 5242 | MG(18:0/0:0/0:0)[rac] | Lipid | Others | Others | Others |
| 5243 | MGDG(18:2(9Z,12Z)/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5244 | Myrigalon B | Lipid | Others | Others | Others |
| 5245 | N,N-dimethyl-Safingol | Lipid | Others | Others | Others |
| 5246 | N-amyl arachidohoyl amine | Lipid | Others | Others | Others |
| 5247 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) | Lipid | Others | Others | Others |
| 5248 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
| 5249 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | Others | Others | Others |
| 5250 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Lipid | Others | Others | Others |
| 5251 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) | Lipid | Others | Others | Others |
| 5252 | NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
| 5253 | NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | Others | Others | Others |
| 5254 | Nonadecyl palmitoleate | Lipid | Others | Others | Others |
| 5255 | Norlithocholic acid | Lipid | Others | Others | Others |
| 5256 | OH-Chlorobactene glucoside laurate | Lipid | Others | Others | Others |
| 5257 | Oleyl alcohol | Lipid | Others | Others | Others |
| 5258 | PA(12:0/21:0) | Lipid | Others | Others | Others |
| 5259 | PA(13:0/0:0) | Lipid | Others | Others | Others |
| 5260 | PA(13:0/16:1(9Z)) | Lipid | Others | Others | Others |
| 5261 | PA(14:0/18:0) | Lipid | Others | Others | Others |
| 5262 | PA(17:1(9Z)/0:0) | Lipid | Others | Others | Others |
| 5263 | PA(17:1(9Z)/13:0) | Lipid | Others | Others | Others |
| 5264 | PA(18:0/0:0) | Lipid | Others | Others | Others |
| 5265 | PA(18:1(9Z)/0:0) | Lipid | Others | Others | Others |
| 5266 | PA(18:3(6Z,9Z,12Z)/14:1(9Z)) | Lipid | Others | Others | Others |
| 5267 | PA(18:3(9Z,12Z,15Z)/0:0) | Lipid | Others | Others | Others |
| 5268 | PA(18:4(6Z,9Z,12Z,15Z)/0:0) | Lipid | Others | Others | Others |
| 5269 | PA(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5270 | PA(20:2(11Z,14Z)/20:0) | Lipid | Others | Others | Others |
| 5271 | PA(20:3(8Z,11Z,14Z)/18:0) | Lipid | Others | Others | Others |
| 5272 | PA(20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z)) | Lipid | Others | Others | Others |
| 5273 | PA(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z)) | Lipid | Others | Others | Others |
| 5274 | PA(21:0/13:0) | Lipid | Others | Others | Others |
| 5275 | PA(22:1(11Z)/16:0) | Lipid | Others | Others | Others |
| 5276 | PA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0) | Lipid | Others | Others | Others |
| 5277 | PA(O-16:0/20:3(8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5278 | PA(O-16:0/22:2(13Z,16Z)) | Lipid | Others | Others | Others |
| 5279 | PA(O-18:0/21:0) | Lipid | Others | Others | Others |
| 5280 | PA(O-20:0/21:0) | Lipid | Others | Others | Others |
| 5281 | PA(P-16:0/0:0) | Lipid | Others | Others | Others |
| 5282 | PA(P-16:0/20:1(11Z)) | Lipid | Others | Others | Others |
| 5283 | PA(P-18:0/16:0) | Lipid | Others | Others | Others |
| 5284 | PA(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5285 | PA(P-20:0/12:0) | Lipid | Others | Others | Others |
| 5286 | PA(P-20:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5287 | PA(P-20:0/18:4(6Z,9Z,12Z,15Z)) | Lipid | Others | Others | Others |
| 5288 | Palmitoylcarnitine | Lipid | Others | Others | Others |
| 5289 | Panaxynol | Lipid | Others | Others | Others |
| 5290 | Pantothenol | Lipid | Others | Others | Others |
| 5291 | PC(0:0/18:0) | Lipid | Others | Others | Others |
| 5292 | PC(0:0/18:1(6Z)) | Lipid | Others | Others | Others |
| 5293 | PC(15:1(9Z)/0:0) | Lipid | Others | Others | Others |
| 5294 | PC(16:0/9:0(CHO)) | Lipid | Others | Others | Others |
| 5295 | PC(16:0/9:0(COOH)) | Lipid | Others | Others | Others |
| 5296 | PC(16:1(9Z)/2:0) | Lipid | Others | Others | Others |
| 5297 | PC(20:1(11Z)/0:0) | Lipid | Others | Others | Others |
| 5298 | PC(20:3(8Z,11Z,14Z)/21:0) | Lipid | Others | Others | Others |
| 5299 | PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
| 5300 | PC(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
| 5301 | PC(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)) | Lipid | Others | Others | Others |
| 5302 | PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) | Lipid | Others | Others | Others |
| 5303 | PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5304 | PC(6:2(3E,5E)/14:2(11E,13E)) | Lipid | Others | Others | Others |
| 5305 | PC(O-11:1(10E)/2:0) | Lipid | Others | Others | Others |
| 5306 | PC(O-15:0/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5307 | PC(O-16:0/18:1(9Z)) | Lipid | Others | Others | Others |
| 5308 | PC(O-16:0/O-1:0) | Lipid | Others | Others | Others |
| 5309 | PC(O-17:0/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5310 | PC(O-18:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5311 | PC(O-20:0/17:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5312 | PC(O-20:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5313 | PC(O-8:0/O-8:0) | Lipid | Others | Others | Others |
| 5314 | PC(P-18:0/17:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5315 | PC(P-18:0/19:0) | Lipid | Others | Others | Others |
| 5316 | PC(P-18:0/20:0) | Lipid | Others | Others | Others |
| 5317 | PC(P-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
| 5318 | PC(P-20:0/20:1(11Z)) | Lipid | Others | Others | Others |
| 5319 | PE(17:1(9Z)/0:0) | Lipid | Others | Others | Others |
| 5320 | PE(18:0/20:4(5Z,8Z,10E,14Z)(12OH[S])) | Lipid | Others | Others | Others |
| 5321 | PE(18:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)(14OH)) | Lipid | Others | Others | Others |
| 5322 | PE(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5323 | PE(20:4(5Z,8Z,11Z,14Z)/0:0) | Lipid | Others | Others | Others |
| 5324 | PE(22:2(13Z,16Z)/22:2(13Z,16Z)) | Lipid | Others | Others | Others |
| 5325 | PE(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5326 | PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(11Z)) | Lipid | Others | Others | Others |
| 5327 | PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
| 5328 | PE(O-16:0/20:1(11Z)) | Lipid | Others | Others | Others |
| 5329 | PE(O-16:0/22:5(7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5330 | PE(O-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5331 | PE(O-18:0/18:0) | Lipid | Others | Others | Others |
| 5332 | PE(O-18:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5333 | PE(O-18:0/18:3(6Z,9Z,12Z)) | Lipid | Others | Others | Others |
| 5334 | PE(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5335 | PE(O-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
| 5336 | PE(O-20:0/20:3(8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5337 | PE(O-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5338 | PE(P-16:0/0:0) | Lipid | Others | Others | Others |
| 5339 | PE(P-16:0/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5340 | PE(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
| 5341 | PE(P-16:0/22:1(11Z)) | Lipid | Others | Others | Others |
| 5342 | PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5343 | PE(P-18:0/0:0) | Lipid | Others | Others | Others |
| 5344 | PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5345 | PE(P-19:1(12Z)/0:0) | Lipid | Others | Others | Others |
| 5346 | PE(P-20:0/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5347 | PE(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5348 | PE-Cer(d14:1(4E)/24:0) | Lipid | Others | Others | Others |
| 5349 | PE-Cer(d14:1(4E)/24:1(15Z)) | Lipid | Others | Others | Others |
| 5350 | PE-Cer(d14:2(4E,6E)/16:0) | Lipid | Others | Others | Others |
| 5351 | PE-Cer(d15:1(4E)/22:0(2OH)) | Lipid | Others | Others | Others |
| 5352 | PE-Cer(d15:1(4E)/24:0) | Lipid | Others | Others | Others |
| 5353 | PE-Cer(d16:1(4E)/20:0) | Lipid | Others | Others | Others |
| 5354 | PE-Cer(d16:1(4E)/24:0(2OH)) | Lipid | Others | Others | Others |
| 5355 | PE-Cer(d16:1(4E)/24:1(15Z)) | Lipid | Others | Others | Others |
| 5356 | PE-Cer(d16:2(4E,6E)/22:0(2OH)) | Lipid | Others | Others | Others |
| 5357 | PG(13:0/0:0) | Lipid | Others | Others | Others |
| 5358 | PG(13:0/21:0) | Lipid | Others | Others | Others |
| 5359 | PG(18:0/18:0) | Lipid | Others | Others | Others |
| 5360 | PG(18:2(9Z,12Z)/22:0) | Lipid | Others | Others | Others |
| 5361 | PG(19:0/21:0) | Lipid | Others | Others | Others |
| 5362 | PG(20:1(11Z)/18:0) | Lipid | Others | Others | Others |
| 5363 | PG(20:2(11Z,14Z)/22:0) | Lipid | Others | Others | Others |
| 5364 | PG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) | Lipid | Others | Others | Others |
| 5365 | PG(22:1(11Z)/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5366 | PG(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
| 5367 | PG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5368 | PG(22:2(13Z,16Z)/21:0) | Lipid | Others | Others | Others |
| 5369 | PG(22:2(13Z,16Z)/22:0) | Lipid | Others | Others | Others |
| 5370 | PG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5371 | PG(O-18:0/18:3(9Z,12Z,15Z)) | Lipid | Others | Others | Others |
| 5372 | PG(O-18:0/22:1(11Z)) | Lipid | Others | Others | Others |
| 5373 | PG(O-20:0/20:0) | Lipid | Others | Others | Others |
| 5374 | PG(P-16:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5375 | PG(P-18:0/14:0) | Lipid | Others | Others | Others |
| 5376 | PG(P-18:0/18:0) | Lipid | Others | Others | Others |
| 5377 | PG(P-18:0/18:1(9Z)) | Lipid | Others | Others | Others |
| 5378 | PGB3 | Lipid | Others | Others | Others |
| 5379 | phenolic phthiocerol | Lipid | Others | Others | Others |
| 5380 | PI(12:0/12:0) | Lipid | Others | Others | Others |
| 5381 | PI(16:0/18:0) | Lipid | Others | Others | Others |
| 5382 | PI(16:0/22:0) | Lipid | Others | Others | Others |
| 5383 | PI(18:0/0:0) | Lipid | Others | Others | Others |
| 5384 | PI(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5385 | PI(19:0/18:0) | Lipid | Others | Others | Others |
| 5386 | PI(20:3(8Z,11Z,14Z)/18:0) | Lipid | Others | Others | Others |
| 5387 | PI(20:4(5Z,8Z,11Z,14Z)/0:0) | Lipid | Others | Others | Others |
| 5388 | PI(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z)) | Lipid | Others | Others | Others |
| 5389 | PI(21:0/20:0) | Lipid | Others | Others | Others |
| 5390 | PI(22:0/17:0) | Lipid | Others | Others | Others |
| 5391 | PI(22:1(11Z)/17:0) | Lipid | Others | Others | Others |
| 5392 | PI(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)) | Lipid | Others | Others | Others |
| 5393 | PI(O-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
| 5394 | PI(P-16:0/0:0) | Lipid | Others | Others | Others |
| 5395 | PI(P-20:0/12:0) | Lipid | Others | Others | Others |
| 5396 | PI(P-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
| 5397 | PI-Cer(d18:0/16:0(2OH)) | Lipid | Others | Others | Others |
| 5398 | PI-Cer(d18:0/16:0) | Lipid | Others | Others | Others |
| 5399 | PI-Cer(d18:0/18:0(2OH)) | Lipid | Others | Others | Others |
| 5400 | PI-Cer(d18:0/22:0) | Lipid | Others | Others | Others |
| 5401 | PI-Cer(d18:1/22:0) | Lipid | Others | Others | Others |
| 5402 | PI-Cer(d20:0/16:0) | Lipid | Others | Others | Others |
| 5403 | PI-Cer(d20:0/18:0) | Lipid | Others | Others | Others |
| 5404 | PI-Cer(d20:0/26:0) | Lipid | Others | Others | Others |
| 5405 | PIM1(16:0/16:1(9Z)) | Lipid | Others | Others | Others |
| 5406 | PIM1(19:0/18:1(9Z)) | Lipid | Others | Others | Others |
| 5407 | PnE(16:0/18:1(9Z)) | Lipid | Others | Others | Others |
| 5408 | PPA(18:1(9Z)/18:1(9Z)) | Lipid | Others | Others | Others |
| 5409 | PS(15:0/20:0) | Lipid | Others | Others | Others |
| 5410 | PS(16:0/17:0) | Lipid | Others | Others | Others |
| 5411 | PS(18:0/18:0) | Lipid | Others | Others | Others |
| 5412 | PS(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
| 5413 | PS(20:0/18:1(9Z)) | Lipid | Others | Others | Others |
| 5414 | PS(20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
| 5415 | PS(20:3(8Z,11Z,14Z)/0:0) | Lipid | Others | Others | Others |
| 5416 | PS(20:5(5Z,8Z,11Z,14Z,17Z)/17:0) | Lipid | Others | Others | Others |
| 5417 | PS(22:0/18:0) | Lipid | Others | Others | Others |
| 5418 | PS(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
| 5419 | PS(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5420 | PS(22:4(7Z,10Z,13Z,16Z)/17:1(9Z)) | Lipid | Others | Others | Others |
| 5421 | PS(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) | Lipid | Others | Others | Others |
| 5422 | PS(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
| 5423 | PS(22:4(7Z,10Z,13Z,16Z)/21:0) | Lipid | Others | Others | Others |
| 5424 | PS(22:4(7Z,10Z,13Z,16Z)/22:0) | Lipid | Others | Others | Others |
| 5425 | PS(22:4(7Z,10Z,13Z,16Z)/22:1(11Z)) | Lipid | Others | Others | Others |
| 5426 | PS(O-16:0/18:2(9Z,12Z)) | Lipid | Others | Others | Others |
| 5427 | PS(O-16:0/20:1(11Z)) | Lipid | Others | Others | Others |
| 5428 | PS(O-16:0/21:0) | Lipid | Others | Others | Others |
| 5429 | PS(O-16:0/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
| 5430 | PS(O-18:0/15:1(9Z)) | Lipid | Others | Others | Others |
| 5431 | PS(O-18:0/22:1(11Z)) | Lipid | Others | Others | Others |
| 5432 | PS(O-18:0/22:4(7Z,10Z,13Z,16Z)) | Lipid | Others | Others | Others |
| 5433 | PS(O-20:0/14:0) | Lipid | Others | Others | Others |
| 5434 | PS(O-20:0/17:1(9Z)) | Lipid | Others | Others | Others |
| 5435 | PS(P-16:0/13:0) | Lipid | Others | Others | Others |
| 5436 | PS(P-16:0/18:0) | Lipid | Others | Others | Others |
| 5437 | PS(P-16:0/19:1(9Z)) | Lipid | Others | Others | Others |
| 5438 | PS(P-16:0/20:2(11Z,14Z)) | Lipid | Others | Others | Others |
| 5439 | PS(P-16:0/22:0) | Lipid | Others | Others | Others |
| 5440 | PS(P-18:0/20:1(11Z)) | Lipid | Others | Others | Others |
| 5441 | PS(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5442 | PS(P-20:0/18:4(6Z,9Z,12Z,15Z)) | Lipid | Others | Others | Others |
| 5443 | PS(P-20:0/19:0) | Lipid | Others | Others | Others |
| 5444 | PS(P-20:0/19:1(9Z)) | Lipid | Others | Others | Others |
| 5445 | PS(P-20:0/20:5(5Z,8Z,11Z,14Z,17Z)) | Lipid | Others | Others | Others |
| 5446 | PS(P-20:0/22:1(11Z)) | Lipid | Others | Others | Others |
| 5447 | PS(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | Lipid | Others | Others | Others |
| 5448 | psychosine sulfate | Lipid | Others | Others | Others |
| 5449 | Ptilosteroid C | Lipid | Others | Others | Others |
| 5450 | Quercetagetin 7-(6 »-acetylglucoside) | Lipid | Others | Others | Others |
| 5451 | Quercetin 5,7,3′,4′-tetramethyl ether 3-galactoside | Lipid | Others | Others | Others |
| 5452 | Quercetin 7-methyl ether 3,3′,4′-trisulfate | Lipid | Others | Others | Others |
| 5453 | Quinestrol | Lipid | Others | Others | Others |
| 5454 | Scillirosidin | Lipid | Others | Others | Others |
| 5455 | SM(d16:1/22:0) | Lipid | Others | Others | Others |
| 5456 | SM(d16:1/22:1) | Lipid | Others | Others | Others |
| 5457 | SM(d16:1/23:0) | Lipid | Others | Others | Others |
| 5458 | SM(d18:0/16:0) | Lipid | Others | Others | Others |
| 5459 | SM(d18:0/18:2) | Lipid | Others | Others | Others |
| 5460 | SM(d18:1/16:0) | Lipid | Others | Others | Others |
| 5461 | SM(d18:1/22:0) | Lipid | Others | Others | Others |
| 5462 | SM(d18:1/22:1) | Lipid | Others | Others | Others |
| 5463 | SM(d18:1/23:0) | Lipid | Others | Others | Others |
| 5464 | SM(d18:1/24:0) | Lipid | Others | Others | Others |
| 5465 | SM(d18:1/24:1(15Z)) | Lipid | Others | Others | Others |
| 5466 | SM(d18:2/15:0) | Lipid | Others | Others | Others |
| 5467 | SM(d18:2/21:0) | Lipid | Others | Others | Others |
| 5468 | SM(d18:2/23:0) | Lipid | Others | Others | Others |
| 5469 | SM(d18:2/24:1) | Lipid | Others | Others | Others |
| 5470 | SM(d19:1/18:0) | Lipid | Others | Others | Others |
| 5471 | Tetrahydrodeoxycorticosterone | Lipid | Others | Others | Others |
| 5472 | TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso3] | Lipid | Others | Others | Others |
| 5473 | TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3] | Lipid | Others | Others | Others |
| 5474 | Theasinensin A | Lipid | Others | Others | Others |
| 5475 | trans-Hexadec-2-enoyl carnitine | Lipid | Others | Others | Others |
| 5476 | Tricosanedioic acid | Lipid | Others | Others | Others |
| 5477 | PA(16:1(9Z)/22:1(11Z)) | Lipid | Others | Others | Others |
| 5478 | PA(20:3(8Z,11Z,14Z)/16:1(9Z)) | Lipid | Others | Others | Others |
| 5479 | PE(P-18:0/19:0) | Lipid | Others | Others | Others |
| 5480 | PI(18:0/18:4(6Z,9Z,12Z,15Z)) | Lipid | Others | Others | Others |
| 5481 | PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/19:1(9Z)) | Lipid | Others | Others | Others |
| 5482 | PE(P-20:0/18:0) | Lipid | Others | Others | Others |
| 5483 | 6,8-Diprenylpratensein | Lipid | Others | Others | Others |
| 5484 | PG(22:4(7Z,10Z,13Z,16Z)/14:0) | Lipid | Others | Others | Others |
| 5485 | PC(18:0/19:0) | Lipid | Others | Others | Others |
| 5486 | Dynorphin B | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5487 | Neoendorphin | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5488 | Leu-Enk-Arg-Arg | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5489 | Leu-Enk-Arg | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5490 | Noradrenaline | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5491 | GABA gamma-Aminobutyric acid | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5492 | Dopamine | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5493 | Glutamate | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5494 | Serotonin | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5495 | Aspartate | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5496 | Acetylcholine | Neuropeptides & Neurotransmitter | Others | Others | Others |
| 5497 | Tyrosine | Neuropeptides & Neurotransmitter | Others | Others | Others |
